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1. INTRODUCTION 
 
“The drive for thinness appears to have started in Western cultures and expanded to the 
less developed areas of the world, where rates of eating disorders are rising. Will the 
drive for muscularity for men now prominent in the West be exported in a similar way? 
(…) Currently, few research studies are available, some of which contradict the 
hypothesis that muscularity is valued only in the West and not in the less developed 
parts of the world.” 
(Gray & Ginsberg, 2007) 
 
1.1 Preamble 
Eating and body image disorders have typically been considered as the disorders of 
women, although recent evidence suggests the emergence of these disorders among men 
as well. The results of the studies conducted over the last two decades indicate that more 
men report being dissatisfied with their muscularity than before (Grieve, Wann, 
Henson, & Ford, 2006; Mishkind, Rodin, Silberstein, & Siegel-Moore, 1986; Pope, 
Phillips, & Olivardia, 2000; Vartanian, Giant, & Passino, 2001). While 25% of men 
reported muscle dissatisfaction in 1972, this number increased to 32% and 45% in 1985 
and 1996 respectively (Berscheid, Walster, & Bohrmstedt, 1973; Cash, Winstead, & 
Janda, 1986; Garner, 1997). Several studies have documented muscle dissatisfaction 
and a desire for a more muscular ideal body among men (Fredrick, Fessler & Hazelton, 
2005; Lynch & Zellner, 1999; McCreary & Sasse, 2000; Olivardia, Pope, Borowiecki, 
& Cohane, 2004).  
 
According to a theory, women have reached parity with men in many domains of life in 
the last few decades, and this led to a crisis in masculinity (Pope, Phillips, & Olivardia, 
2000). Therefore, muscularity is one of the few characteristics left for men to emphasize 
their masculinity. In line with this, in cultures where the traditional male roles (e.g., as 
breadwinners, protectors) have not declined over the years, the pursuit of the muscular 
ideal has not been found as prevalent (Yang, Gray, & Pope, 2005; overview: Gray & 
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Ginsberg, 2007). From an evolutionary perspective, the biological and evolutionary 
factors are believed to define the drive for muscularity in males (i.e., muscular 
appearance –broad chest, smaller waist) is more attractive to women (Jackson, 2002; 
overview: Gray & Ginsberg, 2007).  
 
Besides the evolutionary factors, culture also designates the appealing body. As the 
gender difference in relating to body appearance decreases, more and more males 
experience almost the same sociocultural pressure relating to their appearance as the 
females do (Miller & Halberstadt, 2005; Hungarian review: Túry, Lukács, Babusa, & 
Pászthy, 2008). While women experience pressure towards thinness, men often report 
pressure to obtain and maintain muscularity (Pope, et al., 2001). In the past few years, 
the number of magazines on male body appearance has been expanding and men now 
spend considerable amount of money and time on toiletries (Blond, 2008). The 
increasing body dissatisfaction among males is one of the consequences of these 
changing societal demands (Jones, Bain, & King, 2008). Males’ body dissatisfaction is 
often associated with excessive exercise and the use of anabolic-androgenic steroids 
(Smolak & Stein, 2006). 
 
Body dissatisfaction accompanied by body image distortion can lead to the development 
of muscle dysmorphia (MD; Grieve, 2007; Pope, Katz, & Hudson, 1993). MD is 
characterized by a pathological preoccupation with muscle size and muscularity. Men 
with MD have a pathological belief that they are weak and small, while in reality they 
look unusually muscular (Olivardia, 2001). This special male body image disorder often 
causes impairment in social and occupational functioning, distress and adoption of 
unhealthy behaviours, such as bodybuilding dependence, rigid adherence to dietary 
regimens, or anabolic-androgenic steroid abuse/dependence (Hale, Roth, DeLong, & 
Briggs, 2010; Kanayama, Barry, Hudson, & Pope, 2006; Pope & Katz, 1994). 
 
The preoccupation with the appearance of the body may be as intense and prevalent in 
males as in females. The bodybuilding or „muscle-building” is a consequence of this 
intense obsession, and an increasing industry (e.g., fitness rooms, conditioning sports, 
anabolic steroids, nutritional supplements, cosmetic surgery, etc.) supports this 
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preoccupation. This is very similar –although with an opposite tendency– to the body 
image disorders of the female population, resulting in the development of traditional 
eating disorders (anorexia and bulimia nervosa). These disorders are supported by the 
slimness ideal, and the fitness and beauty industry.  
 
The phenomenon of this male body obsession causes a challenge to the psychiatry, 
because most of the cases are underrecognized. According to Pope et al. (2000), “the 
male body dissatisfaction is a silent epidemic”. In conclusion, the new forms of body 
image disorders and modern obsessions/addictions need extended research to 
understand their pathogenesis and ultimately to develop effective therapeutical 
approaches.  
 
The overwhelming majority of eating disorder literature comes from Western countries, 
giving the impression that eating disorders are culture bound problems of these regions. 
In the last two decades an increasing interest in eating disorders can be observed in 
Central and Eastern Europe as well. This is due to the relatively high prevalence and 
incidence rates of anorexia nervosa (AN) and bulimia nervosa (BN) in some countries 
of this region (Túry, Babusa, Dukay-Szabó, & Varga, 2010; Túry, Babusa, & Varga, 
2010).  
 
The vast majority of studies on MD and muscle dissatisfaction among males have also 
been conducted in Western countries –mostly in the United States. Only little is known 
about this muscle appearance related body image disorder in the Central-Eastern 
European region, including Hungary and only few studies examined the body image 
related disorders, such as MD, among men in other countries than the U.S. The present 
study fills a niche, since it aimed to examine MD, related psychological correlates, and 
anabolic-androgenic steroid use in Hungarian male weightlifters. Additionally, 
exploring cultural differences in the manifestation of male body image disorders (i.e., 
prevalence rates, morbidity) may improve our understanding of these disorders as the 
desire for muscularity may vary from culture to culture.  
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1.2 Historical review of muscle dysmorphia 
The scientific literature on body image disturbances in men is limited in comparison to 
the literature concerning women. Since eating disorders occur in approximately 0.5–3% 
of women, and only one tenth of that for men, most studies of eating and body image 
disorders have focused on women. Furthermore, until recently there were no valid and 
reliable measures of body image disturbances for men. Research suggests an increasing 
number of men, who are concerned with their body shapes, especially with their 
muscularity (Cohane & Pope, 2001; Edwards & Launder, 2000; Leit, Gray, & Pope, 
2002; Mayville, Williamson, White, Netemeyer, & Drab, 2002). Recent studies have 
proposed that men may suffer from a “reverse AN” more commonly referred to as 
muscle dysmorphia (MD; Pope et al., 1993; Pope, Gruber, Choi, Olivardia, & Phillips, 
1997; Pope et al., 2000; review: Túry, Babusa, & Dukay-Szabó, 2011). Reverse AN, or 
MD is sometimes addressed as bigorexia nervosa (Pope & Hudson 1996), or machismo 
nervosa (Connan, 1998). 
 
The very first description of MD –a pathological preoccupation with muscularity, also 
called as reverse AN– was published in 1993 (Pope et al.). The study examined 108 
male bodybuilders, of whom 55 were anabolic-androgenic steroid users. According to 
the interviews, nine men (8.3%) had MD, and three of them had history of AN. Five 
men with MD reported symptoms of mania or hypomania as the consequences of 
anabolic-androgenic steroid use. It should be noted that both AN and body dysmorphic 
disorder are often accompanied by mood disturbances, generally by depression. The 
study also revealed that four men have started using anabolic-androgenic steroids due to 
their body image disorders, while another four have developed MD symptoms due to 
their anabolic-androgenic steroid use.  
 
Prior to this study, Pope and Katz (1988) have studied 41 anabolic-androgenic steroid 
user male bodybuilders and football players.  Nine of the sportsmen had a full affective 
syndrome and five subjects developed psychotic symptoms in association with their 
anabolic-androgenic steroid use. These results were replicated in a study with 156 
athletes (88 [56.4%] were anabolic-androgenic steroid user and 68 [43.6%] were non-
user) which focused on the psychiatric and physical complications of anabolic-
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androgenic steroid use (Pope & Katz, 1994). According to the results, 16 men (10%) 
displayed the symptoms of MD and all of them were anabolic-androgenic steroid user. 
Thirty-six men of the anabolic-androgenic steroid users had affective syndrome, five 
had psychotic symptoms, and six had anxiety symptoms in association with their steroid 
use.  
Steiger (1989) emphasized the endocrinological aspects of MD. According to this 
theory, male hormones have a protective factor against the development of AN. On the 
other hand, the abuse of these hormones may lead to the development of reverse AN. 
 
1.3 The history of muscle dysmorphia in Hungary 
The first description of MD in Hungary appeared in 1997 (Túry & Gyenis) in a case-
report of a 21-year-old male patient who met the criteria of reverse AN and social 
phobia. He thought to be small with a body height of 205 cm and a body weight of 130 
kg, therefore usually avoided social contacts. He engaged in bodybuilding on a regular 
basis and used anabolic-androgenic steroids. With the first Hungarian description of this 
new syndrome the authors called the attention to this probably underrecognized 
disorder. 
 
The first epidemiological study in Hungary was performed among 140 male 
bodybuilders (Túry, Kovács, & Gyenis, 2001). According to the results, 13 subjects 
(9.3%) used anabolic-androgenic steroids. Six men (4.3%, all of them were steroid 
users) fulfilled the criteria of MD described by Pope et al. (1997). The authors 
concluded that this new syndrome is a frequent and often underrecognized disorder in 
the bodybuilder population and suggested several sociocultural factors which may play 
an important role in the development of MD. 
 
The next study about MD in Hungary consisted of the collection of three case reports of 
MD sufferers. These case reports illustrated the underlying psychological 
characteristics, namely body image disorder, perfectionism, social isolation, strong 
attachment to the mother, and distorted intimate relationships (Kovács & Túry, 2001). 
According to the authors’ suggestion, this new syndrome could become more 
widespread in the next years. 
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Recently, there is an increased expectation towards men’s body and appearance in 
Hungary as well (Túry & Babusa, 2012). The male body appearance market, the beauty 
and fitness industry have been increasing in Hungary as well –for instance, there are 
more than 200 fitness clubs in the capital city Budapest. There is also a growing trend 
for male cosmetics and grooming products. The value of groomed, muscular and lean 
male body has also risen. These recently experienced phenomena may indicate that the 
male body ideals are similar to those in the Western cultures.  
 
The appearance of MD in Hungary may be the same like that of AN and BN. A few 
decades ago eating disorders were regarded as the consequences of the Western cultural 
ideals (“3 W-s”: white Western women). Nowadays eating disorders are as widespread 
in Central-East European region as in the Western countries (Rathner et al., 1995). 
However, there are some cultural differences in the morbidity of eating disorders 
between East and West Europe. Surprisingly, Rathner et al. (1995) found the highest 
prevalence of bulimic behaviours in Hungary compared to Austria and Germany. 
Unfortunately, representative epidemiological studies on MD are still lacking in 
Central-East Europe. MD and the muscular ideology might be widespread, but still 
understudied phenomena in the Central-Eastern European cultures. 
 
1.4 Definition and symptoms of muscle dysmorphia 
MD is a psychiatric condition, characterized by a pathological preoccupation with the 
overall muscularity and drive to gain weight without gaining fat. This kind of body 
image disorder was long considered as the reverse form of AN since those men with 
MD believe that they are weak and small but in reality they are unusually muscular 
(Pope et al., 1993). Contrary to AN where the body image disorder is in connection with 
the thin ideal, in the case of MD, the body image disorder relates to the athletic 
(“Schwarzenegger”) ideal. The abuse and/or dependence of anabolic androgenic 
steroids, the hiding behaviour, and the excessive exercise are very common among MD 
sufferers. Table 1 describes the similar dimensions and the major differences in the 
symptomatology of AN and MD (Túry & Gyenis, 1997). MD is considered as a special 
male body image disorder since it is mostly associated with the male bodybuilder 
population.  
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Table 1 
Similarities and differences between anorexia nervosa and muscle dysmorphia (cited 
from Túry & Gyenis, 1997) 
Anorexia nervosa Muscle dysmorphia 
 typical disorder of women  typical disorder of men 
 chronic weight loss, emaciation  significant weight gain, hypermuscular 
physique 
 intense fear of gaining weight  intense fear of losing weight 
 body image disorder relating to thin 
ideal (believe that they are obese)  
 body image disorder relating to the athletic 
ideal (believe that they are thin) 
 demonstrative behaviour  hiding behaviour 
 abuse of laxatives and diet pills  abuse of anabolic-androgenic steroids 
 
Thompson, Heinberg, Altabe, & Tantleff-Dunn (1999) conceptualized the symptoms of 
MD through the dimensions of body image disturbances: 
 
a) Perceptual dimension 
Individuals with MD tend to perceive themselves as thin and small while in reality they 
are extremely muscular. Relating to the perceptual distortion, one study showed that 
42% of the men with MD could well recognize the inaccuracy in their perception of 
their own body sizes in contrast to those who could recognize poorly (50%) or could not 
recognize at all (8%) (Olivardia, Pope, & Hudson, 2000). 
 
b) Cognitive dimension 
MD is characterized by a preoccupation and obsession with the idea that one’s body is 
insufficiently big and muscular even though their well-defined physique (Pope et al., 
2000). The body image distortion can lead to obsessive thoughts and intense anxiety 
about their appearance. Olivardia et al. (2000) found that men with MD reported 
thinking about their lack of muscularity for more than 5 hours per day. Since these 
thoughts are very intrusive and time consuming it can be even difficult to concentrate 
on a task for these men (Pope et al., 2000).  
Specific cognitive distortions –like those in body dysmorphic disorder– are very 
common, such as “black and white thinking”, “filtering”, and “mind reading” (Pope et 
al., 2000). Individuals with MD have little control over these thoughts, which can cause 
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the feeling of helplessness. They often try to overcome these feelings and thoughts via 
compulsive behaviours, such as excessive bodybuilding.  
 
c) Behavioural dimension 
The most common behaviour associated with MD is excessive working out. Men with 
MD spend long hours with lifting weights in the gym and often give up important 
social, occupational, or recreational activities because of the compulsive need to 
maintain their workout and diet schedule (Pope et al., 1997). This compulsive workout 
is distinct from enthusiastic sport activities and should not be confused with them. MD 
sufferers have a compulsive need for working out which leads to a rigid workout 
schedule that they even sacrifice important events to adhere to their strict workout 
regimen. Moreover, men with MD have a special diet that they strictly try to follow. 
The dietary schedule focuses on the “perfect” combination of proteins, carbohydrates, 
fats, and vitamins in order to develop and build their bodies (Olivardia, 2001).  
 
Mirror checking is another prominent behavioural aspect of MD. Extreme mirror 
checking derives from the obsessive thought of being or getting too small which leads 
to an intense urge to check. Men with MD reports significantly more mirror checking 
(9.2 ± 7.5) per day than normal comparison bodybuilders did (3.4 ± 3.3 [Olivardia et al., 
2000]). 
 
Social avoidance or hiding behaviour is a common feature of individuals with MD as 
they feel very uncomfortable and anxious about their body and appearance (Pope et al., 
1997). Therefore, they often cancel or avoid social events where their bodies would be 
exposed to others, wear bulky clothes even in hot weather because they feel ashamed of 
their “weak” bodies. This kind of negative body image can lead to impaired social and 
intimate relationships. 
 
Men with MD commonly use anabolic-androgenic steroids to enhance their muscle 
mass. According to a study, 46% of men with MD reported steroid use, while only 7% 
of the comparison weightlifters without MD (Olivardia et al., 2000). Men continue to 
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use these substances despite being aware of or experiencing the adverse physical or 
psychological consequences (Pope et al., 1997). 
 
As the consequence of overtraining and excessive exercise, men with MD are at risk for 
several injuries, for instance, broken bones, damaged joints and ligaments (Pope et al., 
1997). Because of the compulsive need for lifting weights and the intense fear of losing 
weight they often keep on training even when they are seriously injured.   
 
d) Emotional dimension 
The feelings of guilt when skipping a workout or neglecting the special diet are 
pervasive for those with MD who are so insisting on their workout and diet schedule. 
They often feel depressed and anxious about their appearance and may experience 
intense cognitive distortions when they have to skip a workout.  
 
1.5 Diagnostic criteria for muscle dysmorphia 
The Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revised 
(DSM-IV-TR; American Psychiatric Association, 2000) provides standard criteria for 
the classification of mental disorders. MD was conceptualized as a subtype of body 
dysmorphic disorder; therefore, Pope et al. (1997) described the operational diagnostic 
criteria for MD on the basis of the above mentioned psychiatric disorder. The diagnostic 
criteria for MD is not officially listed in the DSM-IV-TR currently; although, the 
proposed diagnostic criteria could allow and facilitate further research and clinical work 
in this field.  
 
The proposed diagnostic criteria for MD (cited from Pope et al., 1997) are as follows 
(all of the listed criteria must be met for a diagnosis of MD): 
 
1. The person has a preoccupation with the idea that his or her body is not sufficiently 
lean and muscular. 
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2. The preoccupation causes clinically significant distress or impairment in social, 
occupational, or other important areas of functioning as demonstrated by at least two of 
the following four criteria: 
a. The individual frequently gives up important social, occupational, or 
recreational activities because of a compulsive need to maintain his or her 
workout and diet schedule. 
b. The individual avoids situations in which his or her body is exposed to others, 
or endures such situations only with marked distress or intense anxiety. 
c. The preoccupation about the inadequacy of body size or musculature causes 
clinically significant distress or impairment in social, occupational, or other 
important areas of functioning. 
d. The individual continues to work out, diet, or use performance-enhancing 
substances despite the knowledge of adverse physical or psychological 
consequences. 
3. The primary focus of the preoccupation and behaviours is on being too small or 
inadequately muscular, and not on being fat, as in AN, or on other aspects of the 
appearance, as in other forms of body dysmorphic disorder. 
 
1.6 Epidemiology of muscle dysmorphia 
The current prevalence rate of MD in the general population is unknown. Since MD is 
considered as a relatively new psychiatric disorder, only limited epidemiological studies 
are available in this field (Babusa & Túry, 2010).  
 
Most of the studies that have been conducted on MD suggest that it occurs more 
frequently in men as they experience more societal pressure to attain and maintain 
muscular physique (Pope et al., 1997; Olivardia, 2001). Bodybuilders or weightlifters 
are considered as the high risk population for the development of MD (Pope et al., 
1993; Wolke & Sapouna, 2008). Participating in sports that requires high muscle mass, 
such as weightlifting or bodybuilding, apparently increases the risk for developing MD 
(Grieve, 2007). However, it should be noted that sport participation with a pressure 
toward huge muscles, lean body mass, and a desire for attaining a certain weight gain 
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does not directly lead to the development of MD, but it may increase the risk for 
developing the disorder.  
 
As for the prevalence rate, during the very first description of MD, 8.3% (n = 9) male 
bodybuilders out of 108 met the criteria for “reverse AN” (Pope et al., 1993).  Pope and 
Katz (1994) examined 156 male bodybuilders and reported that 10% (n = 16) of them 
had MD. Another study investigated MD among 193 male and female body dysmorphic 
disordered patients and found a 9.3% (n = 18) prevalence rate for MD and all MD cases 
were male (Pope et al., 1997). 
 
Nevertheless, a study conducted among college students found that the subclinical 
forms of MD symptomatology also appear in the general population, and that both men 
and women could be affected (Goodale, Watkins, & Cardinal, 2001). Pope et al. (2000) 
estimated that approximately 100,000 people worldwide meet the proposed diagnostic 
criteria of MD in the general population. Olivardia (2001) noted that the prevalence of 
MD is underestimated and suggested that hundreds of thousands of men might have 
subclinical forms of MD or experience some aspects of the disorder. Given that 
approximately 5 million men have a membership in gym in the United States and at 
least 5% of weightlifters have MD, half a million men might suffer from the disorder. 
Moreover, about 1 million men have body dysmorphic disorder in the United States and 
9% of them have MD, meaning that 90,000 body dysmorphic men might have MD. 
These tentative estimations should be treated carefully and they remain only 
speculations as epidemiological studies are still missing.  
 
Studies proposed that the age of onset of MD is in late adolescence or in the early 
adulthood. Olivardia et al. (2000) found that the mean age of onset for MD was 19.4 ± 
3.6 years. Similarly, Cafri, Olivardia, and Thompson (2008) reported the mean age of 
onset 19.17 ± 4.38 years.  
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1.7 Comorbid conditions 
1.7.1 Eating disorders  
One of the behavioural characteristics of MD is the rigid adherence to the dietary 
schedule. Sometimes the excessive diet can lead to the development of a full-blown 
eating disorder, such as BN.  
 
Many studies pointed out that men with MD have a rigid adherence to their diet plan, 
which is typically high in protein and low in fat. In order to gain more muscle mass they 
count calories, calculate the proportion of the nutritional ingredients (i.e., protein, fat, 
carbohydrate) and eat in every few hours even if they are not hungry (Mossley, 2009). 
Any deviation from the special diet plan results in intense anxiety and the feeling of 
guilt (Pope et al., 1997). Neglecting the rules of the specific diet is usually followed by 
the urge for compensation, such as more intense or extra exercise. This feature of MD is 
also common in AN.   
 
In a study by Olivardia et al. (2000) 29% (n = 7) of men with MD reported a history of 
AN, BN, or binge-eating disorder. Moreover, muscle dysmorphic men had almost the 
same scores on the Eating Disorder Inventory (Garner, Olmstead, & Polivy, 1983) like 
that of eating disordered patients, that is they showed perfectionistic traits, maturity 
fears, feelings of ineffectiveness, and drive for thinness. 
 
The first description of MD revealed its association with AN, since two out of the nine 
men with MD reported previous history of AN (Pope et al., 1993). In another study, two 
out of 16 muscle dsymorphic athletes had a history of AN (Pope & Katz, 1994). 
Following this, Pope et al. (1997) found quite the same results during the interview of 
15 MD sufferers, two of whom reported past history of BN, while no one did in the 
comparison non-MD weightlifter group.  
 
A recent study that revealed the associated features of MD found that disordered eating, 
dieting, vomiting, and the use of diet pills as weight control behaviours are associated 
with the symptoms of MD (McFarland & Kaminski, 2009). 
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Mangweth et al. (2001) compared body image and eating behaviours of male 
bodybuilders and eating disordered patients. According to the study, bodybuilders 
showed similar psychopathological body and eating attitudes like that of eating 
disordered males. Although, bodybuilders are rather concerned with gaining muscle 
than losing fat, they also have an increased preoccupation with their body image, food 
and exercise (Mangweth et al., 2001). The severe dieting practices that are prevalent in 
the bodybuilding sport, indicates that bodybuilders are at increased risk for developing 
an eating disorder and abnormal body image modifying behaviours (Anderson, Barlett, 
Morgan, & Brownell, 1995).  
 
A large amount of bodybuilding books and magazines are available and provide specific 
diet plans to achieve more muscular body. They regularly suggest certain nutritional 
plans for bodybuilders (e.g., what to eat, when to eat, and why to eat) for instance the 
consumption of great amount of protein (40-60 grams of protein and 40-80 grams of 
carbohydrates) 5–6 times a day. A very famous diet of bodybuilders is the so called 
anabolic/catabolic diet, which is based on the two phases of the metabolism (anabolic 
and catabolic) that they have to alternate in order to gain muscle and reduce body fat. 
The diet starts with the anabolic phase (weight gain), which requires the increase of 
caloric intake that aims the growth of muscle mass. The use of high calorie food intake 
inevitably results in the growth of body fat as well. The second, catabolic phase (weight 
loss) is aimed to reduce body fat and retain the lean muscle mass by reducing calorie 
intake (Weider & Reynolds, 1983). These kinds of special diets and the alternation 
between weight gain and weight loss strategies often increase the risk for the 
development of AN or BN (Goldfield, Harper, & Blouin, 1998). 
 
1.7.2 Exercise dependence 
The physical benefits of regular exercise are well-known, including reduced risk for 
cardiovascular disease, certain cancers, and diabetes (U.S. Department of Health and 
Human Services, 1996). Regular and moderate level physical activity plays an 
important role not only in the physical but also in the mental well-being, as it increases 
general well-being, creates positive mood, and reduces the level of depression and 
anxiety (Reed & Ones, 2006). 
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Although, regular physical activity is considered to be healthy, some forms of exercise 
may have negative consequences. Growing body of literature reports that exercise can 
lead to a form of dependence or addiction in case of some individuals (Davis & Fox, 
1993; de Coverley Veale, 1987; Hausenblas & Fallon, 2002; Krejci et al, 1992). 
 
1.7.2.1 Definition and criteria of exercise dependence 
Exercise dependence is defined as “a craving for leisure-time physical activity, resulting 
in uncontrollable excessive exercise behaviour that manifests in physiological (e.g. 
tolerance/withdrawal) and/or psychological (e.g. anxiety, depression) symptoms” 
(Hausenblas & Symons Downs, 2002). Others define exercise addiction as an unhealthy 
reliance or compulsive need for the workout, not necessarily to improve performance in 
competition, but to deal with daily stress and provide relief from bad feelings associated 
with not working out (Baratt, 1994). 
 
Most of the studies examined the exercise dependence in runners (Hailey & Bailey, 
1982; Furst & Germone, 1993), bodybuilders (Smith & Hale, 2005), aerobic 
participants (Kirkby & Adams, 1996), and triathletes (Blaydon & Lindner, 2002). 
 
Terry, Szabo, and Griffiths (2004) proposed the criteria for exercise dependence 
(Hungarian review: Demetrovics & Kurimay, 2008): 
 
1. Salience – The exercise becomes the most important activity in the person’s life 
and dominates their thinking, feelings, and behaviour.  
2. Mood modification – The individual experiences mood modification as a 
consequence of excessive exercise which can be considered as a coping strategy 
(i.e., experiencing an arousal enhancing ‘‘high’’ effect, or tranquilizing feeling 
of ‘‘escape’’ or ‘‘numbing’’). 
3. Tolerance – Increasing amounts of the exercise are required to achieve the 
former effects (e.g. euphoria).  
4. Withdrawal symptoms – Unpleasant feelings and/or physical effects occur when 
the exercise is discontinued or suddenly reduced (e.g. sleeping disturbances, 
moodiness, and irritability). 
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5. Conflict – The individual still continues the excessive exercise even though 
he/she realizes the interpersonal conflicts between the addict and the 
environment, conflicts with other activities (e.g., job, social life, and hobbies). 
6. Relapse – Rapid reinstatement of the previous pattern of exercise and 
withdrawal symptoms after a period of abstinence or control. 
7. The preoccupation with the exercise is not better accounted for by another 
mental disorder. For instance in case of AN the excessive exercise is the 
consequence of the eating disorder and serves as a weight control strategy. Thus 
it has to be considered as the symptom of AN and defined as “secondary 
exercise dependence” (de Coverley Veale, 1987). Exercise dependence can 
develop without any accompanying eating disorder, which is identified as 
“primary exercise dependence” (de Coverley Veale, 1987). 
 
1.7.2.3 Bodybuilding dependence and muscle dysmorphia 
After the first description of exercise dependence, it has been studied in several kinds of 
sports. However, bodybuilding seemed to be a neglected area of interest until the last 
few years, when studies pointed out the relationship between exercise dependence, 
bodybuilding, and MD. Compulsive bodybuilding is considered as a behavioural 
characteristic of MD as MD sufferers spend long hours with lifting weight in order to 
gain muscle mass and achieve muscular physique. They often sacrifice important social 
and occupational activities in order to keep the strict exercise schedule. This kind of 
exercise addiction is called bodybuilding dependence (Smith, Hale, & Collins, 1998; 
Smith & Hale, 2004). Given this, most of the instruments that measure MD symptoms, 
also assess bodybuilding dependence.  
 
Relating to the causal factors of bodybuilding dependence, research revealed that often 
low self-esteem and body image dissatisfaction serve as the basis for bodybuilding 
dependence (Smith et al., 1998; Hurst, Hale, Smith, & Collins, 2000). Smith et al. 
(1998) highlighted that some individuals may have started bodybuilding training 
because they suffered from low self-esteem and poor body image, and they may have 
become dependent on it to feel good about themselves. Bodybuilding training improves 
self concept and body attitudes, and those who are involved in this sport may experience 
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self-efficacy, thus they can become dependent upon it to feel positive about themselves 
(Tucker, 1987).  
 
Hurst et al. (2000) examined exercise dependence in experienced and inexperienced 
bodybuilders and weightlifters. They found that social support and positive comments 
of others also played an important role in the development of bodybuilding dependence. 
Moreover, experienced bodybuilders displayed more exercise dependence than 
inexperienced bodybuilders and weightlifters. These results indicate that bodybuilders 
can become dependent on the actual activity of lifting weights rather than weightlifters. 
 
Smith and Hale (2004) examined bodybuilding dependence in competitive and non-
competitive bodybuilders in both genders. Results showed that competitive 
bodybuilders exhibited more bodybuilding dependence than non-competitive ones, but 
there were no gender differences. Moreover, the study also found positive relationship 
between bodybuilding dependence and MD, confirming previous findings that exercise 
dependence is an important behavioural pattern of MD. 
 
A recent study investigated exercise dependence and drive for muscularity in male 
bodybuilders, power lifters, and fitness lifters (Hale, Roth, DeLong, & Briggs, 2010). 
Results indicated that bodybuilders and power lifters may tend to become 
overcommitted in their weight lifting trainings compared to fitness lifters and may be at 
higher risk for developing exercise dependence. Authors suggested that drive for 
muscularity is clearly related to exercise dependence behaviours. Therefore, those 
individuals who display higher levels of drive for muscularity may be at higher risk for 
developing more addictive exercise behaviour patterns and even more susceptible to the 
negative psychological and social consequences of the addiction than those with less 
drive for muscularity.  
 
1.7.3 Mood and anxiety disorders 
Studies suggest that mood and anxiety disorders often co-occur in MD. Olivardia et al. 
(2000) examined psychiatric disturbances in muscle dysmorphic (n = 24) and normal 
comparison weightlifters (n = 30). Those men with MD showed higher lifetime 
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prevalence of DSM-IV mood and anxiety disorders. Namely, 14 men with MD reported 
a lifetime history of major depressive disorder or bipolar disorder, while only six of the 
normal comparison men. Seven of the muscle dysmorphic men versus only one of the 
comparison men reported a lifetime history of a DSM-IV anxiety disorder. Authors 
noted that the onset of these comorbid psychiatric disorders occurred before or after the 
development of MD, but it seems that compulsive weightlifting may serve as a coping 
strategy to deal with the feelings of anxiety or depression. 
 
A recent study also investigated the correlates of MD (McFarland & Kaminski, 2009). 
Multiple regression analyses suggested that higher levels of depression, anxiety, and 
interpersonal sensitivity were predictive factors of MD and body dissatisfaction. 
Interpersonal sensitivity refers to self-consciousness and sensitivity to criticism from 
others. The authors hypothesize that those men with higher levels of interpersonal 
sensitivity are more vulnerable to media influences and peer pressure, thus, they have a 
higher risk for MD and body dissatisfaction. In this study, those men with high levels of 
MD had also higher endorsement of obsessive-compulsive symptoms, hostility, and 
paranoid ideation. 
 
Another study examined the psychiatric conditions and symptom characteristics 
associated with MD (Cafri et al., 2008). Men with a history of MD had higher rates of 
lifetime mood and anxiety disorders, in comparison to males without a history of MD. 
Men with mood disorders had major depressive disorder (n = 15 out of 23, in the MD 
group vs. n = 8 out of 28, in the control group) and dysthymic disorder (n = 2 out of 23, 
in the MD group). According to the results, men with MD suffered from panic disorder 
(n = 4, vs. one male in the control group), posttraumatic stress disorder (n = 2), 
obsessive-compulsive disorder (n = 1), specific phobia (n = 1), social phobia (n = 1), 
and generalized anxiety disorder (n = 1, vs. one male in the control group).  The study 
findings of Wolke and Sapouna (2008) also pointed out the association between MD 
and the symptoms of anxiety, depression, and obsessive-compulsive disorder. Maida 
and Armstrong (2005) also found positive correlations between symptoms of MD and 
variables, such as anxiety and obsessive-compulsive symptoms. The study of Chandler, 
Grieve, Derryberry, & Pegg (2009) revealed that trait anxiety and obsessive-compulsive 
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symptoms had strong relationships with overall MD symptomatology. Path analysis 
indicated that anxiety-related variables accounted for 77% of the variance in MD 
symptoms. 
 
1.7.4 Poor quality of life and suicidal attempts 
Some research indicates poor quality of life among MD sufferers. Pope, Pope, Menard, 
Fay, Olivardia, and Phillips (2005) compared 14 men who had MD combined with body 
dysmorphic disorder with 49 body dysmorphic men. Results showed that men with MD 
had poorer scores on both measures of quality of life enjoyment and satisfaction and 
mental health related quality of life than the comparison men. Another study compared 
men with (n = 15) and without (n = 36) current history of MD (Cafri et al., 2008). 
Results pointed out that men with current MD displayed higher functional impairment 
(measured by the Muscle Dysmorphic Disorder Inventory – Functional Impairment 
subscale), in a sense that the pursuit of the muscularity adversely affected their social, 
academic, and occupational functioning. 
 
Although limited number of studies are available in this field, the available studies 
suggest that men with MD have poorer quality of life, and more suicidal attempts than 
the general population. In the above mentioned study by Pope et al. (2005), results also 
indicated that MD was associated with greater psychopathology, as men with MD were 
more likely to have attempted suicide, had poorer quality of life, and engaged in severe 
compulsive behaviours (seven men with MD had attempted suicide vs. eight did so in 
the body dysmorphic group); moreover, their quality of life were also poorer comparing 
to the body dysmorphic group and to the general population. The authors hypothesized 
that preoccupation with muscularity and additional physical features combined with 
time-consuming compulsive behaviours (e.g., excessive bodybuilding, dieting, and 
mirror checking) enhances the distress and functional impairment. These results are in 
line with previous studies that indicated a relationship between greater axis I 
comorbidity, functional impairment (Welkowitz, Struening, Pittman, Guardino, & 
Welkowitz, 2000), and increased suicide attempts (Lecrubier, 2001) in the general 
population. 
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1.7.5 Anabolic-androgenic steroid use 
1.7.5.1 Definition of anabolic-androgenic steroids 
“The anabolic-androgenic steroids (AAS) are a family of synthetic drugs related to the 
male sex hormones (androgens), which enhance the growth of skeletal muscles 
(anabolic effect) and also the development of male sexual characteristics (androgenic 
effect)” (Amsterdam, Opperhuizen, & Hartgens, 2010). Taken in supraphysiologic 
doses (which means at least 600 mg of testosterone weekly for several weeks) greatly 
improve fat-free mass, muscle size, and strength (Bhasin, et al., 1996; Kouri, Pope, 
Katz, & Oliva, 1995).  
 
Only elite athletes used these kinds of performance enhancing substances during 1950s. 
From the 1980s, the use of illicit AAS became widespread also in the general 
population (Kanayama, Hudson, & Pope, 2008; Pope et al., 2000). It is a great concern 
that the AAS are available on the black market and most of the users are even not aware 
of the mechanism and adverse health effects of these substances. Moreover, there is 
usually no any kind of medical checkout (e.g., blood test, liver function test) before, 
during, or after the AAS use, which makes the use of these illicit substances more 
dangerous (Pope et al., 2000, Hungarian review: Babusa & Túry, 2010; Túry & Babusa, 
2012). 
 
1.7.5.2 Prevalence of anabolic-androgenic steroid use 
American studies reported a prevalence of AAS use of 4–11% for male and 2.5% for 
female high school students (e.g. Bahrke, Yesalis, Kopstein, & Stephens, 2000). 
According to the results of the U.S. national surveys, the ’Monitoring the Future’ 3.5% 
of 10th graders reported illicit AAS use (Johnston, O’Malley, & Bachman, 2002). In 
another survey among adolescent boys, the lifetime prevalence of illicit AAS use was 
slightly less than in the national survey, 2.6% (Cafri, van den Berg, & Thompson, 
2006). According to the results of a British survey, 4.4% of male and 1.0% of female 
college students reported current or past AAS use (Williamson, 1993). It should be 
noted that girls and women rarely use AAS, firstly, due to the fact that they usually do 
not want to develop extreme muscularity, and secondly, that they also have to face with 
the masculinizing effects of AAS (e.g., beard growth, deepening of the voice). 
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Research evidence showed that the prevalence of AAS use is much higher in some 
certain populations, especially among bodybuilders, weightlifters, and prisoners 
(Thiblin & Petersson, 2005). For example, during the very first description of MD, 108 
male weightlifters were recruited, of whom 51% (n = 55) reported AAS use (Pope et al., 
1993). Kanayama, Pope, Cohane, and Hudson (2003) also found a 50% (n = 48) 
prevalence rate for AAS use among 96 male weightlifters. A recent study found 
similarly high prevalence rate, as 44% (n = 102) of 233 male weightlifters reported 
lifetime AAS use (Pope, Kanayama, & Hudson, 2012). 
 
Some Hungarian data are also available relating to the prevalence of AAS use. One drug 
use survey study revealed that the lifetime prevalence of AAS use among Hungarian 
high school students was 8.8% (Domokos, 2005). The first study of MD in Hungary 
found 9.3% prevalence rate of AAS use among 140 male bodybuilders (Túry, Kovács, 
& Gyenis, 2001). 
 
1.7.5.3 Muscle dysmorphia and anabolic-androgenic steroid use 
Research suggests that body image dissatisfaction can increase the risk of AAS use and 
dependence (Brower, 2002); moreover, the pursuit of muscularity is also a reason for 
steroid use (Olivardia et al., 2000). Previously, during the first description of MD, Pope 
et al. (1993) found far more higher prevalence rate of AAS use since all the four men 
with MD had also reported a lifetime history of AAS use. Later, they found a lower 
prevalence rate, since six out of 15 men with MD reported a history of AAS use (Pope 
et al., 1997). In a study by Kanayama et al. (2003), 17% (n = 8 out of 48) of the AAS 
users reported a lifetime history of MD. Similar to this result, Pope and Katz (1994) 
found that 18.2% (n = 16 out of 88) of AAS user weightlifters reported a history of MD 
versus none of the comparison non-steroid user weightlifters (n = 66). Other study 
results also suggested that AAS user weightlifters (Kanayama et al., 2006) and AAS 
user body builders (Cole, Smith, Halford, & Wagstaff, 2003) displayed marked 
symptoms of MD comparing to the non-users.  
 
The following question is a disturbing one, but there were several debates relating to 
this topic: whether MD symptoms are a cause or an effect of AAS use? Nowadays a 
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consensus has been established, which confirms that the symptoms of MD could be the 
cause for AAS use, meaning that body image pathology precipitates the use of AAS 
(Rohman, 2009). Olivardia et al. (2000) examined MD symptomatology in weightlifter 
men with MD (n = 24) and comparison weightlifters without MD (n = 30). They found 
that 11 men with MD and only two normal comparison weightlifters reported AAS use.  
 
The reason why MD sufferers are more vulnerable than normal weightlifters or 
bodybuilders to AAS use and dependence is the salient underlying psychopathology of 
MD itself (Rohman, 2009). Although, men with MD may develop large muscles with 
the use of AAS, due to their body image disorder they still perceive themselves to be 
small and weak. As a consequence, they increase the dosage of steroids and may use 
them more frequently.  
 
1.7.5.4 Adverse effects of anabolic-androgenic steroids 
AAS use has several kinds of short and long term adverse effects. Many of them are 
caused by that the steroid abuse suppresses the normal production of hormones, which 
may cause reversible or irreversible changes. In fact, the use of AAS very rarely causes 
death, but the potential side effects may reduce the life expectancy. 
 
1.7.5.4.1 Physical side effects of anabolic-androgenic steroids 
Gynecomastia is a common side effect of AAS use, which means the growth of the 
breast tissue under the nipples, caused by the imbalance of testosterone-estrogen 
hormones during the period of AAS use. Once it has developed, the condition is 
irreversible and the enlarged breast can be removed only surgically. According to the 
results of a survey, 10-34% of the AAS users experience gynecomastia (Evans, 2004). 
Another long-term physical side effect of AAS use is the increased level of LDL-
cholesterol and the decreased level of HDL-cholesterol, which increases the risk of 
artherosclerosis (Hurley et al., 1984). Artherosclerosis is the thickening and hardening 
of the walls of medium- and large sized arteries and responsible for coronary artery 
disease and stroke. 
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Many men also report the shrinking of their testicles (testicle atrophy) while they are on 
steroids. This is caused by the suppression of natural testosterone level, which inhibits 
production of sperm. However, this side effect is only temporary, since the size of the 
testicles usually returns to their normal size after a few weeks of discontinuing AAS use 
as normal production of sperm resumes. Reduced sexual function and temporary 
infertility can also occur in males. According to the results of a survey, 40-51% of the 
AAS users experience testicle atrophy (Evans, 2004). 
 
Long-term AAS use is also a great concern, since it may cause prostate enlargement. 
Some study also pointed out the relationship between AAS use and prostate cancer 
(Creagh, Rubin, & Evans, 1988). The high doses of oral AAS are highly hepatotoxic, as 
the steroids are metabolized and can cause liver toxicity. In more serious cases there is 
also a higher risk for fatal liver cysts, liver changes, and cancer (Stimac, Milic, 
Dintinjana, Kovac, & Ristic, 2002). 
 
Steroids also can cause myocardial hypertrophy, which can increase the risk for cardiac 
arrhythmias, hypertension, heart attacks, and sudden cardiac death (Karila et al., 2003; 
Sullivan, Martinez, & Gallagher, 1999). Anabolic steroids have been linked with 
cardiovascular issues, e.g., high blood pressure, or headaches, and kidney failure. 
Another common side effect of AAS use is the development of acne, since steroids 
enlarge the sebaceous glands in the skin. These enlarged glands produce an increased 
amount of oil. Research data show that 40-54% of the AAS users reported the presence 
of acnes (Evans, 2004). AAS use can also accelerate the rate of premature baldness for 
those males who are genetically predisposed.  
 
Anabolic steroid use in adolescence can possibly stunt the growth potential. This is 
because of the premature closure of the epiphysial cartilage, caused by aromatizable 
steroids, which finally leads to a possible growth inhibiting effect, and could results in a 
shorter adult height. This side effect is irreversible. The use of AAS has been also 
linked with ligament and joint injury. Steroids increase muscle mass and muscle 
strength, but the joints and ligaments can not adapt. Putting too much strain on 
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ligaments that cannot properly anchor the new muscle strength, can result in severe 
injury. 
 
1.7.5.4.2 Psychiatric side effects of anabolic-androgenic steroids 
Even though the use of AAS rarely cause immediate acute medical side effects, the use 
of these substances can be dangerous because of their psychiatric side effects. Steroids 
may induce changes in the personality and behaviour, which can have an adverse effect 
on the social, occupational, and other important areas in life.  
 
Many studies suggested that AAS use can cause hypomania or mania, sometimes co-
occurring with increased aggressiveness and mild irritation (e.g., Choi and Pope, 1994; 
Kouri, Pope, & Oliva, 1996; Pope and Katz, 1990). The degree of these effects is 
mostly based on the dosage level of the AAS. The manic symptoms were described by 
irritability, aggression, grandiose beliefs, euphoria, hyperactivity, violence, and 
dangerous behaviour. These manic symptoms are occasionally accompanied by 
psychotic symptoms, such as beliefs about having a special power (Pope et al., 2000; 
Pope & Katz, 1988). Studies which examined the mood disorders and aggression among 
those AAS users who used high dose steroids (> 1000 mg/week) found that 23% of the 
AAS abusers developed mania, hypomania, or major depression, and 3-12% had 
psychotic symptoms (Pope & Katz, 1994; Pope, Kouri, & Hudson, 2000). 
 
Studies also documented depressive symptoms associated with AAS use (Brower, 2002; 
Malone & Dimeff, 1992; Malone, Dimeff, Lombardo, & Sample, 1995; Pope & Katz, 
1994). Depressive symptoms are more likely to present in the withdrawal phase of AAS 
use. Relevant to these studies, some research also reported suicides related to AAS use 
(Brower, Blow, Beresford, & Fuelling, 1989; Papazisis, Kouvelas, Mastrogianni, & 
Karastergiou, 2007; Thiblin, Runeson, & Rajs, 1999). Most of the mood changes are 
only temporarily and experienced for short-term during or after the AAS use. However, 
suicidal cases are of great concern. One study examined older powerlifters and 
documented that 3 of the 8 death were caused by suicide (Parssinen, Kujala, Vartiainen, 
Sarna, & Seppala, 2000). Recent study findings also indicated that suicide was a more 
common cause of death among AAS users than among other substance users (Petersson 
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et al., 2006). Another study found that 6.5% of the AAS user bodybuilders attempted 
suicide after discontinuing steroids (Malon et al., 1995). However, there are some 
studies that have not documented such mood changes during AAS use (Basaria 
Wahlstrom, & Dobs 2001; Bhasin et al., 1996; Tricker et al., 1996).  
 
Sexual dysfunctions are also associated with AAS use (Pope, Phillips, et al., 2000). The 
dysfunction can be experienced in extremities. One extremity is the increased libido and 
the increased sexual drive, which usually occur during the active phase of AAS. The 
other extremity is the decrease of libido and sexual drive, sometimes accompanied by 
impotence, which can be experienced during withdrawal from AAS when the natural 
testosterone level is still suppressed (Pope, Phillips, et al., 2000). 
 
The long term use of AAS may also lead to dependence. One study pointed out that 
AAS may cause withdrawal symptoms, and those men who discontinued AAS use 
reported depression, decreased libido, energy level, and self-esteem (Bahrke, Yesalis, & 
Wrigh, 1990). Although the AAS do not have strong euphorigenic effects, the dysphoric 
effects of the withdrawal may contribute to the development of their dependence (Pope 
& Katz, 1988). Brower (2002) proposed a two-stage model for AAS dependence. In the 
first stage, subjects use AAS for their anabolic (muscle gaining) effects. During this 
stage, the AAS users also experience the psychological effects of AAS, since the 
achievement of their goals (i.e., muscle gain) reinforces their use. In the second stage, 
the psychoactive effects of the AAS use develops and through the high doses of steroids 
affect the brain mediated reward systems. Some AAS users are at risk for dependence 
because of the withdrawal symptoms (e.g., fatigue, depression, low energy levels) and 
also because discontinuity of AAS is usually accompanied by some decrease of muscle 
mass and strength. Brower, Eliopulos, Blow, Catlin, and Beresford (1990) documented 
that 57% of the AAS user male weightlifters fulfilled the DSM-III criteria for 
dependence. Another study examined the symptoms of AAS dependence and 
withdrawal among 49 male weightlifters (Brower, Blow, Young, & Hill, 1991). Eighty-
four percent of the sample reported different symptoms of withdrawal: 52% reported 
steroid craving, 43% fatigue, 41% depressed mood, 24% loss of appetite, 20% 
insomnia, 20% reduced sex drive, 20% headache, and 29% restlessness. 
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Another great concern relating to AAS use is that in most cases the use of AAS is 
associated with other substance use as well. For instance, a study found that 79% of the 
AAS users also used some kind of psychotropic substances (Petersson et al., 2006). 
 
1.7.5.5 Characteristics of anabolic-androgenic steroid users and risk factors for 
anabolic-androgenic steroid use 
Although, AAS use is a growing public health problem and the adverse physical and 
psychiatric effects of these substances are of great concern, the risk factors for AAS use 
are still poorly understood. Recent studies have been exploring the association between 
AAS use and various psychological correlates to find out the risk factors for AAS use. 
Most of these studies focusing on that population which is at risk for AAS use, namely 
on male weightlifters or bodybuilders. Studies suggest that AAS users may have lower 
levels of self-esteem (Brower, Blow, & Hill, 1994; Blouin & Goldfield, 1995) and 
narcissistic or antisocial personality characteristics (Burnett & Kleiman, 1994; Yates, 
Perry, & Andersen, 1990).  
 
Kanayama et al. (2006) examined body image pathology, self-esteem, and attitudes 
toward male roles in AAS user (n = 48) and AAS non-user (n = 41) male weightlifters. 
Results indicated that AAS users displayed greater MD symptoms and had elevated 
scores on the Eating Disorders Inventory (Garner et al., 1983). Moreover, long-term 
AAS users had higher levels of MD symptomatology, and stronger endorsement of 
conventional male roles than non-user. AAS users and non-users did not show any 
difference relating to self-esteem suggesting that AAS use may not be associated with 
low self-esteem, but rather with poor body image.  
 
For the examination of risk factors for AAS use, Kanayama et al. (2003) compared 
AAS user (n = 48) and AAS non-user (n = 45) male weightlifters. Relating to the 
psychosocial factors, AAS users reported poorer relationship with their fathers and 
greater conduct disorder during their childhood than non-users. Relating to the physical 
status, AAS users were less confident about their body appearance. Finally, AAS users 
had higher rates on other illicit substance use or dependence than non-users. 
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A study aimed to characterize the relationship between increased serum level of 
testosterone, mood, and personality among AAS user and non-user weightlifters (Perry 
et al., 2003). Results indicated that increased testosterone level was associated with self-
reported violence and aggression. Moreover, AAS users displayed more cluster B 
personality disorder related characteristics than non-users. 
 
In a cross-sectional cohort study 233 male weightlifters were recruited, of whom 44% 
(n = 102) reported lifetime AAS use (Pope et al., 2012). The study aimed to assess the 
childhood and adolescent attributes retrospectively. According to the results, conduct 
disorder, poor relationship with one’s father, and adolescent concerns with muscularity 
and body appearance emerged as strong risk factors. It should be also noted that only 
one study found significant relationship between BMI, AAS use, overeating, and the use 
of food supplements (Neumark-Sztainer, Story, Falkner, Beuhring, & Resnick, 1999). 
However, other studies have not found similar relation (McCabe & Ricciardelli, 2001b; 
McCabe & Ricciardelli, 2003). 
 
Other studies examined risk factors associated with AAS use among adolescents. Study 
results indicated that AAS users are more likely to use other illicit drugs as well (Bahrke 
et al., 2000; DuRant et al., 1995). The prevalence rate of AAS use was significantly 
higher among male students participated in sports (e.g., football, wrestling, 
weightlifting, and bodybuilding) than students who were not active in sports (Bahrke et 
al., 2000; DuRant et al., 1995).  
 
Cafri et al. (2005) proposed a model for potential risk factors that may lead to body 
change strategies, including AAS use in males (see Figure 1). The theoretical model 
consists of variables that may contribute to dysfunctional body change behaviours in 
males. The model involved six main variables which can lead to a variety of health risk 
behaviours: (1) biological factors, (2) societal factors, (3) psychological functioning, (4) 
social body comparison, (5) body image dissatisfaction, (6) sports. The authors 
suggested that these factors may place an individual at high risk for exhibiting health 
risk behaviours. 
 
DOI: 10.14753/SE.2013.1829
 37
 
Figure 1. Model for putative risk factors for body change strategies in males (Cafri et al., 2005). 
 
In conclusion, the abuse of AAS is a public health problem and may be related with 
adverse physical, behavioural, and psychiatric effects. Although the risk factors for 
AAS use are poorly explored, the deeper understanding of AAS use may help to 
identify those who are at risk for AAS use, and could contribute to the development of 
effective intervention programs. 
 
1.8 Etiology of muscle dysmorphia 
Many approaches help the clearer understanding of MD (Hungarian review: Babusa & 
Túry, 2010; Túry & Babusa, 2012). Some authors propose multidimensional models for 
the etiology of MD, which differentiate predisposing, precipitating, and maintaining 
factors. These models suggest that MD is a complex psychosomatic disorder with 
biological, psychological, and sociocultural components.   
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Olivardia (2001) described a brief biopsychosocial model for the development of MD. 
The model involved genetic factors, drive for muscularity, low self-esteem, appearance-
related social pressures, and body-image consciousness. 
 
Rhea and Lantz (2000) proposed a psychobehavioural model of MD, including six 
factors (see Figure 2). The specific behavioural and psychological characteristics of MD 
can be divided into two major categories: nutrition and physique concerns. The first 
category, nutrition, includes behaviours relating to pharmacological use, supplement 
use, and dietary behaviour. Pharmacological use involves the use of steroids and other 
illicit hormones in order to increase muscular size. Supplement use is concerned with 
the use of legal substances designed to enhance the quality of a workout (e.g., energy 
drinks, creatine). Dietary behaviour involves the strict monitoring of proteins, 
carbohydrates, and fats in order to increase muscle size. This model suggests that 
subjects with MD are more likely to engage in these nutritional behaviours in pursuit of 
enhancing muscular, well-defined physiques than are non-dysmorphic weightlifters. 
The second category, physique concerns, is characterized by concerns relating to body 
size/symmetry, physique protection, and exercise dependence. Body size/symmetry 
focuses on the degree of satisfaction with muscle size and shape. Physique protection 
comprises behaviours designed to avoid having the body viewed by others (e.g., 
wearing bulky clothing, or avoiding situations where the physique may be exposed). 
Exercise dependence involves preoccupation with exercise, maintaining a rigid schedule 
of intense exercise, feeling guilty because of the missed exercises, and exercising even 
when ill or injured. The model was partially corroborated by Olivardia et al. (2000), 
who compared muscle dysmorphic weightlifters with a normal group of weightlifters. 
The data suggest that dysmorphic weightlifters were significantly different from non-
dysmorphic weightlifters in a number of areas including eating attitudes and anabolic 
steroid use. Moreover, the authors found that dysmorphic weightlifters expressed 
significantly greater body dissatisfaction than did non-dysmorphic weightlifters.  
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Figure 2. Psychobehavioural model of muscle dysmorphia (Rhea & Lantz, 2000). 
 
Lantz, Rhea, and Mayhew (2001) proposed a model that included three major categories 
(see Figure 3): (1) precipitating variables (self-esteem and body dissatisfaction), (2) 
psychobehavioural characteristics (body size/symmetry, dietary constraints, use of 
psychopharmacological aids, use of dietary supplements, exercise dependence, and 
physique protection), and (3) negative outcomes (alienation and narcissism). The 
authors suggest that the development of MD is directly influenced by body 
dissatisfaction.  
 
 
Figure 3. Model for the development of muscle dysmorphia (Lantz, Rhea, &Mayhew, 2001). 
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In a recent model, Grieve (2007) involved those categories into the etiological model of 
MD which represent the biopsychosocial model of psychopathology (Kiesler, 1999). 
The model consists of nine factors, which can be divided into four major categories – 
see Figure 4: (1) socioenvironmental factors (i.e., media influences, sport participation), 
(2) emotional factors (i.e., negative affect), (3) psychological factors (i.e., body 
dissatisfaction, ideal body internalization, self-esteem, body distortion, perfectionism), 
(4) physiological factors (i.e., body mass). Most of the variables are interacting with 
each other.  
 
 
Figure 4. Proposed etiological model for muscle dysmorphia (Grieve, 2007). 
 
1.8.1 Biological factors  
1.8.1.1 Neurobiological factors 
The neurobiological factors of MD are still under research. Since MD has been 
conceptualized as a subtype of body dysmorphic disorder, similar neurobiological 
pathology or genetic predisposition are assumed (Rohman, 2009). 
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1.8.1.2 Body mass 
Another biological factor that may contribute to the development of MD is body mass 
index (BMI). BMI measures body composition and body fat calculated from body 
weight and height. (The formula for BMI is as follows: body weight (kg)/ height (m) 2). 
The BMI ranges and categories are as follows: a BMI of less than 18.5 is regarded as 
underweight, a BMI range of 18.6–24.9 is considered as normal weight, between 25–
29.9 is regarded as overweight, and above 30 is considered as obese. 
 
BMI was also included in the conceptual model of MD; however, it has also been noted 
that the relationship between BMI and MD has not been established yet (Grieve, 2007). 
Although, research has supported a strong association between BMI and body 
dissatisfaction, the role of BMI as a contributing factor to MD is still inconsistent (Cafri 
et al., 2005).  
 
Some authors hypothesize an inverse relationship between BMI and the pursuit of 
muscularity, as low BMI would suggest small body size and muscularity, therefore an 
increased desire towards muscle gain is assumed (Cafri et al., 2006). McCabe and 
Ricciardelli (2001a) found that higher BMI was correlated with higher levels of body 
dissatisfaction among preadolescent boys. Furthermore, boys with higher BMIs dieted 
more often and were more likely to engage in body-changing techniques (e.g. eating 
less/more to lose/gain weight, exercise) comparing boys with normal BMIs. Conversely, 
another study found association between lower BMI, steroid use, overeating, and use of 
food supplements (Neumark- Sztainer et al., 1999). Cafri et al. (2006) found that higher 
BMI was a predictor of dieting to gain weight. As for the explanation, weight lifting 
males have a higher BMI and may also be dieting to gain weight in order to increase 
their muscle mass. Contrariwise, a study conducted among adolescent males indicated 
that lower BMI predicted higher importance on muscularity, more peer influence, and 
higher perceived pressure from others towards muscle gain (Ricciardelli, McCabe, 
Lillis, & Thomas, 2006).  
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It should be noted that, the interpretation of BMI has to be treated carefully in this 
respect, as high BMI may indicate either a high level of muscle mass or a high level of 
body fat, and lower BMI may also indicate lean musculature. Therefore, the use of the 
“fat-free mass index” (FFMI; Kouri et al., 1995) as an objective measure of an 
individual’s degree of muscularity would be more appropriate for the measure of male 
body composition.  
The formula for FFMI in males is as follows: 
 
FFMI = LBM + 6.1 x (1.8 – H), 
H2 
 
In this formula LBM refers to lean body mass in kilograms and H height in meters. 
Lean body mass is the total body weight minus the percentage of body fat1.  
The FFMI ranges and categories are as follows: a FFMI range of 16–17 is considered as 
very low level of muscle, between 18–21 is regarded as average/normal muscle, 22–24 
is considered as noticeably muscular, and above 25 is regarded as upper level of 
muscularity attainable without steroids. This formula has been developed only for men, 
thus no similar formula with the cut-off value suggesting steroid use is available for 
women. It also has to be noted that the above described ranges and categories can be 
applied to men with a low or moderate body fat. In other cases the FFMI can reach 
above 26 without steroid use. 
 
1.8.1.3 Pubertal timing 
Pubertal timing has been also investigated as a biological risk factor of MD; however, 
similarly to BMI, the results are inconsistent. Regularly, puberty launches significant 
bodily changes, as well as muscular growth in young males. It can be hypothesized that, 
later maturing boys may have less muscular physique than early maturing peers. 
Therefore, they are at higher risk for engaging even in harmful muscle-enhancing 
techniques (Cafri et al., 2006). O’Dea and Abraham (1999) found that males who had 
lately reached pubertal growth reported more body dissatisfaction and were more likely 
to engage in muscle building techniques (e.g., use of food supplements) comparing to 
                                                 
1 Body fat can be estimated by various methods, such as measuring the thickness of skin folds on different 
body parts with calipers or electrical impedance measuring techniques. 
DOI: 10.14753/SE.2013.1829
 43
males with normal pubertal timing. Results of a longitudinal study indicated that both 
early and late maturing boys engaged in body change strategies in relation to muscular 
ideal (McCabe & Ricciardelli, 2004). However, the earlier maturing boys were more 
susceptible to maladaptive body change behaviours than the later maturing boys. 
 
1.8.2 Psychological factors 
1.8.2.1 Self-esteem 
Research has shown that low self-esteem often contributes to the onset of an eating 
disorder (e.g., Button, Sonuga-Barke, Davies, & Thompson, 1996; Cervera et al., 2003; 
Fairburn, Cooper, & Shafran, 2003; Halvorsen & Heyerdahl, 2006). Moreover, positive 
relationships were found between low self-esteem, depression, and body dissatisfaction 
in both males and females (Blouin & Goldfield, 1995). One study results indicated that 
both body dysmorphic disordered and eating disordered patients reported almost the 
same low levels of self-esteem (Rosen & Ramirez, 1998). Thus, it was hypothesized 
that low self-esteem may also be a key element in the development of MD. 
Furthermore, Pope, Phillips, et al. (2000) proposed that the association between poor 
body image and low self-esteem may be stronger in men than in women.  
 
The relationship between low self-esteem and MD is well-documented in the literature 
(Grieve, 2007; Grieve & Helmick, 2008; Lantz et al., 2001; Pope, Phillips, et al., 2000). 
These studies suggest a negative relationship between self-esteem and MD symptoms, 
as men with MD display lower levels of self-esteem. Often, a low level of self-esteem 
serves as a motivational basis for the behavioural symptoms of MD, for instance 
weightlifting (Crocker, 2002). Olivardia (2001) emphasized that in case of men with 
MD, self-esteem is solely based on their appearance, while in others without the 
symptoms of MD it consists of several factors, including appearance. Those men whose 
self-esteem is dependent upon their appearance may engage in appearance-improving 
behaviours (Crocker, 2002). These behaviours can be excessive exercise, rigid diet, or 
weightlifting/bodybuilding activity. The increased drive for a more muscular body can 
be considered one way of gaining some acceptance or respect from others (Pope, 
Gruber, et al., 2000). Often, the reason for exercising determines whether the exercise 
improves or deteriorates health status and self-esteem. Males who exercised to enhance 
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their appearance rather than to improve their health had lower self-esteem, higher levels 
of body dissatisfaction, and disordered eating (Strelan & Hargreaves, 2005). Olivardia 
et al. (2004) also pointed out that higher levels of muscle belittlement and body image 
dissatisfaction in males were associated with lower self-esteem, depression, and eating 
pathologies.  
 
Some authors indicated that body satisfaction has a central role in self-esteem. Based on 
this theory, a research reported a significant positive relationship between self-esteem 
and body attitudes (Mintz & Betz, 1986). According to the results, men and women who 
had more positive attitudes about their bodies had higher levels of self-esteem. 
Sometimes self-esteem is mediated by body satisfaction and vice versa, body 
satisfaction is mediated by general self-esteem (Davis, Elliot, Dionne, & Mitchell, 
1991). 
 
1.8.2.2 Body image dissatisfaction and distortion 
Body image dissatisfaction usually refers to the feelings about the perceived 
discrepancy between one’s ideal and actual bodily appearance (Keeton, Cash, & Brown, 
1990). Although, body dissatisfaction in women has been widely documented, the 
number of papers focusing on concerns related to men’s appearance has increased only 
in the last few decades. Studies have documented muscle dissatisfaction and a desire for 
a more muscular ideal body among men (Fredrick et al., 2005; Lynch & Zellner, 1999).  
 
Over the last few decades males are becoming more dissatisfied with their bodies and 
recently, many men have developed a drive for muscularity (McCreary, 2007). 
According to the results of the studies conducted over the last 25 years in the U.S., more 
men are reported to be dissatisfied with their bodies and muscularity than two decades 
ago. In 1972, 15% of the men reported body dissatisfaction (Berscheid et al., 1973). In 
1985 this number increased to 32% and by 1997 to 45% (Garner, 1997). In details, in 
1972, 18% of men were dissatisfied with their chest, and 25% with their muscle tone. 
By 1997, 38% of men were dissatisfied with their chest, and 45% with their muscle 
size. Another study pointed out that 95% of men are dissatisfied with some aspects of 
their bodies (Mishkind et al., 1986).  
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Research has shown that different body ideals exist for men and women. The ideal 
regards to men is the muscular ideal, while the ideal concerns to women, is the thin 
body ideal (e.g. Fisher, Dunn, & Thompson, 2002; McCreary & Sasse, 2000). Given 
these different body ideals, women experience pressure towards thinness, and men often 
report pressure to obtain and maintain muscularity. Research has pointed out that men 
generally would like to be more muscular (Ricciardelli, McCabe, & Banfield, 2000). 
One study found that 91% of college men reported that they wanted to be more 
muscular, while no one wanted to be less muscular (Jacobi & Cash, 1994). According to 
the results of another study, male college students chose an ideal body with about 11 
kilograms more muscular than their actual bodies, with a primary increase of their 
biceps, shoulders, and abdomens (Olivardia et al., 2004). McCaulay, Mintz, and Glenn 
(1988) found that 85% of men and 56% of women wanted to be more muscular, 
actually women wanted to be more toned.  
 
A study across three different Western countries (Austria, France, and the U.S.) found 
that men’s ideal bodies were 13 kilograms more muscular than their actual bodies 
(Pope, Gruber, et al., 2000). Furthermore, men estimated that women would prefer a 
male body about 14 kg more muscular than their actual bodies. However, the study was 
also able to point out that women actually did not prefer very muscular male bodies, but 
instead chose an average one. The authors indicated that the discrepancy between 
males’ actual and ideal bodies may be a contributing factor in the development of body 
image disorders, including MD, and men with pathological drive for muscularity may 
be at risk for developing MD.  
 
Although the findings are heterogeneous in terms of the study samples, study designs, 
and outcome measures, research revealed that the prevalence of muscle dissatisfaction 
has been increasing among men. Moreover, some research has pointed out that the drive 
for muscularity may be a precursor to the development of MD (Olivardia, Pope, & 
Hudson, 2000; Pope, Phillips, et al., 2000). 
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Body image distortion is also hypothesized to be a factor in the development of MD 
(Grieve, 2007; Grieve, Truba, & Bowersox, 2009; Olivardia, 2001). Body image 
disturbance has been long identified as a contributing factor of eating disorders, which 
is so prominent that has been involved in the diagnostic criteria of AN (American 
Psychiatric Association, 2000). Body image distortion is defined as the “disturbance in 
the way in which one's body weight or shape is experienced” (American Psychiatric 
Association, 2000). In case of AN, body image disturbance usually refers to the 
distortion of body size as individuals with AN often believe that they are larger than 
their actual body size. Men with MD also report body image distortion with the 
difference that they perceive themselves to be smaller and weaker than they actually are 
(Olivardia, 2001). According to the conceptual model of MD (Grieve, 2007) body 
image distortion is influenced by body image dissatisfaction and vice versa. In other 
words, the higher the body image disturbance, the higher the body image dissatisfaction.  
Grieve et al. (2009) emphasized that individuals with body image distortion are at 
higher risk for developing MD. 
 
1.8.3 Sociocultural factors 
1.8.3.1 Media 
Many research documented the relationship between media exposure, body image 
dissatisfaction, and eating disorder pathology among girls and women (e.g. Cafri, 
Yamamiya, Brannick, & Thompson, 2005; Stice, Schupak-Neuberg, Shaw, & Stein, 
1994; Thompson et al., 1999). In the last two decades research have begun focusing on 
the association between muscular male media images and body dissatisfaction among 
boys and men (Agilita & Tantleff-Dunn, 2004; Leit et al., 2002). The overwhelming 
majority of boys and men are exposed to the media images, such as movies, 
advertisements, magazines, and action figures that usually portray muscular male 
bodies, which enhances the desire for a muscular and well-built physique. Studies 
pointed out the role of the media in self-esteem, the development of body image 
dissatisfaction, and MD (e.g., Tager, Good, & Morrison, 2006). However, some authors 
also emphasize that the media influence is often mediated by the level of internalization 
and appearance comparison (Hargreaves & Tiggemann, 2004; Smolak, Murnen, & 
Thompson, 2005). 
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Similarly as the media-communicated female body ideal has become thinner over the 
years, the male models and actors have become more muscular over the last twenty 
years (Pope, Phillips, et al., 2000). The infiltration of hypermuscular male bodies into 
the media has resulted in the increase of males’ social comparison. This comparison 
may have a relevant role in body image dissatisfaction (Grieve, 2007).  
 
Research shows that the media’s portrayal of muscular ideal plays a significant role in 
the increase of the drive for muscularity in men (McCreary & Sasse, 2000). In many 
Western societies men are exposed to several media sources that represent the ideal 
male body more muscular than the average male body. Thus, the media provided an 
influential basis for a desire to attain the current muscular male ideal body among males 
(Pope, Phillips, et al., 2000).  
 
In the last two decades the market for men’s fitness magazines has skyrocketed (e.g., 
Men’s Fitness, Men’s Health, Muscle & Fitness). For instance, the paid circulation of 
Men’s Health in the U.S. raised more than sixfold in seven years, from 250,000 in 1990 
to 1,5 million in 1997 (Cottle, 1998). One of the most famous fitness magazines, the 
Muscle & Fitness is circulated in 22 countries and has a readership of more than seven 
million people worldwide (Etcoff, 1999). The magazine has a circulation of half a 
million per month alone in the U.S. (Ulrich, 2005). Contrary to the ‘hard-core’ 
bodybuilding magazines (e.g., Pump & Flex), these fitness magazines usually do not 
depict very huge and unrealistically hypermuscular male bodies; however, they still 
strongly focus on muscular and well-developed male body appearance. Most of the 
advertisements in these fitness magazines highlight diet products and muscle-growing 
supplements. For example, in Men’s Health, 35% of the advertisements were 
performance-enhancing supplements that advocated muscle gain and fat loss (Labre, 
2005). Although, most of these magazines have words like “health” and “fitness” in 
their titles, they promote the benefits to being muscular highly in comparison to the 
benefits to being healthy and fit (Pope, Phillips, et al., 2000).  One study showed that 
those males who reported more fitness magazine reading had lower levels of self-
esteem, displayed higher levels of body dissatisfaction, were more concerned about 
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their muscularity, and also used more dietary supplements to increase their muscle mass 
(Hatoum & Belle, 2004). Moreover, fitness magazine reading was correlated with the 
increased intention of steroid use among those males who were not using steroids 
(Morry & Staska, 2001). 
 
Studies have also investigated the direct effects of the media’s portrayal of the ideal 
male body and body image dissatisfaction among males. Lorenzen, Grieve, and Thomas 
(2004) exposed men either to muscular or average males’ photographs. Results 
indicated increased body image dissatisfaction post-exposure in those men who were 
exposed to photos of muscular men. Baird and Grieve (2006) exposed men to magazine 
advertisements that contained either male models plus the products or only the products. 
Men who were exposed to advertisements with male models reported higher body 
image dissatisfaction post-exposure than those who were exposed only to the products. 
Leit et al. (2002) found similar results in their study when they exposed men to 
advertisements showing muscular men or neutral advertisements. Those who were 
exposed to the muscular images displayed greater discrepancy between their perceived 
level of muscularity and the ideal body, resulted in greater body image dissatisfaction.  
 
In the etiological model of MD Grieve (2007) proposed that media exposure directly 
influences body image dissatisfaction through different mechanisms. One possible 
mechanism is social comparison: the media communicated male body ideals are 
attractive and muscular. The exposure of such ideals may result in contrast effect in that 
men evaluate their own bodies as less attractive and muscular compared to the media 
ideals. Through this effect social comparison enhances body dissatisfaction. Another 
possible mechanism that decreases the levels of body satisfaction is the increase of 
anxiety and self-consciousness about a problem, namely not being muscular enough, 
and also providing a solution to the problem. Those men who are more susceptible to 
this media message also have higher levels of body dissatisfaction and they are at higher 
risk to develop MD than those who are less vulnerable (Grieve, 2007).  
 
To conclude, the increased exposure to the media and the muscular ideal play an 
influential role in the increase of drive for muscularity and some related disturbances. In 
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the last few decades the Western cultures seem to have placed an increasing value on 
the male body. For instance, the proportion of partially undressed muscular male 
models in women’s magazines rose from 3% in 1950 up to 35% in 1990 (Pope, Phillips, 
et al., 2000). Whereas, in those countries and cultures where the media do not 
emphasize the muscular ideal, men report lower levels of body image dissatisfaction 
(Yang et al., 2005). One study conducted in Taiwan, showed that the Asian culture is 
less focused on the muscular male body comparing to the Western cultures (Yang et al., 
2005). Moreover, the study also revealed that Taiwanese men were less likely to use 
steroids and experience symptoms of MD than U.S. men. The study was also able to 
highlight the cultural differences in the importance of muscular male body appearance 
and related body image disturbances. Hungarian studies are still missing in this field; 
however, the cultural differences would be interesting in this respect. 
 
1.8.3.2 Peer experiences and parental influences  
Recent research has shown that peer-experiences, specifically appearance- and weight 
related teasing in childhood can also be a relevant factor in the development of eating 
and body image disorders (Thompson, Cattarin, Fowler, & Fisher, 1995). According to 
the study results of Thompson et al. (1995), the frequency of childhood teasing had a 
strong relationship with body image and eating disturbances. Studies also suggest that 
childhood weight related teasing is a predictor for increased body dissatisfaction and 
eating disturbances (Eisenberg, Neumark-Sztainer, & Story, 2003; Stice, 2002). 
Childhood teasing and bullying experiences relating to the lack of musculature or 
weight has been identified as a risk factor for MD in males. Men with MD often report a 
history of weight related (being underweight or overweight) teasing during childhood 
and adolescence (Olivardia, 2001). As the consequence of this childhood bullying 
experience, they become preoccupied with their body appearance and physique to make 
an end of the harassment.  
 
Pubertal timing may also play an important role in the development of MD (Cafri et al., 
2006). During adolescence, boys are getting more muscular so that they also get closer 
to the muscular male body ideal. Boys who experience delayed puberty have less 
developed physique and are more likely to experience childhood teasing. As a 
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consequence, they are more likely to engage in extreme body change strategies and 
harmful muscle-growing behaviours (McCabe & Ricciardelli, 2001a, 2004).  
 
Based on the aforementioned evidences, one study aimed at investigating the 
relationship between MD, childhood bullying experiences, and some related mental 
health problems in a sample of male bodybuilders (Wolke & Sapouna, 2008). 
According to the results, 21% of the bodybuilders reported childhood bullying 
victimization. Those bodybuilders who reported higher frequencies of regular childhood 
teasing were more likely to develop MD symptoms. Moreover, results also indicated 
that childhood bullying victimization and MD had a strong relationship with low self-
esteem, anxiety, and symptoms of depression and obsessive-compulsive disorder. Study 
results also revealed that the association between childhood bullying experience, global 
psychopathology, and low self-esteem was mediated by MD.   
 
Increasing peer popularity may also lead to the engagement in muscle-gaining 
techniques (McCabe, Ricciardelli, & Finemore, 2002). O’Koon (1997) pointed out that 
the main reasons for steroid use among adolescent boys were to increase their 
popularity among peers and also to increase their personal appeal. 
 
Studies have shown that parental influences also have a great role in the development of 
increased drive for muscularity (Hungarian review: Varga& Babusa, 2012). Ricciardelli 
and McCabe (2004) found that the perceived parental pressure to achieve the muscular 
ideal was associated with weight and muscle gain strategies in adolescent boys. 
Although both parents have a strong influence on child’s body image and body-esteem, 
research indicate that specifically fathers have an even stronger influence on their 
adolescent boys’ body image and increased muscle-gaining strategies (McCabe & 
Ricciardelli, 2003; Vincent & McCabe, 2000).  
 
In conclusion, the evidence suggests that the media, peer, and parental influences 
contribute to the drive for muscularity in adolescent boys. Therefore, Stanford and 
McCabe (2005) examined the influence of media, parents, and peers on adolescent 
boys’ body image and body change strategies. Results indicated that parents had the 
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strongest influence on body image, and the media and peers had a lesser influence. 
However, the messages about shape and increasing muscles from each of the 
sociocultural sources (media, parents, and peers) predicted muscle-gaining strategies 
among adolescent boys.  
 
1.9 Treatment possibilities of muscle dysmorphia 
First of all, it should be noted that there is no empirically validated treatment for MD. 
However, because of the etiological similarities with eating disorders, it is hypothesized 
that those treatments that seem to be effective for eating disorders would be also 
effective for MD (Olivardia, 2007; Hungarian review: Babusa, 2011). Moreover, the 
treatments of obsessive-compulsive disorder and body dysmorphic disorder also provide 
a basis that may be helpful for the treatment of MD. 
 
Another consideration is that men with MD rarely seek for treatment (Olivardia, 2007; 
Pope, Phillips, et al., 2000). If they do so, they do it because of secondary problems due 
to MD or substance abuse (e.g., depression, sexual dysfunctions, anxiety). When a 
person with MD engages in treatment, several therapeutical methods can be used. 
 
1.9.1 Psychoeducation 
As in the treatment of eating disorders, psychoeducation can be a necessary and relevant 
part of the treatment of MD. During the initial phase of the treatment, the assessment of 
the body image and the discussion about realistic body image ideals can be beneficial. 
Other topics for discussion may involve proper nutrition, the dangers of steroid use, and 
the onset and development of MD (Grieve et al., 2009; Olivardia, 2007). 
 
1.9.2 Cognitive-behavioural therapy 
Cognitive-behavioural techniques proved to be effective in the treatment for eating 
disorders and body dysmorphic disorder (Rosen, Reiter, & Orosan, 1995), suggesting 
that these therapeutical techniques could be useful in the treatment of MD (Olivardia, 
2007). The purpose of cognitive strategies is to identify and modify distorted thinking 
patterns. For example, one typical distorted thinking pattern in MD is the “all or nothing 
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thinking”. During the therapy the patient is expected to observe and later on challenge 
these thoughts. The patient has to develop some coping skills to deal with maladaptive 
behaviours; therefore, relaxation techniques may be beneficial (Olivardia, 2007; Pope, 
Phillips, et al., 2000).  
 
The aim of the behavioural strategies is the reduction of maladaptive behaviours, such 
as mirror checking, excessive exercise, and reassurance seeking. Social exposure may 
be also useful as a behavioural strategy. Other techniques, such as self-monitoring and 
identifying the triggers for the maladaptive behaviours also can be used. The therapy 
could also aim at stopping AAS use (Olivardia, 2007; Pope, Phillips, et al., 2000).  
 
1.9.3 Psychodynamic psychotherapy 
Exploring the potential causes of the development of MD in a safe and supportive 
environment can be helpful (Olivardia, 2007). Therefore, exploration of the 
development of masculinity, peer experiences, such as teasing and bullying experiences, 
relationship with the father, or important life events that may have contributed to the 
development of MD is advisable. 
 
Relating to the psychodynamic therapy, we also have to consider the self-theoretical 
approach of MD (Babusa & Túry, 2007). In this respect the quality of the early mother-
child realationship has an influence on the developing self –both on the body and the 
psychological self– of the child (Fonagy & Target, 1998). The damage of the early self 
is crucial in that respect how we can experience our body later in our lifes. Therefore, 
therapy should also focus on the disorders of the self and the inner object relations. 
 
1.9.4 Pharmacotherapy 
Those medications that help to decrease obsessive-compulsive symptoms of the 
disorder –and also effective in the treatment of eating disorders and body dysmorphic 
disorder– should be useful in the treatment of MD (Olivardia, 2007; Pope, Phillips, et 
al., 2000). Therefore, the use of selective serotonin reuptake inhibitors (SSRIs) during 
the treatment may be also beneficial.  
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Many studies have suggested that MD is prominent among those men who are 
participating in sports; therefore, some authors emphasize the role of athletic trainers in 
the recognition of MD symptoms, as well as in the intervention strategy. Leone, Sedory, 
and Gray (2005) proposed a conceptual model for developing an intervention strategy to 
individuals with possible MD and suggested that this model can be an effective first 
step during the intervention (see Figure 5). They offer that athletic trainers should 
approach the individual with possible MD in a nonconfrontational manner and should 
focus on the motivation for the intervention. 
 
Other authors highlighted the role of family members, close friends, and partners in the 
recognition of MD (Pope, Phillips, et al., 2000). The authors argued that many boys and 
men are ashamed about their muscularity and appearance concerns, and they often do 
not disclose them. They offered a list of twelve clues to the MD and some related body 
image disorders in boys and men (Pope, Phillips, et al., 2002, pp. 194–195). 
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Figure 5. Conceptual model for developing an intervention strategy to individuals with possible muscle 
dysmorphia (Leone et al., 2005). 
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2. OBJECTIVES 
2.1 General objectives of the study 
 
Currently, the epidemiology and prevalence rate of MD in Central-Eastern European 
countries, including Hungary, is unknown. The general objective of the study was the 
examination of MD symptomatology and related psychological correlates in Hungarian 
high risk populations. Moreover, the exploration of cultural differences in the 
manifestation of MD (i.e., prevalence rates, morbidity) is also an important field and 
may contribute to our understanding of this body image disorder.  
 
The current work consisted of three different studies, and each of them targeted certain 
aims. The first preliminary study aimed to reveal MD among Hungarian male 
weightlifters and university students. Since there was no available measure of MD 
symptoms in Hungary, the study also examined the usability of the Hungarian version 
of the Muscle Appearance Satisfaction Scale (MASS; Mayville, Williamson, 
Netemeyer, & Drab, 2002), a measure of MD symptoms. The second study aimed to 
examine the psychometric properties of the Hungarian version of the MASS (MASS-
HU) among male weightlifters and undergraduate students. The study analyzed the 
factor structure, the internal consistency, the test-retest reliability, and the construct 
validity of the MASS-HU. The first preliminary study and the second questionnaire 
validation study provided an appropriate framework for the epidemiological study of 
MD among male weightlifters (Study 3). The third study was a larger scale study, 
conducted among male weightlifters, with multiple aims: (1) to reveal the prevalence 
rate of MD among Hungarian male weightlifters, (2) to determine a tentative cut-off 
score of the MASS, (3) to examine the psychological correlates of MD, (4) to reveal the 
prevalence rate of AAS use among Hungarian male weightlifters, (5) to examine the 
characteristics and risk factors of AAS use. Since the third study was a broad spectrum 
study, we presented it in full details. 
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2.2 Examination of muscle dysmorphia in male weightlifters and university 
students – aims 
 
Since no validated measure for the assessment of MD symptoms was available in 
Hungary, the study aim was the preliminary investigation of the potential usability of 
the Muscle Appearance Satisfaction Scale (Mayville et al., 2002), a measure of MD 
symptoms, in Hungary. Therefore, this preliminary study explored MD symptoms in a 
Hungarian high risk population of male weightlifters as well as among university 
students. Specifically, eating disorder related psychopathological characteristics and 
body attitudes in these samples were studied.  
 
2.3 Adaptation of the Muscle Appearance Satisfaction Scale in Hungary – 
aims and hypotheses 
 
Research interest has grown considerably in recent years in the area of male body image 
disorders and specifically in MD. Research has also focused to study MD in the last 
decade in Hungary. Therefore, the importance of the validation of the MASS in 
Hungary has grown over the years. Furthermore, the validation of the MASS would 
make it possible to carry out cross-cultural comparative studies. 
 
The main purpose of the second study was to examine the psychometric properties of 
the MASS among male weightlifters and undergraduate students in Hungary. Therefore, 
the factor structure, scale score reliability, test–retest reliability, construct, and 
discriminant validity of the MASS were investigated. The secondary aim was the the 
exploration of the relationship between aspects of MD, self-esteem, exercise-related, 
and other variables. 
 
Hypothesis 1. Studies documented that the age of onset of MD was in early adulthood 
(19.17±4.38 years, Cafri et al., 2008; 19.4±3.6 years, Olivardia et al., 2000). It was 
expected that younger men would have higher scores on the MASS, and they would 
display more symptoms of MD.  
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Hypothesis 2. Grieve (2007) involved body mass in the conceptual model of MD since 
increased body mass and the achievement of muscular and mesomorphic body shape are 
important for men with MD. Thus, men with higher BMI were predicted to report more 
symptoms of MD.  
 
Hypothesis 3. The conceptual model of MD (Grieve, 2007) along with other studies 
(Grieve & Helmick, 2008; Lantz et al., 2001; Pope, Gruber, et al., 2000) identified low 
self-esteem as an etiological factor in MD. It was hypothesized that men with lower 
level of self-esteem were expected to display higher levels of MD.  
 
Hypothesis 4. Studies suggested that men with MD showed increased desire for gaining 
muscle mass and drive for muscularity (Olivardia, 2001; Pope et al., 1997). Thus, an 
inverse relationship was hypothesized between drive for thinness and aspects of MD.  
 
Hypothesis 5. MD is accompanied by excessive exercise and weightlifting activity 
(Pope et al., 1997). A positive correlation between MD symptoms and the years of 
exercise was assumed.  
 
Hypothesis 6 and 7. There is a growing literature regarding the use of anabolic-
androgenic steroids and food supplements among men suffering from MD, suggesting 
that these men are more likely to use these substances to increase muscle mass 
(Kanayama et al., 2006; Olivardia et al., 2000; Pope & Katz, 1994). Thus, it was 
hypothesized that current steroid users (H6) and food supplement users (H7) report 
more symptoms of MD.  
 
Hypothesis 8. The conceptual model of MD (Grieve, 2007) also involves sport 
participation –mainly bodybuilding/weightlifting– as a risk factor. It was assumed that 
weightlifting activity indicates more MD symptoms in the undergraduates group. 
 
2.4 Muscle dysmorphia among Hungarian male weightlifters – aims and 
hypotheses 
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Since the third study was a larger scale study, it had multiple purposes. The first aim 
was to identify a group of male weightlifters with unique features of MD, which can be 
distinctive from “normal” non-muscle dysmorphic weightlifters. The secondary aim of 
the study was to explore differences between muscle dysmorphic and normal non-
muscle dysmorphic groups of male weightlifters based on various psychological 
correlates. The third aim of the study was to define the tentative cut-off score of the 
MASS as there is no available cut-off score for the scale. The determination of a cut-
point would allow the use of the MASS as a meaningful screening measure for the 
identification of those male weightlifters who are at-risk for developing MD. To our 
knowledge, only one study assessed the prevalence rate of AAS use in Hungarian male 
weightlifters (Túry et al., 2001). Since AAS use has many adverse effects and 
presumably has different risk factors like that of MD, we also aimed to set out the 
prevalence rate of AAS use among male weightlifters to examine the characteristics of 
AAS users, and to determine the risk factors associated with AAS use.  
 
Hypothesis 1. Studies from the last twenty years reported considerable prevalence rate 
of MD among male weightlifters. Pope et al. (1993) found 8.3%, Pope and Katz (1994) 
reported 10%, and Hildenbrandt et al. (2006) identified 17% of their weightlifter sample 
as muscle dysmorphic with the use of latent class analysis. The previous smaller scale 
Hungarian study found 4% prevalence rate of MD among male weightlifters (Túry et 
al., 2001). It was assumed that the prevalence rate of MD among Hungarian male 
weightlifters in the current study is comparable with previously reported data. 
 
Hypothesis 2. Growing body of literature suggests that men with MD use AAS and food 
supplements to increase their muscle mass more frequently than normal weightlifters 
(Cole, Smith, Halford, & Wagstaff, 2003; Kanayama et al., 2006; Olivardia et al., 2000; 
Pope & Katz, 1994). Therefore, it was hypothesized that the MD group report a higher 
frequency of AAS and supplement use. 
 
Hypothesis 3. Several studies pointed out the relationship between low self-esteem and 
MD (Grieve, 2007; Grieve & Helmick, 2008; Lantz et al., 2001; Pope, Gruber, et al., 
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2000). It was hypothesized that MD group would have a lower level of self-esteem than 
normal weightlifters. 
 
Hypothesis 4. Research pointed out that eating disorders are also prevalent among men 
with MD (Mangweth et al., 2001; McFarland & Kaminski, 2009; Pope et al., 1993; 
Pope et al., 1997; Olivarardia et al., 2000). It was assumed that MD group would 
display more eating disorder related psychopathological characteristics than normal 
weightlifters. 
 
Hypothesis 5. Many studies found an association between MD and anxiety disorders 
(Chandler & Grieve, 2009; Maida & Armstrong; 2005; McFarland & Kaminski, 2009; 
Olivardia et al., 2000; Cafri et al., 2008), thus it was hypothesized that MD group would 
have a higher level of anxiety compared to normal weightlifters. 
 
Hypothesis 6. Research showed that the prevalence of AAS use is considerably high in 
the bodybuilder and weightlifter population (Thiblin & Petersson, 2005). Pope et al. 
(1993) and Kanayama et al. (2003) reported 51% and 50%, respectively. Pope et al. 
(2012) found 44% prevalence rate of AAS use among male weightlifters. Previous 
Hungarian smaller scale study found 9.3% prevalence rate of AAS use among male 
weightlifters (Túry et al, 2001). It is assumed that the prevalence rate of AAS use 
among Hungarian male weightlifters in the current study will be comparable with 
previously reported data. 
 
Hypothesis 7. Research evidence suggests that AAS users display higher levels of MD 
symptoms than non-users (Kanayama et al., 2003; Rohman, 2009; Olivardia et al., 
2000; Pope et al., 1993). Therefore, higher levels of MD symptoms were assumed 
among AAS user male weightlifters.  
 
Further, we aimed to explore those psychological characteristics (self-esteem, self-
efficacy, trait anxiety, and eating disorder related psychopathological characteristics) 
which may be associated with the use of AAS.  
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3. METHODS 
3.1. Study design and sample  
 
3.1.1 Examination of muscle dysmorphia in male weightlifters and university 
students 
 
Two independent samples were recruited for this study: 
Sample 1: Participants in this group were male weightlifters (n = 60) recruited in fitness 
centers and gyms.  
 
Sample 2: Participants were age-matched undergraduate male students (n = 60), 
reporting no weightlifting activity.  
 
All participants provided written informed consent, took part in the study on a voluntary 
basis and were not remunerated for participation. Participants were asked to complete 
the paper-and-pencil questionnaire anonymously, which took approximately 10 
minutes.  
 
3.1.2 Adaptation of the Muscle Appearance Satisfaction Scale in Hungary 
 
Three independent samples were recruited for the questionnaire based study: 
 
In Sample 1, male weightlifters (n = 289) participating in weightlifting activity were 
recruited in fitness centers and gyms located in Budapest and its outskirts. The only 
exclusion criterion was age below 18. They were invited to complete the online 
questionnaire anonymously, which took approximately 15-20 min. Invitations to take 
part in an exercise-related study, called “Exercise and Quality of Life”, were given 
either personally or sent by the owners of several gyms and fitness clubs via email. The 
invitation letter contained general information about the study, the address of the 
website of the online questionnaire, and the username and password for the entrance. 
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The website presented an introductory letter that contained the elements of the informed 
consent. Participants were asked to confirm their agreement in the study, by clicking on 
a button, acknowledging that they have read the informed consent and were comfortable 
with that. After the completion of the questionnaire, participants submitted their 
responses, which were downloaded in an excel spreadsheet. The responses were then 
imported in SPSS for data analysis. 
 
In Sample 2, male undergraduate students (n = 240) were asked to complete the paper-
and-pencil questionnaire anonymously during or after a university class in a large 
university located in Budapest. 
 
An additional sample (Sample 3) of male weightlifters (n = 43) were recruited in gyms 
in order to assess the test–retest reliability of the MASS. Participants were asked to 
write a code on their questionnaire. This code allowed the researchers to perform a two-
week follow-up. 
 
3.1.3 Muscle dysmorphia among Hungarian male weightlifters 
 
The sample size of the second study was complemented by 15 new participants, thus the 
total sample size of the third study was 304 male weightlifters.   
 
3.1.4 Ethical approval 
Ethical approval for the studies was obtained from the Semmelweis University Regional 
and Institutional Committee of Science and Research Ethics (3/2009). All participants 
provided informed consent. They were not remunerated for participation and taking part 
in the study was voluntary. 
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3.2. Measuring instruments 
 
3.2.1 Examination of muscle dysmorphia in male weightlifters and university 
students 
 
3.2.1.1 Muscle Appearance Satisfaction Scale 
Muscle Appearance Satisfaction Scale (MASS; Mayville et al., 2002; Hungarian 
version: Babusa & Túry, 2011; Hungarian validation: Babusa, Urbán, Czeglédi, & Túry, 
2012) is a short, 19-item scale developed to measure cognitive, affective, and behavioral 
dimensions of MD and it’s symptoms. The multidimensional self-report measure has 
five subscales: 
 
(1) Bodybuilding Dependence: this subscale reflects an excessive weightlifting 
activity and also a compulsive tendency to work outs. The subscale includes 
such statements as “If my schedule forces me to miss a day of working out with 
weights, I feel very upset”. 
(2) Muscle Checking: items in this subscale reflect mirror checking and reassurance 
seeking behavior to assess the appearance of one’s muscles. The subscale 
includes such statements as “I often spend a lot of time looking at my muscles in 
the mirror”. 
(3) Substance Use: this subscale evaluates a willingness to try anabolic-androgenic 
steroids and other potentially risky supplements to gain muscle mass. The 
subscale includes such statements as “I often spend money on muscle building 
supplements”. 
(4) Injury Risk: items in this subscale assess the symptoms of overtraining and 
beliefs related to unsafe weightlifting behaviour. The subscale includes such 
statements as “I often keep working out even when my muscles or joints are sore 
from previous workouts”. 
(5) Muscle Satisfaction: this subscale evaluates the satisfaction with the individual’s 
own muscle size and shape. The subscale includes such statements as “When I 
look at my muscles in the mirror, I often feel satisfied with my current muscle 
size”. 
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The scale contains both positive- and reverse-worded items. The items were rated on a 
five-point Likert-type scale (1 = strongly disagree, 5 = strongly agree). Scores ranged 
from 19 to 95 with higher scores reflecting a tendency towards MD. Examination of the 
internal consistency of the MASS has proved that the scale total score had good 
reliability (α = .87 and .82; Mayville et al., 2002) and test-retest reliability (r = .87, 
Mayville et al., 2002). All in all, the evaluation of psychometric properties of the MASS 
supported its internal consistency, test-retest reliability, construct validity, and a stable 
five-factor structure in samples of male weightlifters. Alpha coefficients in the current 
study samples were .85 (95% CI [.79, .90]) for weightlifters and .81 (95% CI [.74, .87]) 
for undergraduates. 
 
It has to be mentioned that there was no available measure assessing MD symptoms in 
Hungarian language before this study. Therefore, previous research studying MD used 
neither the MASS, nor other MD-related measures in Hungary. During the construction 
of the Hungarian version of the MASS, we focused on achieving conceptual 
equivalence. Thus, we applied the forward-backward-forward translation technique. In 
the first step, two independent professional bilingual translators translated the original 
English version of the MASS into Hungarian. Then, the two independent professional 
bilingual translators and one member of the research group reviewed and reconciled the 
forward translation. After that, the reconciled forward translation was translated back 
into English by another two independent bilingual translators. In the second step, the 
research group and the professional forward translators reviewed and compared the 
backward translation with the original English questionnaire. The back-translated 
questionnaire was similar in meaning to the original English questionnaire. The aim of 
the final step was to reconcile the items of the MASS and produce the final forward 
translation.  
 
3.2.1.2 Body Attitude Test 
Body Attitude Test (BAT; Probst, Vandereycken, Van Coppenolle, et al. 1995; 
Hungarian version: Túry & Szabó, 2000) is a 20-item self-report instrument developed 
to measure attitudes towards body image. The scale has four dimensional factors: (1) 
Negative Appreciation of Body Size, (2) Lack of Familiarity with one's own Body, (3) 
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General Body Dissatisfaction, and (4) a rest factor. Items were rated on a 6-point Likert-
type scale (0 = never, 5 = always). The scale contains both positive and reverse-worded 
items. Scores ranged from 0 to 100, higher score indicates deviated body experience. 
The cut-off score is 36 for pathological body attitude. Previous work on different 
Hungarian samples has shown that the scale has good reliability (α = .89-90, test-retest: 
r = .92) construct and convergent validity (Czeglédi, Urbán, & Csizmadia, 2010). Alpha 
coefficients in the current study samples were .77 (95% CI [.68, .85]) for weightlifters 
and .82 (95% CI [.75, .88]) for undergraduates. 
 
3.2.1.3 Eating Disorders Inventory 
Eating Disorder Inventory (EDI; Garner et al., 1983; Hungarian version: Túry, Sáfrán, 
Wildmann, & László, 1997) is a 64-item scale developed to measure behavioural and 
psychological traits in AN and BN in eight subscales: 
(1) Drive for Thinness subscale measures excessive concern with body weight and 
an intense drive for a thin body.  
(2) Bulimia subscale indicates binge eating episodes and self-induced vomiting.  
(3) Body Dissatisfaction measures the belief that some body parts are too large or 
fatty.  
(4) Ineffectiveness subscale reflects to the lack of general self-efficacy and the 
feeling of inadequacy.  
(5) Perfectionism subscale assesses the increased desire towards high personal 
achievements.  
(6) Interpersonal Distrust subscale reflects the feeling of alienation and fear of too 
close relationships.  
(7) Interoceptive Awareness assesses the “lack of confidence in recognizing and 
accurately identifying emotions and sensations of hunger or satiety” (Garner et 
al., 1983).  
(8) Maturity Fears measures the fears of the demands of adulthood and the general 
positive feelings relating to the security of the childhood. 
 
The subscales contain both positive- and reverse-worded items. Items were rated on a 6-
point Likert-type scale (1 = never, 6 = always). In the present study, four subscales 
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assessing the psychological characteristics of individuals with eating disorders 
(Ineffectiveness, Perfectionism, Interpersonal Distrust, and Interoceptive Awareness) 
and one subscale measuring the attitudes towards body shape (Body Dissatisfaction) 
were used. Higher scores on the subscales indicate higher levels of eating disorder 
related pychopathological characteristics. In a previous study conducted on a Hungarian 
sample, the subscales demonstrated adequate reliability (α = .71–.93; test-retest: r = .79) 
and construct validity (Túry et al., 1997). Alpha coefficients in the current study 
samples were acceptable for weightlifters (α = .61–.79) and ranged from poor to 
acceptable for undergraduates (α = .59–.74). 
 
3.2.2 Adaptation of the Muscle Appearance Satisfaction Scale in Hungary 
 
3.2.2.1 Sociodemographic and anthropometric data 
Six questions were devised to reveal the sociodemographic (age, marital status, place of 
usual residence, educational qualifications) and anthropometric data (body height and 
body weight) of the participants. 
 
3.2.2.2 Exercise-related variables 
Besides the demographic and anthropometric questions we also targeted some exercise-
related variables. These questions consisted of: (1) years of exercise (i.e., “How long do 
you have been lifting weights?”), (2) current use of anabolic-androgenic steroids and (3) 
food supplements in yes/no response format question (i.e., “Do you currently use 
anabolic androgenic steroids?” and “Do you currently use food supplements?”) in the 
weightlifter group, and (4) any weightlifting activity in yes/no-response format question 
(i.e., “Are you engaged in any weightlifting activity?”) in the undergraduates group. 
 
3.2.2.3. Muscle Appearance Satisfaction Scale 
The general description of the Muscle Muscle Appearance Satisfaction Scale (MASS; 
Mayville et al., 2002) has been detailed in Study 1. Alpha coefficients in the current 
study samples are presented in Tables 7 and 8. 
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3.2.2.4 Eating Disorders Inventory – Drive for thinness subscale 
The Eating Disorder Inventory (EDI; Garner et al., 1983) has been described in details 
in Study 1. In the present study, only the seven-item Drive for Thinness subscale of the 
inventory was used, which assesses attitudes towards weight, body shape, and eating, 
i.e., preoccupation with diet, concern over body weight, drive for losing weight, and 
fear of gaining weight. Scores ranged from 0 to 21 (scoring procedure see: Garner et al., 
1983), with higher scores reflecting a greater drive for thinness. Alpha coefficients in 
the current study samples for the Drive for Thinness subscale were .70 (95% CI [.64, 
.75]) for weightlifters and .73 (95% CI [.67, .78]) for undergraduates. 
 
3.2.2.5 Rosenberg Self-Esteem Scale 
Rosenberg Self-Esteem Scale (RSES; Rosenberg, 1965; Hungarian version: Paksi, 
Felvinczi, & Schmidt, 2004) is a 10-item scale for the measurement of global self-
esteem understood as a person’s overall evaluation of his or her worthiness as a human 
being. Items were rated on a Likert-type scale (1 = strongly disagree, 4 = strongly 
agree). The scale contains both positive and reverse-worded items. Scores range from 
10 to 40, with higher scores reflecting higher self-esteem. Previous studies on the 
Hungarian version of RSES demonstrated adequate internal consistency (α = .77; Paksi 
et al., 2004; α = .79 and .85; Czeglédi et al., 2010). Alpha coefficients in the current 
study samples were .82 (95% CI [.78, .85]) for weightlifters and .86 (95% CI [.83, .88]) 
for undergraduates. 
 
3.2.3 Muscle dysmorphia among Hungarian male weightlifters 
 
3.2.3.1 Sociodemographic and anthropometric data 
Seven questions were devised to reveal the sociodemographic (age, marital status, place 
of usual residence, educational qualifications) and anthropometric data (body height, 
body weight, and desired body weight) of the participants. 
 
3.2.3.2 Exercise-related variables 
Besides the demographic and anthropometric questions we also targeted some exercise-
related variables. These questions consisted of:  
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(1) years of exercise (i.e., “For how long have you been lifting weights?”),  
(2) the amount of time spent with exercise (i.e., “How long is your regular exercise?”), 
(3) current use of anabolic-androgenic steroids in yes/no response format (i.e., “Do you 
currently use anabolic-androgenic steroids?”),  
(4) past use of anabolic-androgenic steroids in yes/no response format (i.e., “Have you 
used anabolic-androgenic steroids in the past?”), 
(5) use of food supplements in yes/no response format (i.e., “Do you currently use food 
supplements?”). 
 
3.2.3.3 Training objectives and subjective satisfaction 
A short, four-item questionnaire concerning the subjective satisfaction with body weight 
and musculature and the subjective importance of weight loss and muscle mass gain as 
training objectives was constructed for the purpose of this study. The purpose of this 
scale was the assessment of general importance of weight loss and muscle mass gain as 
training objectives, as well as subjective satisfaction with body weight and musculature 
at the present time. Items were rated on a 5-point Likert-type scale (1 = not 
important/satisfied at all, 5 = very important/satisfied), with higher scores reflecting 
higher importance or satisfaction.  
 
3.2.3.4 Weight dissatisfaction 
Weight dissatisfaction was counted as the desired body weight minus the actual body 
weight (self-reported). This parameter indicates how far or close a person is from the 
weight that he would like to have. With the use of the weight dissatisfaction parameter 
we were also able to define the direction of the weight dissatisfaction; thus, a positive 
sign indicated the desire of weight loss and a negative sign indicated the desire of 
weight gain. Both positive and negative signs indicate weight dissatisfaction, while 
value zero suggests weight satisfaction, since there is no difference between actual and 
desired body weight. On the basis of this continuous variable we created a further 
discrete variable –body weight category: (1) would like to lose weight, (2) would like to 
remain in the current weight, (3) would like to gain weight. 
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3.2.3.5 Muscle Appearance Satisfaction Scale 
The general introduction of the Muscle Appearance Satisfaction Scale (Mayville et al., 
2002) has been described in Study 1. The examination of the psychometric properties of 
the Hungarian version of the MASS (MASS-HU) supported the use of the construct in 
male weightlifter population. Alpha coefficients in the current study sample ranged 
from acceptable to good, and are presented in Table 13. 
 
3.2.3.6 Eating Disorders Inventory 
The general description of the Eating Disorders Inventory (EDI; Garner et al., 1983) has 
been detailed in Study 1. In the present study two subscales that assessed the attitudes 
towards weight, body shape, and eating (i.e., Drive for Thinness and Bulimia) and three 
subscales that assessed the psychological characteristics of individuals with eating 
disorders (i.e., Perfectionism, Interoceptive Awareness, and Interpersonal Distrust) were 
used. Higher scores on the subscales indicate higher levels of eating disorder related 
pychopathological characteristics. Alpha coefficients in the current study were 
acceptable, and are presented in Table 13. The Bulimia subscale of the EDI had 
unacceptable internal consistency (α = .40, 95% CI [.29, .50]); thus this measure had to 
be excluded from the analysis due to low Cronbach's alpha value (< .6).   
 
3.2.3.7 SCOFF Questionnaire 
The SCOFF Questionnaire (Morgan, Reid, & Lacey, 1999; Hungarian translation: Túry 
F.) is a brief screening tool using five questions addressing core features of AN and BN. 
The measure consists of five items in yes/no response format question. Two or more 
“yes” answers to the questions are recommended as the cut-off to indicate a likely case 
of AN or BN. The authors recommended the use of SCOFF as a screening tool that can 
raise the suspicion of a likely case of eating disorder rather than to use it as a diagnostic 
tool.  
 
Alpha coefficient is presented in Table 13. Further methodological considerations 
relating to the scale are discussed in the Limitations section. 
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3.2.3.8 Exercise Addiction Inventory 
The Exercise Addiction Inventory (EAI; Terry et al., 2004; Hungarian version: 
Demetrovics & Kurimay, 2008) is a short, six-item scale developed to measure exercise 
addiction. Items were rated on a 5-point Likert-type scale (1 = strongly disagree, 5 = 
strongly agree). Scores range from 6 to 30, with higher scores reflecting attributes of 
addictive exercise behavior. The items have been developed to reflect the main 
characteristics of exercise addiction, such as perceived importance of exercise, 
subjective experience reported as a consequence of exercise, frequency of exercise 
needed to achieve the desired benefits, presence of withdrawal symptoms, perceived 
conflicts between the sufferer and family arising from the exercising, and possible 
occurrences of relapse. 
 
The authors of the EAI also provided a theoretical and convenient cut-off score for the 
identification of those who are at risk for exercise addiction, and can distinguish 
between those who may be symptomatic or asymptomatic of exercise addiction. The 
cut-off score for individuals considered at-risk of exercise addiction was 24. This cut-
off point represents those individuals with scores in the top 15% of the total scale score. 
A score of 13–23 was indicative of a symptomatic individual and a score of 6–12 
indicated an asymptomatic individual. A recent Hungarian study demonstrated that the 
EAI has good psychometric properties and also suggested new thresholds for the EAI: 
0–13 = asymptomatic, 14–23 = symptomatic non-dependent, 24–30 = at risk for 
exercise dependence (Mónok et al., 2012).  
 
Previous works on Hungarian samples demonstrated adequate internal consistency for 
the scale (α = .72; Mónok et al., 2012; Paksi, Rózsa, Kun, Arnold, & Demetrovics, 
2009). Alpha coefficient in the current study sample is presented in Table 13. 
 
3.2.3.9 State-Trait Anxiety Inventory – Trait Anxiety subscale 
The State-Trait Anxiety Inventory (STAI; Spielberger, Gorssuch, Lushene, Vagg, & 
Jacobs, 1983; Hungarian version: Sipos, Sipos, & Spielberger, 1988) is used to assess 
state and trait-based levels of anxiety. The STAI is a 40-item self report measure that 
assesses both how a person feels at the moment (state anxiety) and how he or she 
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generally feels (trait anxiety). Because the focus of this study is on the overall 
personality and long-term characteristics of the participants, we assessed only the trait 
anxiety in the current study. The Trait Anxiety subscale is a 20-item measure that 
contains both positive and reverse-worded items. The items were rated on a four-point 
Likert-type scale (1 = not at all, 4 = very much so). Scores range from 20 to 80; higher 
scores indicate greater trait anxiety. Previous studies on the Hungarian version of the 
STAI demonstrated adequate reliability (α = .86; Sipos, 1978). In the present study, the 
Cronbach’s alpha for the STAI was good and is presented in Table 13. 
 
3.2.3.10 Rosenberg Self-Esteem Scale 
The general description of the Rosenberg Self-Esteem Scale (RSES; Rosenberg, 1965) 
has been detailed in Study 2. Alpha coefficient in the current study sample was good 
and is reported in Table 13. 
 
3.2.3.11 General Self-Efficacy Scale 
The General Self-Efficacy Scale (GSES; Schwarzer & Jerusalem, 1995; Hungarian 
version: Kopp, Schwarzer, & Jerusalem, 1993) is a ten-item measure that has been 
designed to assess optimistic self-beliefs to cope with a variety of difficult demands in 
life. The GSES in general refers to the sense of personal competence to deal effectively 
with a variety of stressful situations; in other words, it reflects the belief that one's 
actions are responsible for successful outcomes. These items were rated on a four-point 
Likert-type scale (1 = not at all true, 4 = exactly true). Scores range from 10 to 40, with 
higher scores reflecting higher perceived self-efficacy. Previous studies on the 
Hungarian version of the GSES demonstrated adequate reliability (α = .82; Salavecz, 
Neculai, & Jakab, 2006; α = .83; Rózsa et al., 2003). Alpha coefficient in the current 
study sample was good and is reported in Table 13.  
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3.3. Data analyses 
 
3.3.1 Examination of muscle dysmorphia in male weightlifters and university 
students 
 
3.3.1.1 Analyses of the examination of muscle dysmorphia symptoms, eating disorder 
variables, and body attitudes 
To explore the differences of MD symptoms, eating disorder related 
psychopathological characteristics, and body attitudes between weightlifters and 
undergraduates, a series of independent sample t-tests and Mann-Whitney U-tests were 
performed. Effect size was calculated using Cohen’s d. An effect size of more than .2 
was considered to be a small effect size. An effect size of .5 or more signified a 
medium-size effect, and an effect size of .8 or more indicated a large effect size (Cohen, 
1992). Group differences were explored using multiple linear regression analysis 
adjusted to age and BMI. 
 
3.3.1.2 Analyses to explore the explanatory variables of muscle dysmorphia 
To investigate explanatory variables that are associated with MD among male 
weightlifters, multiple linear regression analyses were performed, adjusted to age and 
the strength and direction of relationships between the dependent variable (levels of MD 
symptoms based on the MASS scores). Furthermore, explanatory variables (group 
participation –weightlifter or undergraduate–, body weight, desired body weight, EDI 
subscales: body dissatisfaction, ineffectiveness, perfectionism, interpersonal distrust, 
interoceptive awareness, maturity fears; body attitudes, and age) were assessed by 
determining regression coefficients (adjusted β), and t-test statistics. The proportion of 
the variance in the dependent variable explained by the explanatory variables (adjusted 
R
2
) has also been determined. 
 
3.3.1.3 Analyses of the study variables in self-reported steroid users and non-users 
Comparing the self-reported steroid users and non-users in the weightlifter group, a 
series of independent sample t-tests and Mann-Whitney U-tests were performed and the 
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means (SD) of the different study variables were compared. Effect size was calculated 
using Cohen’s d. Group differences were explored using multiple linear regression 
analysis adjusted to age and BMI. The SPSS 16.0 statistical software package was used 
for statistical analyses.  
 
3.3.2 Adaptation of the Muscle Appearance Satisfaction Scale in Hungary 
 
3.3.2.1 Analyses of the factorial structure of the Hungarian version of the Muscle 
Appearance Satisfaction Scale 
We examined the factorial structure of the Hungarian version of the MASS with 
exploratory factor analysis (EFA) with MPLUS 6.0. Based on the fact that the 
distribution of answers to the items showed considerable floor or ceiling effects, we 
treated the answers as an ordinal scale, and the robust weighted least squares estimation 
was used in EFA (Brown, 2006). We applied GEOMIN rotation in EFA, which is an 
oblique type of rotation; therefore correlations between factors are allowed (Browne, 
2001). In the EFA, goodness of fit is characterized by the root-mean-square error of 
approximation (RMSEA), its 90% confidence interval (90% CI) and its closeness of fit. 
Closeness of model fit using RMSEA (CFit of RMSEA) is a statistical test (Browne & 
Cudek, 1993), which evaluates the statistical deviation of RMSEA from the value .05. 
Nonsignificant probability values (p > .05) indicate acceptable model fit. The further fit 
index reported in this study is comparative fit index (CFI) which is expected to be above 
.95.  
 
3.3.2.2 Analyses of the reliability of the Muscle Appearance Satisfaction Scale 
The scale score reliability for the MASS total score and subscale scores were calculated 
using Cronbach’s alpha coefficient. To examine the test-retest reliability, intraclass 
correlation is sometimes required; however, some authors argue for the use the product-
moment correlation, if we do not want to take systematic error into account (Rousson, 
Gasser, & Seifert, 2002). In our analysis, we reported the intraclass correlations based 
on a two-way random model, and we also reported Pearson’s correlations in order to be 
comparable with previous studies. 
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3.3.2.3 Analyses of the construct validity of the Muscle Appearance Satisfaction Scale 
To test the construct validity multivariate regression analyses were estimated with the 
MASS subscales as observed outcome variables in both groups. The MASS subscales’ 
scores were calculated with the sum of the items belonging to one factor for the sake of 
the comparability with previous and following studies. In the weightlifter sample the 
model was estimated with the factors of the MASS as observed variables, and age, body 
mass index, self-esteem, drive for thinness, current use of steroids, and current use of 
food supplements as explanatory variables. This model is presented in Figure 6.  
 
 
Figure 6. Multivariate model to explain Muscle Appearance Satisfaction Scale subscales in the 
weightlifter sample. 
In this fully saturated model, the error covariances of Muscle Appearance Satisfaction Scale subscales are 
not presented for the sake of clarity. 
 
Similarly to the previous model, in the undergraduate sample the model was estimated 
with the factors of the MASS identified in this group as observed variables, and age, 
body mass index, self-esteem, drive for thinness, and weightlifting activity as 
explanatory variables. The above models were saturated models, therefore the level of 
fit was not estimated due to the perfect fit. The SPSS 16.0 and MPLUS 6.0 statistical 
software packages were used for statistical analyses.  
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3.3.3 Muscle dysmorphia among Hungarian male weightlifters 
  
3.3.3.1 Analyses to explore the prevalence of muscle dysmorphia 
To set out the estimated prevalence rate of MD and in order to identify a group of 
weightlifters with the common features of MD, latent class analysis (LCA) was 
conducted, by which a homogenous group –a subgroup of males with MD– can be 
distinguished within a heterogeneous group (male weightlifters). LCA is a statistical 
method for identifying unmeasured class membership among subjects using categorical 
and/or continuous observed variables. Therefore, LCA creates subgroups on the basis of 
previously defined variables, by which the associations between the groups can be 
reduced. Several studies have used LCA to find distinct diagnostic categories given the 
presence/absence of several symptoms or types of attitudes (e.g., Demetrovics et al., 
2012; Fink et al., 2004; Keel et al., 2004). Moreover, a recent study also used LCA to 
reveal a MD group within male weightlifters (Hildebrandt, Schlundt, Langenbucher, & 
Chung, 2006). Ten variables were involved in the analysis: (1–5) five subscales of the 
MASS, (6) Exercise Addiction Inventory, (7) quantity time X frequency of exercise as 
continuous variable, and (8) supplement use, (9) current AAS use, (10) lifetime AAS 
use as categorical variables (see Table 14). Variable 7 (QF of exercise) indicates 
quantity-frequency of exercise, that had been calculated the amount of time in hours 
spent weightlifting per day multiplied by the number of days spent with work out per 
week (Hildebrandt, Langenbucher, & Schlundt, 2004; Hildenbrandt et al., 2006).  The 
variables that have been involved in the LCA are associated with the criteria for MD 
(Pope et al., 1997). Latent class analysis was performed with 2 to 4 classes with the full 
sample (n = 304) with MPLUS. The LCA (Collins & Lanza, 2010; Vermunt & 
Magidson, 2002) is a latent variable analysis with a dichotomous latent variable –i.e., 
men with MD– and continuous indicators such as scores of MASS and also with 
categorical indicators such as AAS use. To determine the number of latent classes and 
the relative goodness of fit of the models, the Bayesian Information Criteria (BIC) 
parsimony index was used, with the minimization of cross-classification probabilities, 
entropy and the interpretability of clusters. Lower BIC value indicates a better-fitting 
model, and higher entropy value indicates better classification quality. Furthermore, the 
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likelihood-ratio difference test (Lo-Mendell-Rubin Adjusted LRT Test) was also used 
during the final determination of the number of latent classes, which compares the 
estimated model with a model having one less class than the estimated model (Muthén 
& Muthén, 1998). A low p value (< .05) indicates that the estimated model is fitting 
better than the model with one less class. 
 
3.3.3.2 Analyses to determine the cut-off score for the MASS 
To define the tentative cut-off score of the MASS a sensitivity analysis was carried out. 
As there is no existing ‘gold standard’ available for the measurement of MD symptoms 
in Hungary, a sensitivity analysis based on the membership in the MD group in the 
latent class analysis was conducted. Thus, considering the MD group as a gold standard, 
sensitivity and specificity values were calculated for several MASS cut-off points. The 
accuracy of the MASS can be assessed by calculating the proportion of cases who are 
classified as belonging in the MD group versus the non-MD cases. Sensitivity (i.e., the 
proportion of true positives that are correctly identified by the MASS) and specificity 
(i.e., the proportion of true negatives that are correctly identified by the MASS) were 
defined according to the suggestion of Altman and Bland (1994a) and Glaros and Kline 
(1988). To explore the probability that the MASS will give the correct “diagnosis”, the 
positive predictive values, the negative predictive values, and the accuracy values were 
calculated for several MASS cut-off points. Positive predictive value (PPV) was defined 
as the proportion of individuals with positive test results who were correctly diagnosed 
(Altman & Bland, 1994b; Glaros & Kline, 1988). Negative predictive value (NPV) was 
defined as the proportion of participants with negative test results who were correctly 
diagnosed (Altman & Bland, 1994b; Glaros & Kline, 1988). 
 
3.3.3.2 Analyses to assess the psychological correlates of muscle dysmorphia  
Comparisons of the three groups resulted from the LCA (i.e., normal weightlifters, low 
risk MD group, and high risk MD group) with respect to continuous variables were 
performed by one way analysis of variance (ANOVA; F-value), followed by post-hoc 
Tukey-Kramer pairwise comparison of means. If homogeneity of variance was violated, 
robust Welch ANOVA (W-value) was applied, followed by post-hoc Games-Howell 
pairwise comparison of means. In case of non-normally distributed variables and 
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homogeneity of variance, Kruskal-Wallis test (H-value) was conducted. If the 
homogeneity of variance was violated, adjusted rank Welch test (rW3-value) was 
applied. Tests of pairwise stochastic equalities was used as post-hoc test. 
 
3.3.3.3 Analysis to assess the characteristics of anabolic-androgenic steroid users 
For the comparison of psychological correlates of steroid non-users, past- and current 
steroid users, one-way analysis of variance (ANOVA; F-value) was used, followed by 
post-hoc Tukey-Kramer pairwise comparison of means. If homogeneity of variance was 
violated, Robust Welch ANOVA (W-value) was applied, followed by post-hoc Games-
Howell pairwise comparison of means. In case of non-normally distributed variables 
Kruskal-Wallis test (H-value) or adjusted rank Welch test (rW3-value) were applied, 
followed by post-hoc tests of pairwise stochastic equalities. 
 
3.3.3.4 Analysis to explore the risk factors of lifetime AAS use 
To investigate the predictors of lifetime AAS use among male weightlifters, binary 
logistic regression analysis was performed adjusted to age and level of education. The 
SPSS 16.0, MPLUS 6.0, and ROPstat statistical software packages were used for 
statistical analyses.  
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4. RESULTS 
4.1 Examination of muscle dysmorphia in male weightlifters and university 
students 
 
4.1.1 Characteristics of the samples 
Table 2 presents the descriptive statistics and comparison of weightlifter and 
undergraduate groups in terms of anthropometric data. The mean body height of the 
participants in the male weightlifter and in the undergraduate samples did not differ 
significantly, t(118) = 0.115, p = .909, Cohen’s d = 0.02. The participants of the 
weightlifter group reported the desire to gain some weight, whereas those in the 
undergraduate group reported the intention to lose some. The body weight, BMI, and 
desired body weight of the male weightlifters were significantly higher compared to the 
undergraduates. The mean body weight of the weightlifters was 88.5 kg (SD = 14.73) 
and their desired body weight was 93.6 kg (SD = 15.56). Undergraduates reported a 
mean body weight of 80.0 kg (SD = 12.47) and desired body weight of 78.7 kg (SD = 
9.45), which were significantly lower comparing to the weightlifters, t(118) = 3.430, p < 
.001, Cohen’s d = 0.63 and W(118) = 6.351, p < .001, Cohen’s d = 1.16, respectively. 
Conversely, the mean BMI (M = 27.0, SD = 3.09) and the desired BMI (M = 28.6, SD = 
4.29) of the weightlifters were significantly higher compared to the undergraduates, 
t(118) = 3.899, p < .001, Cohen’s d = 0.71 and Z = 6.700, p < .001, Cohen’s d = 1.32, 
respectively. Participants in the weightlifter group lifted weights at a mean of four times 
per week. 
 
Table 2 
Anthropometric data of weightlifters and undergraduates  
 Weightlifter 
group 
 (n = 60) 
Undergraduate 
group  
(n = 60) 
Test statistic Cohen’s d 
M (SD) M (SD) 
Age (years) 27.7 (7.53) 27.8 (7.45) Z = 0.061 –0.01 
Body height (cm) 180.6 (7.23) 180.5 (8.62) t(118) = 0.115 0.02 
Body weight (kg) 88.5 (14.73) 80.0 (12.47) t(118) = 3.430*** 0.63 
Desired body weight (kg) 93.6 (15.56) 78.7 (9.45) W(118) = 6.351*** 1.16 
Body Mass Index 27.0 (3.9) 24.5 (3.2) t(118) = 3.899*** 0.71 
Desired Body Mass index 28.6 (4.29) 24.1 (2.23) Z = 6.700*** 1.32 
Note. * p < .05. ** p < .01. *** p < .001.  
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4.1.2 Examination of study variables in male weightlifters and university students 
Table 3 presents the comparison of the study variables of the weightlifter and 
undergraduate groups. The weightlifter group had significantly higher scores on the 
Ineffectiveness, Z = 3.124, p < .01, Cohen’s d = 0.60, Perfectionism, W(109) = 3.432, p < 
.001, Cohen’s d = 0.63, and Interpersonal Distrust, Z = 2.508, p < .05, Cohen’s d = 0.47 
subscales of the EDI. Furthermore, participants in the weightlifter group also scored 
significantly higher on the Body Attitude Test, t(118) = 2.234, p < .05, Cohen’s d = 0.41. 
For the examination of the MD symptoms, MASS total score and subscale scores were 
investigated in both study samples. The weightlifter group scored significantly higher 
on the MASS total scale, W(96) = 7.407, p < .001, Cohen’s d = 1.35, the Bodybuilding 
Dependence, Z = 7.351, p < .001, Cohen’s d = 1.55, the Muscle Checking, Z = 7.351, p 
< .001, Cohen’s d = 0.80, the Substance Use, Z = 6.762, p < .001, Cohen’s d = 1.27, and 
the Injury Risk, W(107) = 4.790, p < .001, Cohen’s d = 0.88, subscales of the MASS. The 
Muscle Satisfaction subscale of the MASS did not indicate a significant group 
difference, W(114) = 0.246, p = .806, Cohen’s d = –0.05.  
 
To identify group differences between weightlifters and university student, multiple 
linear regression analysis was performed. The variables which proved to be significant 
during the comparison of groups were used in the analysis, adjusted to age and BMI. 
According to the results, the Ineffectiveness, β = –.27, p = .005, the Perfectionism, β = –
.30, p = .001, and the Interpersonal Distrust, β = –.20, p = .038, subscales of the EDI, 
and the Bodybuilding Dependence, β = –.59, p < .001, the Muscle Checking, β = –.34, p 
< .001, the Substance Use, β = –.49, p < .001, and the Injury Risk, β = –.34, p < .001, 
subscales of the MASS and the MASS total, β = –.52, p < .001, indicated significant 
group differences. In respect to Body Attitude we did not find significant group 
difference, β = –.05, p = .571. 
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Table 3 
Study variables of weightlifters and undergraduates 
 Weightlifter 
group 
 (n = 60) 
Undergraduate 
group  
(n = 60) 
Test statistic Cohen’s d 
M (SD) M (SD) 
Body Dissatisfaction (EDI) 5.6 (5.46) 4.2 (4.44) Z = 1.500 0.28 
Ineffectiveness (EDI) 2.9 (4.02) 1.1 (1.37) Z = 3.124*** 0.60 
Perfectionism (EDI) 6.3 (3.85) 4.1 (2.89) W(109) = 3.432*** 0.63 
Interpersonal Distrust (EDI) 3.1 (3.81) 1.7 (2.21) Z = 2.508* 0.47 
Interoceptive Awareness (EDI) 2.1 (3.7) 0.9 (1.42) Z = 1.394 0.43 
Body Attitude Test 22.9 (10.51) 18.8 (9.47) t(118) = 2.234* 0.41 
Bodybuilding Dependence (MASS) 12.8 (4.18) 7.2 (3.01) Z = 7.351*** 1.55 
Muscle Checking (MASS) 7.8 (3.95) 5.2 (2.32) Z = 7.351*** 0.80 
Substance Use (MASS) 8.9 (4.18) 4.9 (1.43) Z = 6.762*** 1.27 
Injury Risk (MASS) 9.2 (3.42) 6.5 (2.47) W(107) = 4.790*** 0.88 
Muscle Satisfaction (MASS) 9.1 (3.24) 9.2 (2.67) W(114) = 0.246 –0.05 
MASS total 47.9 (13.21) 33.2 (7.88) W(96) = 7.407*** 1.35 
Note. * p < .05. ** p < .01. *** p < .001.  
 
4.1.3 Characteristics of self-reported steroid users and non-users 
In the present sample of 60 male weightlifters, the prevalence of current steroid use was 
9.2 % (n = 11) and the prevalence of food supplement use was 65% (n = 39). Since no 
one in the undergraduate group reported current steroid or food supplement use, we 
examined the characteristics of the steroid users in the weightlifter group (Table 4).  
According to the results, self-reported steroid users had significantly higher desired 
body weight and desired BMI,  t(58) = 3.139, p < .001, Cohen’s d = 1.42 and Z = 2.398, p 
< .05, Cohen’s d = 1.19, respectively. Steroid users reported higher levels of 
ineffectiveness, Z = 2.721, p < .01, Cohen’s d = 0.62, compared to steroid non-users. 
Moreover, current steroid users displayed significantly higher levels of MD symptoms; 
thus, current steroid users scored significantly higher on the MASS total scale, t(58) = 
2.879, p < .05, Cohen’s d = 1.34, Bodybuilding Dependence, t(58) = 1.917, p < .05,  
Cohen’s d = 0.87, Substance Use, Z = 3.622, p < .001, Cohen’s d = 1.83, and Injury 
Risk, Z = 2.293, p < .05, Cohen’s d = 0.84, subscales of the MASS than steroid non-
users. 
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To explore group differences between steroid users and non-users, multiple linear 
regression analysis was performed. The variables which proved to be significant during 
the comparison of groups were involved in the analysis, adjusted to age and BMI. 
According to the results, desired body weight, β = –.39, p = .001, desired BMI, β = –.29, 
p = .007, the Bodybuilding Dependence, β = –.29, p = .031, and the Substance Use, β = 
–.57, p < .001, subscales of the MASS, and the MASS total, β = –.40, p = .001, showed 
significant group differences. Finally, steroid use proved to be a trend predictor of 
Injury Risk, β = –.23, p = .072. The Ineffectiveness subscale of the EDI did not indicate 
significant group difference, β = –.18, p = .176. 
 
Table 4 
Study variables of steroid users and steroid non-users  
 Steroid users 
 (n = 11) 
Steroid non-users 
(n = 49) 
 
Test statistic Cohen’s d 
M (SD) M (SD) 
Age (years) 25.0 (8.47) 28.4 (7.26) Z = 1.887 –0.45 
Actual body weight (kg) 96.0 (20.46) 86.9 (12.81) t(58) = 1.411 0.63 
Body height (cm) 183.6 (7.13) 180.0 (7.17) t(58) = 1.475 0.49 
BMI 28.4 (5.02) 26.8 (3.63) Z = 0.841 0.39 
Desired body weight (kg) 109.6 (19.84) 90.1 (12.01) t(58) = 3.139** 1.42 
Desired BMI 32.5 (5.31) 27.8 (3.56) Z = 2.398* 1.19 
Body Dissatisfaction (EDI) 4.6 (3.23) 5.8 (5.85) Z = 0.269 –0.23 
Ineffectiveness (EDI) 4.9 (3.41) 2.4 (4.04) Z = 2.721** 0.62 
Perfectionism (EDI) 5.6 (3.20) 6.46 (3.99) t(58) = 0.645 –0.22 
Interpersonal Distrust (EDI) 4.0 (3.49) 3.0 (3.88) Z = 1.193 0.26 
Interoceptive Awareness (EDI) 4.36 (5.10) 1.6 (3.18) Z = 1.692 0.76 
Body Attitude Test 24.0 (11.14) 22.7 (10.47) t(58) = 0.358 0.12 
Bodybuilding Dependence (MASS) 15.7 (5.83) 12.2 (3.47) t(58) = 1.917* 0.87 
Muscle Checking (MASS) 10.2 (5.21) 7.3 (3.46) Z = 1.883 0.77 
Substance Use (MASS) 14.0 (5.31) 7.7 (2.85) Z = 3.622*** 1.83 
Injury Risk (MASS) 11.4 (3.80) 8.6 (3.16) Z = 2.293* 0.84 
Muscle Satisfaction (MASS) 9.4 (3.47) 9.0 (3.22) Z = 0.269 0.13 
MASS total 61.0 (17.75) 45.0 (10.08) t(58) = 2.879* 1.34 
Note. * p < .05. ** p < .01. *** p < .001.  
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4.1.4 Examination of the risk factors of muscle dysmorphia symptoms 
To investigate the relationship between MASS and other constructs and variables, 
multiple linear regression analysis was performed, adjusted to age (Table 5). According 
to the results, the weightlifting activity was a significant predictor of MD symptoms, β 
= -.373, p < .001. Ideal body weight revealed a significant positive association with the 
level of MD, β = .331, p < .01. Finally, interoceptive awareness also emerged as a 
significant predictor of MD symptoms, β = .222, p < .05. The explained variance of the 
model is 45.9%.  
 
Table 5 
Explanatory variables of the Muscle Appearance Satisfaction Scale (multiple linear 
regression analysis) 
 
Predictor variables 
Weightlifter and undergraduate 
groups 
(n = 120) 
β t 
Group (1 Weightlifter, 2 Undergraduate) –.373 –4.518*** 
Body weight (kg) –.168 –1.476 
Ideal body weight (kg) .331 2.777** 
Body Dissatisfaction (EDI) –.075 –.876 
Ineffectiveness (EDI) .108 .975 
Perfectionism (EDI) –.016 –.210 
Interpersonal Distrust (EDI) –.134 –1.432 
Interoceptive Awareness (EDI) .222 2.090* 
Maturity Fears (EDI) .106 1.410 
Body Attitude Test .158 1.748 
Age (years) –.058 –.733 
R2 45.9% 
Note: R2 means adjusted explained variance.   
* p < .05. ** p < .01. *** p < .001.  
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4.2 Adaptation of the Muscle Appearance Satisfaction Scale in Hungary 
 
4.2.1 Characteristics of the samples 
The descriptive statistics of all groups are provided in Table 6. The main weightlifter 
group was significantly older, t = 15.2, p < .0001, Cohen’s d = 1.33, and had a greater 
body weight, t = 9.2, p < .001, Cohen’s d = 0.83, and BMI, t = 12.3, p < .001, Cohen’s d 
= 1.09, than the undergraduate group. The undergraduate students had significantly 
higher body height than the weightlifter group, t = 12.1, p < .001, Cohen’s d = 0.30. The 
distributions of highest education level, marital status, and place of resident were 
different in the main weightlifter group and undergraduate group: χ² = 136.3, p < .001, 
w = 1.0; χ² = 82.9, p < .001, w = 0.72; χ² = 8.5, p < .05, w = 0.17 respectively. 
Weightlifters displayed more divergent education levels than undergraduates, 18% of 
weightlifters had less than high school education. A higher proportion of weightlifters 
were married than the undergraduates. Finally, a larger proportion of weightlifters lived 
outside of the capital than undergraduates. 
 
As for the exercise-related variables in the weightlifter group, 10% (n = 29) reported 
current steroid use, 65% (n = 188) reported current food supplement use, and the mean 
of the years of exercise was 6.1 (SD = 6.08). Seventeen percent (n = 41) reported 
current weightlifting activity in the undergraduate group. 
 
 
 
 
 
 
 
 
 
 
 
DOI: 10.14753/SE.2013.1829
 83
Table 6 
Demographics and other characteristics of the samples 
 Weightlifters 
 
(n = 289) 
Undergraduate 
students 
(n = 240) 
Weightlifters 
for test-retest 
analysis  
(n = 43) 
Anthropometric and demographic 
variables 
M (SD) M (SD)  M (SD) 
Age (years) 28.0 (7.43) 20.3 (2.78) 30.4 (6.52) 
Body weight (kg) 87.8 (14.76) 75.6 (14.70) 88.4 (5.65) 
Height (cm) 179.6 (6.06) 181.6 (7.48) 179.1 (11.1) 
BMI 27.2 (4.13) 22.9 (3.98) 27.5 (3.02) 
    
Level of education n (%) n (%) n (%) 
Less than high school  52 (18)  6 (14) 
High school graduate 144 (50) 240 (100) 23 (53) 
College graduate or more  92 (32)  14 (33) 
Marital status    
Single  156 (54) 216 (90) 14 (32) 
Married or in a relationship  124 (43) 24 (10) 27 (63) 
Divorced  9 (3) 0 2 (5) 
Place of residence     
Budapest  104 (36) 106 (44) 9 (22) 
Outside Budapest  185 (64) 134 (56) 34 (78) 
 
Psychological variables M (SD) M (SD)  
Self-Esteem (RSES)  20.2 (3.91) 21.2 (5.05)  
Drive for thinness (EDI)  2.4 (3.12) 1.2 (2.40)  
Note. BMI = body mass index. RSES = Rosenberg Self-esteem Scale. EDI = Eating Disorder Inventory.  
 
4.2.2 Examination of the factor structure of the Muscle Appearance Satisfaction 
Scale 
We performed an exploratory factor analysis with the robust weighted least squares 
estimation and GEOMIN rotation to evaluate the factor structure of 19 items on the 
weightlifter and undergraduate samples separately. The decision of the factor solution 
was based on the goodness of fit index (RMSEA < .08, Cfit [90% CI] > .05), the 
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interpretability of the solution and salient factor loadings (> .30). We examined one-, 
two-, three-, four-, five-, six-factor solutions in both samples.  
 
In the weightlifter sample, the RMSEA values were .167 [.159, .175], Cfit < .0001 for 
the one-factor solution; .122 [.113, .131], Cfit < .001 for the two-factor solution; .103 
[.094, .113], Cfit < .001 for the three-factor solution; .081 [.071, .092], Cfit < .001 for 
the four-factor solution; .060 [.048, 0.073], Cfit = .085 for the five-factor solution and 
finally .055 [.041, .069], Cfit = .252 for the six-factor solution. CFI values were .725, 
.870, .919, .957, 980 and .986 respectively. Based on the fit indices and interpretability 
of factors, we retained the five-factor solution in the weightlifter sample: χ² = 180.1, df 
= 86, CFI = .980, TLI = .960. The factors, factor labels, factor loadings and the 
correlation between factors are presented in Table 7. All items had salient factor loading 
(> .30) with only one exception of the item referring to self-worth (Bodybuilding 
Dependence factor, item 15). The self-worth item did not have any salient factor 
loadings. In the EFA, we replicated the original five-factor solution in the weightlifter 
sample. The correlations among the factors in the weightlifter group ranged from .01 to 
.56 (see Table 7). Although the Muscle Satisfaction factor did not correlate with any 
other factors, the other four factors had moderate correlations with each other.  
In the undergraduate sample, RMSEA values were .183 [.174, .192], Cfit < .0001 for 
the one-factor solution; .079 [.068, .090], Cfit < .001 for the two-factor solution; .061 
[.049, .073], Cfit = .072 for the three-factor solution; .047 [.032, .062], Cfit = .607 for a 
four-factor solution; .032 [.000, .050], Cfit = .946 for the five-factor solution and 
finally, .022 [.000, .045], Cfit = .984 for the six-factor solution. CFI values were .591, 
.933, .965, .982, 993 and .997 respectively. Based on the fit indices and interpretability 
of factors, we retained the three-factor solution in the undergraduate sample: χ² = 221.0, 
df = 117, CFI = .965, TLI = .949. The factors and factor loadings are presented in Table 
8. In EFA, we found a three-factor solution instead of the original five factors. The 
items referring to muscle satisfaction were represented as a separate factor. The items 
referring to bodybuilding dependence and injury risk were represented in one factor, 
and the items referring to muscle checking and substance use were represented in the 
third factor. Two items, “addicted” and “supplements”, had salient cross-loadings on 
two factors (Factor 2 and Factor 3).  
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Table 7 
Exploratory factor analysis of Muscle Appearance Satisfaction Scale items in the 
weightlifter group 
MASS Item Factor 1 
Muscle 
Satisfaction 
Factor 2 
Bodybuilding 
Dependence 
Factor 3 
Substance 
Use 
Factor 4 
Muscle 
Checking 
Factor 5 
Injury 
Risk 
Comm. 
Factor loadings 
Item 4 Satisfied with 
size 
 .84  .02 –.04  .19 .09 .75 
Item 1 Mirror 
satisfied 
 .72 –.18  .17 –.02 .00 .61 
Item 14 Tone  .64  .11  .00 –.03 –.11 .29 
Item 2 Schedule  .01  .76  .02 –.06 .03 .58 
Item 8 Bad workout  .10  .67  .04 –.01 .01 .47 
Item 7 Addicted  .01  .64  .20  .15 .01 .71 
Item 12 Time at gym –.07  .42 –.06  .09 .12 .29 
Item 9 Anything to 
grow 
–.03  .10  .87  .01 .00 .84 
Item 6 Steroids  .04  .03  .79 –.07 .06 .64 
Item 17 Bigger means  .04 -.05  .65  .10 .28 .74 
Item 5 Supplements –.03  .28  .49  .04 –.07 .41 
Item 18 Reassurance  .04 –.04  .12  .87 –.03 .82 
Item 3 Ask friends  .06  .00  .00  .81 –.06 .62 
Item 19 Resist 
checking 
–.02  .15  .02  .68 .14 .72 
Item 11 Mirror –.11  .22 –.04  .59 .07 .57 
Item 16 I ignore pain  .01  .00  .00 –.03 .91 .81 
Item 13 One must 
ignore 
–.04  .02  .15 –.02 .74 .66 
Item 10 Sore  .10  .19 –.02  .06 .60 .58 
Item 15 Self-worth –.07  .18  .17  .22 .21 .37 
Eigenvalues 7.25 2.23 1.39 1.36 1.07  
Factor correlations 
Bodybuilding 
Dependence 
–.07      
Substance Use .17 .39***    
Muscle Checking .01 .52*** .47***   
Injury Risk .07 .56*** .39*** .45***  
Descriptive statistics 
Cronbach α 
[95% CI] 
.75 
[.70, .79] 
.73# 
[.67, .77] 
.80 
[.76, .84] 
.83 
[.79, .86] 
.81 
[.76, .84] 
 
Mean 9.33 11.06 8.67 8.41 9.47 
SD 2.96 4.05 4.31 3.93 3.46 
Note. Rotation method is GEOMIN. Salient factor loadings (> .30) are shown in boldface. Comm. = 
communalities. # Calculated without “self-worth” item. *** p < .001. 
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Table 8 
Exploratory Factor Analysis of the Muscle Appearance Satisfaction Scale items in the 
undergraduate group 
MASS item Factor 1 
Muscle 
Satisfaction 
Factor 2 
Dependence and 
Injury Risk 
Factor 3 Muscle 
Checking and 
Substance Use 
Comm. 
Factor loadings 
Item 4 Satisfied with size .94 –.06 –.03 .88 
Item 14 Tone .87 –.20 .02 .81 
Item 1 Mirror satisfied .82 .01 –.26 .69 
Item 10 Sore .00 .93 –.20 .71 
Item 16 I ignore pain .10 .74 .02 .57 
Item 12 Time at gym –.05 .63 .26 .64 
Item 13 One must ignore .12 .62 –.01 .39 
Item 5 Supplements –.09 .57 .32 .62 
Item 8 Bad workout .10 .47 .26 .42 
Item 7 Addicted .02 .43 .44 .59 
Item 2 Schedule .01 .42 .22 .31 
Item 18 Reassurance –.10 –.02 .91 .79 
Item 9 Anything to grow .10 –.13 .78 .54 
Item 19 Resist checking –.12 .20 .61 .54 
Item 11 Mirror –.12 .19 .58 .49 
Item 17 Bigger means .24 .20 .55 .54 
Item 6 Steroids –.02 .06 .53 .31 
Item 15 Self-worth .07 .17 .51 .39 
Item 3 Ask friends .06 .09 .51 .32 
Eigenvalues 7.25 2.69 1.56  
Factor correlations 
Dependence and Injury Risk –.04    
Muscle Checking and Substance 
Use 
.10 .54***  
Descriptive statistics 
Cronbach α 
[95% CI] 
.88 
[.85, .90] 
.76# 
[.71, .81] 
.79 
[.75, .83] 
 
Mean 9.33 20.32 13.09 
SD 2.96 6.16 4.58 
Note. Rotation method is GEOMIN. Salient factor loadings (> .30) are shown in boldface. Comm. = 
communalities. 
# The internal consistency was calculated without item “addicted”.  
*** p < .001.  
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4.2.3 Reliability of the Muscle Appearance Satisfaction Scale 
 
4.2.3.1 Scale score reliability  
The scale score reliability of the MASS was calculated using Cronbach’s alpha 
coefficient in both groups (see Table 7 and Table 8). The MASS and its subscales had 
good score reliability in the weightlifter group (α = .73–.83). The Cronbach α of the 
total scale was excellent (α = .87, 95% CI [.85, .89]). The score reliabilities of the three 
factors in the undergraduate group were satisfactory (αs = .76–.88). The Cronbach α of 
the total scale was good (α = .81, 95% CI [.77, .84]). 
 
4.2.3.2 Test-retest reliability  
In order to calculate the test-retest reliability, correlation coefficients and intraclass 
correlations of the MASS scores were calculated in Sample 3. The time interval 
between the two administrations was two weeks. Correlations and intraclass correlations 
are presented in Table 9. The results indicated that the total scale and the subscales 
scores had excellent test-retest reliability. The test-retest correlations were between .84–
.91 measured by Pearson’s correlation, and .82–.91 measured by intraclass correlation. 
The lowest correlation was found in the Injury Risk subscale. The total scale and all 
subscales showed test–retest correlations greater than .80. 
 
Table 9 
Test-retest reliability and intraclass correlation coefficients of the Muscle Appearance 
Satisfaction Scale 
Scale Test-retest correlations 
(n = 43) 
Intraclass correlation 
(n = 43) 
 r  ICC [95% CI] 
Bodybuilding Dependence .89*** .87 [.78, .93] 
Muscle Checking .90*** .86 [.76, .92] 
Substance Use .91*** .90 [.82, .94] 
Injury Risk .84*** .82 [.68, .90] 
Muscle Satisfaction .91*** .91 [.84, .95] 
MASS Total .91*** .90 [.82, .94] 
Note.  r = Pearson’s correlation. ICC = intraclass correlation. 
*** p < .001.  
 
DOI: 10.14753/SE.2013.1829
 88
4.2.4 Construct validity of the Muscle Appearance Satisfaction Scale 
The authors estimated a multivariate regression analysis in each group to examine the 
construct validity of the MASS factors. Table 10 presents coefficients of the 
multivariate model for weightlifters (see Figure 6). The analysis provided support for 
Hypothesis 1, 3, 6, and 7. Hypothesis 1 was supported as younger age was associated 
with Muscle Checking, Substance Use, Injury Risk, and Bodybuilding Dependence 
factors of the MASS. Hypothesis 3 was confirmed as lower self-esteem was related with 
muscle dissatisfaction, Muscle Checking, Substance Use, and Bodybuilding 
Dependence factors of the MASS. Hypothesis 6 was supported as current steroid use 
was correlated with Muscle Checking, Substance Use, Injury Risk, and Bodybuilding 
Dependence factors. Finally, Hypothesis 7 was also supported as the use of food 
supplements was associated with Substance Use, Muscle Checking, and Bodybuilding 
Dependence factors. Contrary to expectations, Hypothesis 2, 4, and 5 were not 
supported by the model. Thus, Hypothesis 2 was not confirmed as BMI was negatively 
related with Injury Risk factor. Hypothesis 4 was neither confirmed as Drive for 
thinness was not significantly correlated with any factor of the MASS. Finally, 
Hypothesis 5 was also not supported as fewer years spent with exercising was linked 
with Muscle Satisfaction. 
 
In the undergraduate group, the multivariate analysis involved only three factors which 
scores were also calculated with the sum of the items. Items belonged to the factors 
where the highest factor loading was observed. Only the items “addicted” and 
“supplements” were not used in the calculation due to double loadings. The regression 
coefficients are presented in Table 11. In this model we had only three observed scores. 
The analysis provided support for Hypothesis 3, 4, and 8. Hypothesis 3 was supported 
as lower self-esteem was associated with muscle dissatisfaction and Muscle 
Checking/Substance Use factors. Hypothesis 4 was confirmed as Drive for thinness was 
related with Muscle Checking/Substance Use factor. Finally, Hypothesis 8 was also 
supported as weightlifting activity was linked with all factors of the MASS. Contrary to 
the expectations, Hypothesis 1 and 2 were not supported by the model as neither age, 
nor BMI was significantly correlated with any factor of the MASS.  
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Table 10 
Multivariate analysis of the predictors of the Muscle Appearance Satisfaction Scale subscales in the weightlifter sample 
(standardized coefficients). 
Factors Age BMI Self-esteem Drive for 
Thinness 
Years of 
exercise 
Food 
supplementation 
Current 
steroid use 
R2 
Muscle Satisfaction .05 .09 –.31*** .01 –.18** .06 –.04 14.8 % 
Substance Use –.15** .05 –.12* –.04 –.02 .30*** .37*** 33.4 % 
Injury Risk –.32*** –.17** –.09 –.07 .07 .08 .11* 17.8 % 
Muscle Checking –.20*** .05 –.14* .08 –.02 .14* .18** 15.2 % 
Bodybuilding 
Dependence 
–.24*** .06 –.17** .09 .11 
.15** 
.16** 17.8% 
Note. Significant coefficients are shown in boldface. BMI = body mass index. 
* p < .05. ** p < .01. *** p < .001.  
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Table 11 
Multivariate analysis of the Muscle Appearance Satisfaction Scale  subscales in the undergraduate sample (standardized coefficients). 
Factors Age BMI Self-esteem Drive for 
Thinness 
Weightlifting 
activity 
R2 
Muscle Satisfaction .01 -.11 –.36*** .06 –.13* 17.6% 
Bodybuilding 
Dependence and Injury 
Risk 
.03 -.01 –.08 .07 .40*** 16.8% 
Muscle Checking and 
Substance Use 
–.03 .07 –.15* –.12* .20* 7.8% 
Note. Significant coefficients are shown in boldface. BMI = body mass index. 
* p < .05. ** p < .01. *** p < .001. 
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4.3 Muscle dysmorphia among Hungarian male weightlifters  
 
4.3.1 Characteristics of the sample 
Table 12 contains descriptive statistics (means, standard deviations, ranges, frequencies) 
for the anthropometric, exercise-related, and demographic variables. Participants in the 
current study had the mean age of 27.8 (SD = 7.40) years. The mean body height of the 
study sample was 179.5 cm (SD = 6.05), and the mean body weight was 87.5 (SD = 
14.63) kg. The desired body weight of the respondents (M = 90.7, SD = 14.56 kg) was 
significantly higher than their actual body weight, t(303) = 5.595, p < .001, Cohen’s d = 
0.49. The difference between their actual and desired body weight was 3.2 kg (SD = 
9.89). Conversely, one point difference was found between their actual (M = 27.1, SD = 
4.08) and ideal BMIs (M = 28.1, SD = 3.87), t(303) = 5.547, p < .001, Cohen’s d = 0.55. 
Participants lifted weights at a mean of four times per week for six years. Almost 20% 
of the sample had less than high school education, 50% graduated in high school, and 
31% graduated in college. Relating to the marital status, half of the sample (53%) was 
single, less than half was married or lived in relationship (44%), and a small proportion 
was divorced (2.3%). Finally, 35 % of the respondents lived in Budapest and the larger 
proportion of sample (65%) lived outside of the capital. 
DOI: 10.14753/SE.2013.1829
 92
Table 12 
Descriptive statistics of the sample: anthropometric, demographic, and exercise-related 
variables 
 
 Total sample 
(n = 304) 
Anthropometric variables Range M (SD) 
Age  (years) 18–58 27.8 (7.40) 
Body height (cm) 161–198 179.5 (6.05) 
Body weight (kg) 51–156 87.5 (14.63) 
Desired body weight 60–160 90.7 (14.56) 
Difference between desired and actual 
body weight (kg) 
–26–51 3.2 (9.89) 
Body mass index 16.1–47.1 27.1 (4.08) 
Desired body mass index 19.6–46.3 28.1 (3.87) 
Difference between desired and actual 
body mass index 
–7.9–15.9 1 (3.04) 
Exercise related variables   
Workouts/week 1–14 3.9 (1.22) 
Years of exercise 0–41 6.1 (6.03) 
Highest level of education  n (%) 
Less than high school   58 (19.1%) 
High school graduate  151 (49.7%) 
College graduate or more   95 (31.3%) 
Marital status   
Single   163 (53.6%) 
Married or in a relationship   133 (43.8%) 
Divorced   8 (2.6%) 
Place of residence    
Budapest   107 (35.2%) 
Outside Budapest   197 (64.8%) 
 
 
Table 13 presents the descriptive statistics (ranges, means and 95% CIs, SDs, Cronbach 
alphas and 95% CIs) of the study variables. Internal consistency reliabilities of the 
applied measures ranged from acceptable to good.  
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Table 13 
Descriptive statistics of the psychological variables of the sample 
Variables Total sample 
(n = 304) 
Range M (SD) 
[95% CI]  
Cronbach α (item number) 
[95% CI] 
Bodybuilding Dependence (MASS) 5–25 13.3 (4.64) 
[12.8, 13.8] 
.74 (5) 
[.69, .79] 
Muscle Checking (MASS) 4–20 8.3 (3.87) 
[7.9, 8.8] 
.82 (4) 
[.79, .85] 
Substance Use (MASS) 4–20 8.6 (4.28) 
[8.1, 9.1] 
.81 (4) 
[.77, .84] 
Injury Risk (MASS) 3–15 9.4 (3.44) 
[9.0, 9.8] 
.80 (3) 
[.76, .84] 
Muscle Satisfaction (MASS) 3–15 9.3 (2.67) 
[9.0, 9.6] 
.74 (3) 
[.69, .79] 
MASS total 22–83 48.9 (13.37) 
[47.4, 50.4] 
.87 (19) 
[.85, .89] 
Exercise Dependence 6–30 16.5 (5.08) 
[15.9, 17.1] 
.74 (6) 
[.69, .78] 
Trait Anxiety (STAI) 21–71 40.0 (8.60) 
[39.1, 41.0] 
.87 (20) 
[.85, .89] 
Self-Esteem (RSES) 18–40 30.3 (3.92) 
[29.8, 30.7] 
.82 (10) 
[.78, .85] 
Self Efficacy (GSES) 10–40 30.5 (4.27) 
[30.0, 31.0] 
.88 (10) 
[.85, .90] 
SCOFF 0–5 0.5 (0.71) 
[0.4, 0.5] 
.26 (5) 
[.12, .39] 
Drive for thinness (EDI) 0–18 2.4 (3.12) 
[2.1, 2.8] 
.70 (7) 
[.64, .74] 
Bulimia (EDI) 0–14 0.7 (1.60) 
[0.5, 0.9] 
.40 (7) 
[.29, .50] 
Interoceptive Awareness (EDI) 0–18 1.3 (2.30) 
[1.0, 1.6] 
.70 (10) 
[.64, .75] 
Perfectionism (EDI) 0–16 4.5 (3.68) 
[4.1, 4.9] 
.72 (6) 
[.66, .76] 
Interpersonal Distrust (EDI) 0–17 2.5 (3.08) 
[2.2, 2.9] 
.75 (7) 
[.71, .79] 
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Relating to the body weight goal categories, 9.5% (n = 29) of the participants would like 
to remain in their current body weight, 30.9% (n = 94) would like to lose weight, and 
59.5% (n = 181) would like to gain weight. Half of the participants (48.4%) wanted to 
achieve notable weight gain (at least 5 kg). 
 
Figure 7 shows the means of subjective satisfaction with body weight and musculature 
and subjective importance of weight loss and muscle mass gain as training objectives in 
different weight goal categories (i.e., would like to lose weight, would like to remain in 
the current weight, and would like to gain weight). According to the results of the 
comparison of the means, body weight goals were significantly associated not only with 
body weight satisfaction and subjective importance of weight loss, rW3(2) = 35.723,  p < 
.001, and H(2) = 74.026, p < .001, respectively, but also with muscle mass satisfaction 
and subjective importance of muscle mass gain, H(2) = 8.525, p = .014, and rW3(2) = 
23.945, p < .001, respectively. Results of the post-hoc tests of pairwise stochastic 
equalities indicated that those who would like to remain in their current body weight 
had significantly higher level of muscle mass satisfaction, comparing to those who 
would like to gain or lose weight. In this respect, the latter two groups did not differ 
significantly. The level of the subjective importance of muscle mass gain was 
significantly higher among those who would like to gain weight comparing to those 
who would like to lose weight and those who would like to remain in their current 
weight. In this respect, the latter two groups did not differ significantly. 
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Figure 7. Subjective satisfaction with body weight and musculature and subjective importance of weight 
loss and muscle mass gain as training objectives in different weight goal categories. The figure presents 
95% confidence intervals of the means. 
 
4.3.1.1 Prevalence of exercise dependence among Hungarian male weightlifters 
In the current study the prevalence rate of exercise dependence categories were: 29.6% 
(n = 90) asymptomatic, 61.2% (n = 182) symptomatic non-dependent, and 9.2% (n = 
28) at risk for exercise dependence. The exercise dependence categories – 
asymptomatic, symptomatic non-dependent, and at risk for exercise dependence – were 
defined using the modified cut-off scores of Exercise Addiction Inventory (Mónok et 
al., 2012). 
 
4.3.1.2 Prevalence of eating disorders among Hungarian male weightlifters 
In the present study a short screening tool (SCOFF) for the assessment of eating 
disorders was used. Two or more scores indicated a likely case of AN or BN. Results 
suggested that 8.5% (n = 26) of the participants was likely to have an eating disorder 
(AN or BN). 
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4.3.2 Prevalence of muscle dysmorphia among Hungarian male weightlifters 
(latent class analysis) 
To identify a group of muscle dysmorphic male weightlifters, a latent class analysis was 
performed with ten variables associated with the diagnostic criteria of MD. We 
estimated one to four class solutions. Table 15 demonstrates the information based 
criteria and entropy for the model solutions. The Akaike information criteria (AIC), 
Bayesian information criteria (BIC), and sample size–adjusted BIC declined as more 
latent classes were added. The three- and four-latent class solution had the highest levels 
of entropy. Based on the L-M-R test, the three-class solution was accepted. Table 14 
reports the descriptive statistics for indicators of the LCA 3-class model, which included 
high risk MD group (18.0%, n = 55), low risk MD group (51.6%, n = 157), and normal 
weightlifters group (30.2%, n = 92).  
 
The high risk MD group represents those weightlifters who can be characterized by the 
diagnostic criteria of MD (Pope et al., 1997). This group had the highest means on all 
subscales of the MASS, except on the Muscle Satisfaction subscale, on which all three 
classes had almost the same means. This group displayed the highest level of exercise 
addiction (M = 21.7, SE = 0.90); conversely exercised the most frequently and spent the 
most time with work-outs (quantity-frequency of exercise: M = 11.6, SE = 1.16). The 
frequency of supplement use was also the highest (86.7%) in this group comparing to 
the other two groups. The lifetime (67.8%) and current prevalence (40.6%) of AAS use 
were also the highest comparing to the other classes.  
 
The group of normal weightlifters represents those males who had the lowest means on 
the indicator variables. Thus, this group had the lowest means on all subscales of the 
MASS, exercise addiction (M = 12.2, SE = 0.55), and quantity-frequency of exercise (M 
= 6.0, SE = 0.36). Moreover, the frequency of supplement use (50.4%), the lifetime 
(10.7%) and current prevalence (1.1%) of AAS use were also the lowest in this group 
comparing to the other classes. 
One additional group of weightlifters was identified, the low risk MD group, who had 
the medium means on the indicator variables comparing to the normal weightlifters and 
high risk MD group. That is, this group had medium means on all subscales of the 
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MASS, exercise addiction (M = 17.2, SE = 0.56), and quantity-frequency of exercise (M 
= 8.1, SE = 0.40) relative to the other classes. The frequency of supplement use 
(66.8%), the lifetime (24.0%) and current prevalence (5.2%) of AAS use also 
represented in-between values relative to the normal and muscle dysmorphic groups. 
 
The results support Hypothesis 1 as the prevalence rate of MD among Hungarian male 
weightlifters in this study is comparable to the international data. Additionally, these 
results also confirmed Hypothesis 2 as the prevalence of both current and lifetime use of 
AAS and supplements was far more higher in the high risk MD group comparing to the 
other two groups. The lifetime prevalence of AAS use was 68% in the high risk MD 
group and still 41% of the participants in this group were current AAS user. These 
prevalence rates were notably lower in the low risk MD group as the lifetime prevalence 
of AAS use was 24% and only 5% of them used AAS currently. The prevalence of AAS 
use was the lowest in the group of normal weightlifters as the lifetime prevalence of 
AAS use was 11% and only 1% of them used AAS currently. 
 
Table 14 
Descriptive statistics for indicators of the latent class analysis 3-class model 
Variables Normal 
weightlifters  
(n = 92) 
Low risk MD 
group 
(n = 157) 
High risk MD 
group 
(n = 55) 
 M (SE) M (SE) M (SE) 
1. Bodybuilding Dependence (MASS) 8.6 (0.44) 14.4 (0.60) 18.4 (0.81) 
2. Muscle Checking (MASS) 5.6 (0.32) 8.3 (0.45) 12.9 (0.66) 
3. Substance Use (MASS) 5.5 (0.28) 8.2 (0.45) 14.9 (0.72) 
4. Injury Risk (MASS) 6.3 (0.67) 10.1 (0.25) 12.7 (0.52) 
5. Muscle Satisfaction (MASS) 9.1 (0.31) 9.1 (0.22) 9.8 (0.39) 
6. Exercise Dependence (EAI) 12.2 (0.55) 17.2 (0.56) 21.7 (0.90) 
7. QF of exercise 6.0 (0.36) 8.1 (0.40) 11.6 (1.16) 
8. Supplement use (%) 50.4% 66.8% 86.7% 
9. Current AAS use (%) 1.1% 5.2% 40.6% 
10. Lifetime AAS use (%) 10.7% 24.0% 67.8% 
Note. SE = standard error. Variables 1-5 represent the 5 subscales of the Muscle Appearance Satisfaction Scale. 
Variable 6 is the Exercise Addiction Inventory. Variable 7 (QF of exercise) indicates quantity-frequency of 
exercise. Variables 8-10 were retrieved from the exercise related variables. 
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Table 15 
Fit indices for the latent class analysis of the models 
Number of 
latent classes 
AIC BIC SSABIC Entropy L-M–R 
test 
p 
2 classes 12452 12557 12468 0.820 502.7 0.0052 
3 classes 12282 12427 12303 0.821 188.7 0.0287 
4 classes 12190 12376 12218 0.847 110.2 0.0843 
Note. AIC = Akaike Information Criteria; BIC = Bayesian Information Criteria; SSABIC = Sample size 
adjusted Bayesian Information Criteria; L-M-R Test = Lo-Mendell-Rubin adjusted likelihood ratio test 
value; p: p-value associated with LM-R Test. 
 
4.3.3 Determination of the tentative cut-off score of the Muscle Appearance 
Satisfaction Scale 
Based on the membership in the high risk MD group as a ‘gold standard’, the 
sensitivity, specificity, positive predictive value, negative predictive value, and accuracy 
of the MASS at several possible cut-off points were calculated (Table 16). Cut-off 
scores of 60, 61, and 62 showed the best accuracy. A cut-off at 60 resulted in acceptable 
sensitivity (83%), with a higher specificity (98%) and accuracy (95%). At the next cut-
off score at 61 the sensitivity was better (89%) with a still high specificity (96%) and 
accuracy (95%). At the cut-off point of 62, sensitivity was acceptable (84%) with 
almost the same specificity (97%) and accuracy (95%). Based on the results, the cut-off 
of 62 was chosen on the basis that it maximizes the presence and absence of MD. 
During the trade-off between sensitivity and specificity –where increased specificity 
(proportion of true negatives) is obtained at the expense of decreased sensitivity 
(proportion of true positives)– we aimed to exclude all non-MD cases instead of 
detecting all MD cases. It is argued that, for screening tests specificity has to be 
sacrifice for the sake of sensitivity as false positive cases will be identified in further 
assessments (Rey, Morris-Yates, & Stay, 1992). Although we suggest a score of 62 of 
the MASS as an appropriate cut-off for identifying MD cases among male weightlifters, 
information about the sensitivity and specificity of the scale at several cut-points is 
listed in Table 16. Thus, users of the scale may determine a different cut-off as a more 
appropriate one.  
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Table 16 
Calculation of cut-off score for the Muscle Appearance Satisfaction Scale 
 
True 
positive 
(n) 
True 
negative 
(n) 
False 
positive 
(n) 
False 
negative
(n) 
Sensitivity 
(%) 
Specificity 
(%) 
PPV 
(%) 
NPV 
(%) 
Accuracy 
(%) 
50/51 55 176 0 73 43 100 100 71 76 
51-52 55 176 73 0 100 71 43 100 76 
52-53 55 183 66 0 100 73 45 100 78 
53-54 55 193 56 0 100 78 50 100 82 
54/55 55 200 49 0 100 80 53 100 84 
55/56 55 209 40 0 100 84 58 100 87 
56/57 54 211 38 1 98 85 59 100 87 
57/58 53 215 34 2 96 86 61 99 88 
58/59 53 225 24 2 96 90 69 99 91 
59/60 52 228 21 3 95 92 71 99 92 
60/61 49 239 6 10 83 98 89 96 95 
61/62 49 239 10 6 89 96 83 98 95 
62/63 46 242 7 9 84 97 87 96 95 
63/64 43 243 6 12 78 98 88 95 94 
64/65 41 245 4 14 75 98 91 95 94 
65/66 40 247 2 15 73 99 95 94 94 
66/67 35 248 1 20 64 100 97 93 93 
67/68 32 248 1 23 58 100 97 92 92 
Note. PPV = positive predictive value; NPV = negative predictive value. 
 
4.3.4 Psychological correlates of muscle dysmorphia 
Table 17 reports one-way ANOVA results for the comparison of anthropometric data, 
age, and psychological correlates of the normal weightlifters, low risk, and high risk 
MD groups. The analysis provided support for Hypothesis 3, 4, and 5.  
 
4.3.4.1. Anthropometric data and age 
An analysis of variance showed that the high risk and low risk MD group were 
significantly younger than the normal weightlifters, F(2) = 8.363, p < .001. The high risk 
MD group had significantly higher BMI comparing to the low risk MD group and 
normal weightlifters, F(2) = 4.324, p = .014. Moreover, their desired BMI and weight 
dissatisfaction were also significantly higher comparing to the low risk MD group and 
normal weightlifters, W(2) = 16.187, p < .001 and F(2) = 7.873, p < .001, respectively. 
Additionally, the low risk MD group reported significantly higher desired BMI than the 
normal weightlifters. 
 
DOI: 10.14753/SE.2013.1829
 100
4.3.4.2 Psychological correlates 
Hypothesis 3 was confirmed as the high risk MD group had the lowest level of self-
esteem comparing to the other two groups; moreover, the low risk MD group also had 
significantly lower level of self-esteem than normal weightlifters, F(2) = 12.847, p < 
.001.  
 
Hypothesis 4 was supported as high risk MD group displayed higher levels of eating 
disorder related psychopathological characteristics, than normal weightlifters: the high 
risk MD group had significantly higher levels of drive for thinness, H(2) = 11.468, p = 
.003, and interoceptive awareness, rW3(2) = 5.777, p = .004, comparing to the group of 
normal weightlifters and had significantly higher levels of perfectionism, H(2) = 29.861, 
p < .001, and interpersonal distrust, rW3(2) = 4.399, p = .014, comparing to the normal 
weightlifters and low risk MD group. Additionally, the low risk MD group reported 
significantly higher levels of drive for thinness, perfectionism, and interoceptive 
awareness than normal weightlifters.  
 
Hypothesis 5 was also supported as the high risk MD group had significantly higher 
level of trait anxiety comparing to the normal weightlifters and low risk MD group; 
moreover, the low risk MD group also had significantly higher level of trait anxiety than 
normal weightlifters, F(2) = 11.510, p < .001.  
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Table 17 
One-way ANOVA for the comparison of anthropometric data, age, and psychological 
correlates of the normal weightlifters, low risk, and high risk muscle dysmorphia groups  
 
Variable Normal 
weightlifters  
(n = 92) 
Low risk MD 
group 
(n = 157) 
High risk MD 
group  
(n = 55) 
η2 Test statistic 
 M (SD) 
[95% CI] 
M (SD) 
[95% CI] 
M (SD) 
[95% CI] 
  
Age 30.4 (7.81)b,c 
[28.7, 32.0] 
26.9 (7.16)a 
[25.8, 28.0] 
26.2 (6.34)a 
[24.5, 27.9] 
.053 F(2) = 8.363*** 
BMI 26.7 (4.01)c 
[25.8, 27.5] 
26.9 (4.08)c 
[26.3, 27.5] 
28.6 (3.93)a,b 
[27.5, 29.6] 
.028 F(2) = 4.324* 
Desired BMI 26.8 (3.03)b,c 
[26.2, 27.4] 
27.9 (3.65)a,c 
[27.4, 28.5] 
30.7 (4.51)a,b 
[29.5, 31.9] .116 W(2) = 16.187*** 
Weight 
dissatisfaction 
0.5 (7.99)c 
[-1.1, 2.2] 
3.4 (10.03)c 
[1.8, 5.0] 
7.0 (11.12)a,b 
[4.0, 10.0] .050 F(2) = 7.873*** 
Trait Anxiety 
(STAI) 
37.3 (8.33)b,c 
[35.5, 39.0] 
40.2 (8.41)a,c 
[38.9, 41.5] 
44.0 (7.98)a,b 
[41.9, 46.2] 
.071 F(2) = 11.510*** 
Self-Esteem 
(RSES) 
31.6 (3.92)b,c 
[30.8, 32.4] 
30.2 (3.72)a,c 
[29.6, 30.8] 
28.3 (3.70)a,b 
[27.3, 29.3] 
.079 F(2) = 12.847*** 
Self-Efficacy 
(GSES) 
31.0 (4.41) 
[30.1, 31.9] 
30.5 (3.93) 
[29.9, 31.1] 
29.7 (4.90) 
[28.4, 31.1] 
.010 F(2) = 1.506 
Drive for 
Thinness (EDI) 
1.9 (3.06)b,c 
[1.2, 2.5] 
2.7 (3.14)a 
[2.2, 3.2] 
2.8 (3.11)a 
[2.0, 3.6] 
.015 H(2) = 11.468** 
Interoceptive 
Awareness (EDI) 
0.6 (0.97)b,c 
[0.4, 0.8] 
1.4 (2.15)a 
[1.0, 1.7] 
2.3 (3.59)a 
[1.3, 3.2] 
.058 rW3(2) = 5.777** 
Perfectionism 
(EDI) 
2.9 (2.92)b,c 
[2.3, 3.5] 
4.8 (3.59)a,c 
[4.2, 5.3] 
6.2 (4.09)a,b 
[5.1, 7.3] 
.098 H(2) = 29.861*** 
Interpersonal 
Distrust (EDI) 
1.9 (2.16)c 
[1.5, 2.4] 
2.4 (3.00)c 
[1.9, 2.9] 
4.0 (4.09)a,b 
[2.9, 5.1] 
.051 rW3(2) = 4.399* 
Note. CI = confidence interval. η2 is a measure of effect size for use in ANOVA with .02 representing 
small, .05 medium, and .08 large effect sizes. Superscripts indicate significant (p < .05) group differences 
during post-hoc tests. 
Weight dissatisfaction was counted as the actual body weight minus the desired body weight.  
a Significant difference between normal weightlifters and other groups. 
b Significant difference between low risk MD group and other groups. 
c Significant difference between high risk MD group and other groups. 
* p < .05. ** p < .01. *** p < .001. 
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4.3.4.3 Eating disorders in normal weightlifters, low risk, and high risk muscle 
dysmorphia groups 
Table 18 presents the prevalence rate of cases likely to have eating disorder in normal 
weightlifters, low risk, and high risk MD groups. The number of cases likely to have 
eating disorder was almost the same in the high risk MD group and low risk MD group 
(10.9% and 9.5%, respectively). Furthermore, the results of the Chi-square test did not 
indicate significant association between MD and eating disorders, χ2(2) = 1.735, p = 
.420.  
 
Table 18 
The prevalence of cases likely to have eating disorder in normal weightlifters, low risk, 
and high risk muscle dysmorphia groups  
SCOFF category Normal 
weightlifters 
n (%) 
Low risk MD 
group 
n (%) 
High risk MD 
group 
n (%) 
Cases without eating disorder 87 (94.5%) 142 (90.4%) 49 (89.0%) 
Cases likely to have eating disorder 5 (5.4%) 15 (9.5%) 6 (10.9%) 
 
4.3.4.4 Body weight goals in normal weightlifters, low risk, and high risk MD groups 
Figure 8 presents the frequency of different weight goals (i.e., weight loss, remain in the 
current weight, and weight gain) in normal weightlifters, low risk, and high risk MD 
groups. Results of the Chi-square test indicated that the frequency of the desire toward 
weight gain was significantly higher in the high risk MD group (73%) comparing to the 
low risk MD group (62%) and normal weightlifters (47%). Additionally, the frequency 
of the desire toward weight loss was significantly lower in the high risk MD group 
(20%) comparing to the other two groups (31% and 38%, respectively), χ2(4) = 12.456, p 
< .001. 
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Figure 8. The frequency of different weight goals in normal weightlifters, low risk, and high risk muscle 
dysmorphia groups 
 
 
4.3.5 Anabolic-androgenic steroid use 
 
4.3.5.1 Prevalence of anabolic-androgenic steroid use among Hungarian male 
weightlifters 
The results relating to the AAS use supported Hypothesis 6 as of the 304 subjects, 
17.4% (n = 53) reported past AAS use and 10.2% (n = 31) reported current AAS use. 
Based on these data, the lifetime prevalence of AAS use among the participants was 
27.6% (n = 84). The prevalence of food supplement use was also high since more than 
half (65.1%, n = 198) of the respondents reported the use of them.  
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4.3.5.2 Characteristics of anabolic-androgenic steroid users 
To examine the characteristics of AAS users, one-way analysis of variance was applied 
(results are displayed in Table 20). Because some earlier studies have differentiated 
current and past AAS users (Cole et al., 2003; Goldfield & Woodside, 2009; Kanayama 
et al., 2006) and also because the psychological correlates may be different in these two 
groups, current and past AAS users were distinguished and compared with non-users in 
the present study. 
 
4.3.5.2.1 Anthropometric data and age 
According to the results, current steroid users had significantly higher BMI than non-
users and past users, F(2) = 10.383, p < .001. Despite of their higher BMI, current steroid 
users also reported significantly higher desired BMI than past steroid users and non-
users. Past steroid users also had significantly higher desired BMI than steroid non-
users, W(2) = 12.922, p < .001. Age did not significantly relate to steroid use, F(2) = 
0.421, p = .657.  
 
4.3.5.2.2 Muscle dysmorphia related variables 
Results also confirmed Hypothesis 7 as current steroid users displayed significantly 
higher levels of MD symptoms; thus, current AAS users scored significantly higher on 
the MASS total scale, F(2) = 23.974, p < .001, Bodybuilding Dependence, F(2) = 9.395, p 
< .001, and Substance Use, rW3(2) = 80.926, p < .001, subscales of the MASS than the 
past steroid users and non-users, and scored significantly higher on the Muscle 
Checking, H(2) = 15.623, p < .001, and Injury Risk, H(2) = 14.980, p < .001, subscales of 
the MASS than steroid non-users. Past steroid users scored significantly higher on the 
MASS total scale, the Bodybuilding Dependence, the Substance Use, and the Injury 
Risk subscales of the MASS than steroid non-users. Interestingly the Muscle 
Satisfaction subscale of the MASS did not indicate any significant difference between 
the groups, W(2) = 0.136, p = .873.  
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4.3.5.2.3 Exercise dependence 
Results also revealed that both current and past steroid users had higher levels of 
exercise dependence than steroid non-users, F(2) = 9.389, p < .001. Moreover, the 
examination of the prevalence rate of exercise dependence among steroid non-users and 
lifetime steroid users revealed that the prevalence rate of exercise dependence was 
significantly higher in lifetime steroid users (14.3%, n = 12) compared to steroid non-
users (7.3%, n = 16), χ2(2) = 10.983, p < .001.  Table 19 presents the prevalence rates of 
asymptomatic, symptomatic non-dependent, and at risk for exercise dependence among 
steroid non-users and lifetime steroid users. Sixty-nine percent of the lifetime steroid 
users and 58% of steroid non-users were identified as symptomatic non-dependent. 
 
Table 19 
The prevalence of asymptomatic, symptomatic non-dependent, and at risk for exercise 
dependence among steroid non-users and lifetime steroid users 
Exercise dependence category Steroid non-users 
n (%) 
Lifetime steroid users 
n (%) 
Asymptomatic 76 (34.5%) 14 (16.7%) 
Symptomatic non-dependent 128 (58.2%) 58 (69.0%) 
At risk for exercise dependence 16 (7.3%) 12 (14.3%) 
Note. Exercise dependence categories (i.e., asymptomatic, symptomatic non-dependent, and at risk for 
exercise dependence) were defined using the modified cut-off scores of Exercise Addiction Inventory 
(Mónok et al., 2012). 
 
 
4.3.5.2.4 Eating disorders 
The prevalence of the likely cases of eating disorders among steroid non-users was 10% 
(n = 22) and 4.8% (n = 4) among lifetime steroid users. Results of the Chi-square test 
did not indicate this significant association between lifetime steroid use and eating 
disorders, χ2(1) = 2.133, p = .144. 
 
4.3.5.2.5 Psychological correlates 
The results of the examination of the supposed psychological correlates of AAS use 
indicated that neither trait anxiety, F(2) = 0.544, p = .581, nor self-esteem, F(2) = 0.581, p 
= .560, had significant association with AAS use. However, current steroid users had 
the lowest level of self-efficacy comparing to past steroid users and non-users, F(2) = 
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4.031, p = .019. Eating disorder related psychopathological variables did not show any 
significant relationship with AAS use, except the interpersonal distrust. Namely, current 
steroid users displayed higher level of interpersonal distrust relative to the past steroid 
users and non-users, H(2) = 9.916, p = .007. 
 
Table 20 
One-way ANOVA for the comparison of anthropometric data, age, and psychological 
correlates of steroid non-users, past and current steroid users 
Variable Steroid  
non-users  
(n = 220) 
Past steroid 
users 
(n = 53) 
Current steroid 
users  
(n = 31) 
η2 Test statistic 
 M (SD) 
[95% CI] 
M (SD) 
[95% CI] 
M (SD) 
[95% CI] 
  
Age 27.7 (7.62) 
[26.7, 28.7] 
27.6 (7.42) 
[25.6, 29.7] 
29.0 (5.67) 
[26.9, 31.0] 
.003 F(2) = 0.421 
BMI 26.7 (3.96)c 
[26.1, 27.2] 
27.3 (3.41)c 
[26.3, 28.2] 
30.1 (4.75)a,b 
[28.4, 31.9] 
.065 F(2) = 10.383*** 
Desired BMI 27.4 (3.34)b,c 
[26.9, 27.8] 
29.0 (3.83)a,c 
[27.9, 30.1] 
31.6 (5.12)a,b 
[29.8, 33.5] .120 W(2) = 12.922*** 
Weight dissatisfaction 
(kg) 
2.3 (9.99)b 
[1.0, 3.7]  
5.6 (10.20)a 
[2.8, 8.4]  
5.0 (7.75) 
[2.2, 7.9]  
.020 F(2) = 3.025+ 
Bodybuilding 
Dependence (MASS) 
12.7 (4.56)b,c 
[12.1, 13.3] 
14.2 (4.52)a,c 
[12.9, 15.4] 
16.2 (4.19)a,b 
[14.7, 17.8] 
.059 F(2) = 9.395*** 
Muscle Checking 
(MASS) 
7.8 (3.63)c 
[7.4, 8.3] 
9.1 (4.40) 
[7.8, 10.3] 
10.5 (3.67)a 
[9.2, 11.9] 
.051 H(2) = 15.623*** 
Substance Use 
(MASS) 
7.4 (3.56)b,c 
[6.9, 7.8] 
10.2 (4.30)a,c 
[9.0, 11.4] 
14.3 (3.49)a,b 
[13.0, 15.5] 
.263 
rW3(2) = 
80.926*** 
Injury Risk (MASS) 9.0 (3.51)b,c 
[8.5, 9.4] 
10.3 (3.06)a 
[9.5, 11.2] 
11.2 (2.61)a 
[10.2, 12.2] 
.053 H(2) = 14.980*** 
Muscle Satisfaction 
(MASS) 
9.3 (2.80) 
[8.9, 9.7] 
9.1 (2.35) 
[8.5, 9.8] 
9.3 (2.27) 
[8.5, 10.2] 
.001 W(2) = 0.136 
MASS total 46.2 (12.31)b,c 
[44.6, 47.8] 
52.9 (13.74)a,c 
[49.1, 56.7] 
61.5 (11.06)a,b 
[57.5, 65.6] .137 F(2) = 23.974*** 
Exercise Dependence 
(EAI) 
15.8 (5.07)b,c 
[15.1, 16.4] 
17.8 (4.03)a 
[16.7, 18.9] 
19.4 (5.41)a 
[17.4, 21.3] 
.059 F(2) = 9.389*** 
Self-Esteem (RSES) 30.4 (3.98) 
[29.9, 31.0] 
30.1 (3.99) 
[29.0, 31.2] 
29.7 (3.44) 
[28.4, 30.9] 
.004 F(2) = 0.581 
DOI: 10.14753/SE.2013.1829
 107
Trait Anxiety (STAI) 39.8 (8.81) 
[38.6, 40.9] 
40.1 (8.45) 
[37.8, 42.4] 
41.5 (7.29) 
[38.8, 44.2] 
.004 F(2) = 0.544 
Self-Efficacy (GSES) 30.8 (4.31)c 
[30.2, 31.4]  
30.6 (3.95)c 
[29.5, 31.7]  
28.5 (4.11)a,b 
[27.0, 30.0]  
.026 F(2) = 4.031* 
Drive for Thinness 
(EDI) 
2.6 (3.27) 
[2.1, 3.0] 
2.2 (2.97) 
[1.4, 3.0] 
2.0 (2.17) 
[1.2, 2.8] 
.004 H(2) = 0.107 
Interoceptive 
Awareness (EDI) 
1.3 (2.40) 
[0.9, 1.6] 
1.4 (2.15) 
[0.8, 2.0]  
1.4 (1.76) 
[0.7, 2.0] 
.001 H(2) = 2.249 
Perfectionism (EDI) 4.3 (3.70) 
[3.8, 4.8] 
4.4 (3.40) 
[3.4, 5.3] 
5.7 (3.86) 
[4.3, 7.1] 
.013 H(2) = 4.288 
Interpersonal Distrust 
(EDI) 
2.3 (2.83)c 
[1.9, 2.6] 
2.4 (2.39)c 
[1.7, 3.1] 
4.9 (4.61)a,b 
[3.2, 6.6] 
.065 H(2) = 9.916** 
Note. CI = confidence interval. η2 is a measure of effect size for use in ANOVA with .02 representing 
small, .05 medium, and .08 large effect sizes. Superscripts indicate significant (p < .05) group differences 
during post-hoc tests.  
Weight dissatisfaction was counted as the actual body weight minus the desired body weight.  
a Significant difference between steroid non-users and other groups. 
b Significant difference between past steroid users and other groups. 
c Significant difference between current steroid users and other groups. 
+ p < .10. * p < .05. ** p < .01. *** p < .001. 
 
 
4.3.5 Examination of the risk factors of lifetime anabolic-androgenic steroid use 
Twenty-eight percent (n = 84) of the participants reported lifetime AAS use. To identify 
the risk factors of lifetime AAS use among male weightlifters, binary logistic regression 
analysis was performed. The variables which proved to be significant during the one-
way ANOVA for the comparison of psychological correlates of steroid non-users, past- 
and current steroid users were used in the model, adjusted to age and level of education. 
Table 21 provides the predictor variables of lifetime steroid use that were tested in the 
model. Considering the strong linear relationship between BMI and desired BMI, r = 
.71, p < .001, the weight dissatisfaction variable (calculated as desired body weight 
minus actual body weight) was used in the model instead of the desired BMI. As 
presented in Table 21, the positive attitude and the willingness to try AAS and other 
potentially risky supplements to gain muscle mass (measured by the Substance Use 
subscale of the MASS) significantly increased the odds for AAS use, OR = 1.24, p < 
.001. Higher BMI was also identified as a significant predictor of lifetime AAS use, OR 
= 1.09, p = .039. Finally, the level of education also emerged as a significant predictor 
of lifetime AAS use. Namely, those weightlifters whose level of education was at most 
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high school graduate had more than twofold odds to use AAS, OR = 2.33, p = .025, than 
those whose highest level of education was college graduate or more. The explained 
variance of the model is 33%. 
 
 
 
Table 21 
Explanatory variables of lifetime anabolic-androgenic steroid use (binary logistic 
regression analysis) 
 Predictor variables OR 95% CI for OR 
Bodybuilding dependence (MASS) 0.97 [0.88, 1.07] 
Muscle checking (MASS) 0.99 [0.90, 1.08] 
Substance use (MASS) 1.24*** [1.14, 1.35] 
Injury risk (MASS) 1.02 [0.91, 1.14] 
Exercise dependence 1.03 [0.95, 1.12] 
BMI 1.09* [1.00, 1.19] 
Weight dissatisfaction 1.03 [0.99, 1.07] 
Self-efficacy 0.97 [0.90, 1.05] 
Interpersonal distrust (EDI) 1.03 [0.93, 1.13] 
Age 1.03 [0.98, 1.07] 
Level of educationa 2.33* [1.11, 4.87] 
Nagelkerke R2 33%
Note: R2 means explained variance. OR = odds ratio; CI = confidence interval. 
Level of educationa: the level of education was dichotomized, where 1 = level of education was at most 
high school graduate and 0 = level of education was college graduate or more. 
* p < .05. *** p < .001.  
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5. DISCUSSION 
5.1 Examination of muscle dysmorphia in male weightlifters and university 
students  
 
The preliminary study intented to explore the potential usability of the MASS in 
Hungary. Results indicated that the translated Hungarian version of the MASS 
demonstrates initial cultural appropriateness and reliability when used with independent 
samples of Hungarian male weightlifters (n = 60) and university students (n = 60). The 
study showed each subscale of the instrument to have a satisfactory level of internal 
consistency. According to our knowledge this was the first Hungarian study that used 
the MASS, a specific measure for the assessment of MD symptoms (Babusa & Túry, 
2012). 
 
The study examined MD symptoms, associated features of body image, and eating 
disorder related psychopathological characteristics in male weightlifters and university 
students. Results showed that weightlifters had a higher tendency towards MD 
symptoms, and displayed more eating disorder related psychopathological 
characteristics, compared to the undergraduate group. Their attitudes towards their body 
image also differed.  
 
The symptoms of MD were related to steroid use, since current self-reported steroid 
users displayed higher tendency for MD symptoms than self-reported steroid nonusers. 
This result is in line with with previous data (Kanayama et al., 2006; Cole et al., 2003; 
Rohman, 2009). Furthermore, MD was associated with current weightlifting activity, 
higher ideal body weight and eating disorder related psychopathological characteristics, 
i.e. interoceptive awareness. Participating in sports that requires high muscle mass, such 
as weightlifting or bodybuilding, apparently increases the risk of MD. Moreover, 
individuals who participate in such sports are more likely to use anabolic steroids 
(Irving, Wall, Neumark-Sztainer, & Story, 2002). Anabolic steroids in sufficient doses 
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increase body mass and strength (Kadi, Eriksson, Holmner, & Thornell, 1999) and high 
density body mass could be a precursor for MD (Grieve, 2007). Sport participation with 
a pressure toward huge muscles, lean body mass and a desire for attaining a certain 
weight gain may not lead directly to the development of MD, but it can increase the risk 
for developing the disorder.  
 
To summarize, the preliminary study demonstrated that the Hungarian version of the 
MASS is reliable, but more rigorous testing of its psychometric properties and 
applicability is required. Furthermore, the study results highlighted the positive 
relationship between MD symptoms, eating disorder related psychopathological 
characteristics, and steroid use. These results suggest the idea that MD and body image 
related concerns among males may not be strictly confined to the Western cultures and 
their body ideals. Recently, there is an increased expectation towards men’s body and 
appearance in Hungary as well (Túry & Babusa, 2012). The male body appearance 
market, the beauty and fitness industry have been increasing –for instance, there are 
more than 200 fitness clubs in the capital city Budapest. There is also a growing trend 
for male cosmetics and grooming products. The value of groomed, muscular and lean 
male body has also risen. The tendency suggests that the male body ideals are similar 
like that of in Western countries. The question for further research is: Does this 
tendency manifest in male body image pathologies or remain as a transient “fashion 
trend”? Where are we now in the progress of assimilation of the Western ideals? The 
appearance of MD in Hungary may be the same like that of AN and BN. A few decades 
ago eating disorders were regarded as the consequences of the Western cultural ideals 
(“3 Ws”: white Western women). Now eating disorders are as widespread in Central-
East European region as in Western countries (Rathner et al., 1995). However, there are 
some cultural differences in the morbidity between East and West Europe. Surprisingly, 
Rathner et al. (1995) found the highest prevalence of bulimic behaviour in Hungary 
compared to Austria and Germany. The appearance of MD in Hungary might be similar 
like that of AN and BN. Unfortunately, epidemiological studies on MD are still lacking 
in Central-East Europe. MD and the muscular ideology might be wide-spread, but still 
understudied phenomenon in the Central-Eastern European countries. 
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5.2 Adaptation of the Muscle Appearance Satisfaction Scale in 
Hungary 
 
The purpose of the second study was the psychometric evaluation of the Hungarian 
version of the MASS. Considering that little work has been done on the examination of 
the factor structure of the MASS and MD symptomatology outside of the U.S., we 
investigated the psychometric properties of the Hungarian version of the MASS and 
MD symptomatology among Hungarian male weightlifters and undergraduate students. 
 
In the weightlifter sample, we replicated the original five-factor structure (Mayville et 
al., 2002), with one item exception. The self-worth item (Bodybuilding Dependence 
factor, item 15) did not have any salient factor loadings, so we suggest excluding this 
item from the Hungarian version of the MASS. However, in the undergraduate sample, 
we found a three-factor solution instead of the original five factors. Besides the original 
Muscle Satisfaction factor, the items referring to Bodybuilding Dependence and Injury 
Risk were represented in one factor, and the items referring to Muscle Checking and 
Substance Use were represented in the third factor. These results suggest that the 
Hungarian version of the MASS can be adequately used among male weightlifters, but 
it works somehow differently among non-weightlifters. These findings correspond with 
previous research showing that the MASS has different factorial structure in the 
weightlifters and in the general population. Originally, the MASS was developed on 
male weightlifter samples and showed a stable five-factor structure (Mayville et al., 
2002). Nevertheless, a recent study conducted among Irish and British men suggested a 
unidimensional six-item version of the MASS in the general population (Ryan & 
Morrison, 2010). 
 
Scale score reliability and test-retest reliability of the MASS were also supported. In the 
weightlifter group, the aspects of MD were associated with low self-esteem, food 
supplementation, current steroid use, fewer years of exercise, younger age, and lower 
BMI. The drive for thinness was not linked with the aspects of MD, suggesting a 
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difference between these two constructs and supporting the discriminant validity of the 
MASS. Our results support previous research studies demonstrating the relationship 
between low self-esteem and muscle dissatisfaction (McCreary, 2007; Olivardia et al., 
2004). A number of studies have pointed out the importance of being muscular in males 
(e.g. Fisher et al., 2002; Jacobi & Cash, 1994; Pope, Phillips, et al., 2000). One of the 
reasons why muscularity is so important to men is that it is associated with masculinity 
(Weinke, 1998). This implies that the more muscular a man is, the more masculine he 
perceives himself to be. Those men whose self-esteem is dependent upon their 
appearance may engage in appearance-improving behaviors (Crocker, 2002). These 
behaviors can be excessive exercise, rigid diet, or weightlifting/bodybuilding activity. 
The relationship between low self-esteem and MD is also well-documented (Grieve, 
2007; Grieve & Helmick, 2008; Lantz et al., 2001; Pope, Phillips, et al., 2000).  
 
In agreement with previous studies, we found that anabolic steroid use and food 
supplementation were associated with MD, as men with MD symptoms were more 
likely to use these substances to increase muscle mass (Kanayama et al., 2006; 
Olivardia et al., 2000; Pope & Katz, 1994). The relationship between fewer years of 
exercise and muscle satisfaction may seem odd, given that men with MD exercise 
excessively; however, the results also indicated the association between younger age 
and MD. Considering this, in younger individuals, fewer years have been spent 
exercising. The latter finding is in accordance with previous study results which 
reported that the age of onset of MD was in early adulthood (Cafri et al., 2008; 
Olivardia et al., 2000). Finally, lower BMI was only weakly associated with one aspect 
of MD, namely injury risk. Although the BMI is included in the conceptual model of 
MD, it has also been noted that the relationship between BMI and MD has not been 
established yet (Grieve, 2007). Moreover, the interpretation of BMI has to be treated 
carefully in this respect, as high BMI may indicate either a high level of muscle mass or 
a high level of body fat, and lower BMI may also indicate lean musculature. Therefore, 
the use of the “fat-free mass index” (FFMI; Kouri et al., 1995) as an objective measure 
of an individual’s degree of muscularity would be more appropriate in future studies. 
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In the undergraduates, aspects of MD were associated with low self-esteem, low drive 
for thinness, and current weightlifting activity. The relationship between low self-
esteem and MD in the undergraduate sample indicates that muscular appearance and 
muscle satisfaction may have a general role in self-esteem among males. The weak 
association between low drive for thinness and MD may indicate that males with greater 
MD symptoms have also a desire to increase muscle mass. However, further 
examination is necessary to clarify the relationship, since a previous study also pointed 
out the relationship between MD and the drive for thinness (Olivardia, 2001). The 
present subscale of the EDI also refers to the drive for leanness, which partially explains 
the relationship with MD. Different sample composition and possibly the different 
exercise motivations, e.g., weight loss or weight control in the undergraduate group may 
serve another explanation. Finally, weightlifting activity was associated with MD, and 
those undergraduates with weightlifting activity displayed greater MD symptoms. The 
conceptual model of MD also highlighted that participation in those sports which focus 
on muscular appearance and muscle gain, e.g., weightlifting or bodybuilding increases 
the risk for developing MD (Grieve, 2007). 
 
To summarize, our study provided two main results. First, the construct validity and 
reliability of the Hungarian version of the Muscle Appearance Satisfaction Scale 
(MASS-HU) were supported in the weightlifter sample. Based on the psychometric 
examination of the MASS-HU, symptoms of MD can be measured with the five-factor, 
18-item Hungarian version of the MASS among male weightlifters. We hope that the 
MASS-HU will encourage and stimulate further research and clinical work in the field 
of MD in Hungary. Second, our study results also confirmed previous findings 
demonstrating the relationship between low self-esteem and muscle dissatisfaction 
among males. The current study is in line with a previous study (Túry et al., 2001), 
pointed out that the muscle dissatisfaction and the muscular ideal seem to be frequent 
phenomena not only in the U.S. and western countries, but also in Hungary. 
 
The study has limitations that are important to acknowledge. First, the main limitation 
of the present study is the use of convenience sampling. Second, as self-report measures 
were used in the study, there was no objective measure of anthropometric data. Third, 
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the direction of causal relationships remained uncertain during the analyses. The main 
purpose was to test the associations between the factors of the MASS and other 
variables; thus we did not distinguish the antecedents and consequences. Future 
research with a prospective study design could clarify the nature of these associations. It 
would also be important to examine whether the impact of antecedent variables such as 
age, BMI, and self-esteem on steroid use, for example, is mediated by muscle 
appearance satisfaction. Fourth, we did not use sexual orientation measures; sexual 
orientation is often associated with body image dissatisfaction and disordered eating 
among men (Chaney, 2008; Kaminski, Chapman, Haynes, & Own, 2004; Strong, 
Williamson, Netemeyer, & Geer, 2000). Finally, the lack of the Hungarian version for 
MD assessment did not allow for testing the concurrent validity of the MASS. The 
adaptation of another MD-related questionnaire in Hungary, the Muscle Dysmorphia 
Inventory (Rhea, Lantz, & Cornelius, 2004), would allow for the examination of the 
concurrent validity of the measure. Since non-clinical samples were used for the 
development and validation of the MASS, cut-off scores are not available (Mayville et 
al., 2002). An assessment of discriminative validity and a definition of cut-off scores 
with the use of a clinical sample reporting the characteristic symptoms of MD would be 
beneficial. Such future research could facilitate the use of the MASS as a diagnostic 
tool. 
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5.3 Muscle dysmorphia in Hungarian male weightlifters  
 
5.3.1 Characteristics of Hungarian male weightlifters 
In the third study we examined Hungarian male weightlifters and explored the 
prevalence rate and various psychological characteristics of MD and AAS use within 
this high risk population. However, it is worth mentioning some general characteristics 
of the total sample since this is only the second study among male weightlifters in 
Hungary. Since the previous study was conducted ten years ago (Túry et al., 2001), it is 
also useful to compare our results with the results of the first Hungarian study to follow 
time trends. If we compare the anthropometric data of the participants of the previous 
and the present studies, the differences are notable. Participants in the currents study 
had the mean age of 27.8 (SD = 7.40) years, which is significantly higher than in the 
previous study reported by Túry et al. (2001), 26.2 years; t(303)=3.800, p < .001. The 
mean body height of our study sample was 179.5 cm (SD = 6.05), which was 
significantly lower than the mean body height of the participants in the study of Túry et 
al. (2001), 180.7 cm, t(304) = 3.391, p = .001.  The body weight, BMI, and desired body 
weight of the male weightlifters in our sample were significantly higher compared to the 
study results of Túry et al. (2001). Ten years ago the body weight of the male 
weightlifters was 83.2 kg and their BMI was 25.5. By 2011 their body weight increased 
to 87.5 kg and their BMI to 27.1, t(303) = 5.176, p < .001 and t(303) = 6.955, p < .001, 
respectively. Weightlifters in 2001 reported a desired body weight of 87.2 kg. Despite 
of the higher body weight of the weightlifters in 2011, they still would like to increase 
their body weight and reported a desired body weight of 90.7 kg, t(303) = 4,213, p < .001. 
The difference of the means between the actual and desired body weight of the 
participants in the previous (4 kg) and present study (3.2 kg) did not differ significantly, 
t(303 )= 1.455, p = .147.  
 
More interestingly, the number of males who are dissatisfied with their body weight 
significantly increased in this population. In 2001, 43% of the male weightlifters were 
satisfied with their body weight; however in 2011 only 9.5% of the participants reported 
weight satisfaction, χ2(2) = 144.461, p < .001. Conversely, the number of those males 
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who wanted to lose or gain some weight increased from 2001 to 2011. In 2001, only 
16% of the weightlifter males wanted to lose some weight; by 2011 this number raised 
to 31%. Ten years ago the number of weightlifter males who wanted to gain weight was 
41%; by 2011 this number increased to 60%. Moreover, in the study of Túry et al. 
(2001) only 4.3% of the male weightlifters wanted to achieve notable weight gain (at 
least 5 kg); in the present study we found significantly higher rate, since almost half of 
the participants (48.4%) reported a desire to gain notable weight, χ2(1) = 1433.801, p < 
.001. 
 
These results are in line with previous international studies suggesting increasing body 
dissatisfaction among males over the last few decades (Berscheid et al., 1973; Cash et 
al., 1986; Garner, 1997; Grieve et al., 2006; Mishkind et al., 1986; Pope, Phillips, et al., 
2000; Vartanian et al., 2001). The populations in the present and the previous studies 
are consisted of male weightlifters, therefore results should not be generalized to the 
general Hungarian male population. Nevertheless, our results comparing to the previous 
results highlight the changing trends in male body image concerns and body size ideals. 
Considering that we examined these trends ten years after, the changes are dramatic.  
 
Several studies pointed out the prevalence of exercise dependence among weightlifters 
(Hale et al., 2010; Hurst et al., 2000; Smith et al., 1998; Smith & Hale, 2004). In the 
present study we also examined the prevalence rate of exercise dependence among 
Hungarian male weightlifters. According to the results, 9.2% of the male weightlifters 
were at risk for exercise dependence and further 61.2% were symptomatic non-
dependent. In a recent Hungarian study, the prevalence rate of exercise dependence 
categories in exercising population were: 44.8% asymptomatic, 52.0% nondependent 
symptomatic exercisers, and 3.2% at risk for exercise dependence (Mónok et al., 2012). 
Results indicated that the prevalence rate of exercise dependence was significantly 
higher in the present sample of male weightlifters compared to the result of the above-
mentioned study, χ2(2) = 54.918, p < .001. However, the prevalence rates in our study 
were significantly lower compared to the international prevalence rates. Hale et al. 
(2010) examined the prevalence rate of exercise dependence among male weightlifters 
and power lifters. According to the results 15.1% (n = 22) of the participants were 
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identified as at risk for exercise dependence, 77.4% (n = 113) as symptomatic non-
dependent, and 7.5% (n = 11) as nondependent asymptomatic. The prevalence rate of 
exercise dependence (both ‘at risk’ and ‘symptomatic non-dependent’) in the study of 
Hale et al. (2010) was significantly higher compared to the prevalence rate in our study 
population (based on both the new cut-off scores suggested by Mónok et al. (2012): χ2(1) 
= 215.374, p < .001; and  the original cut-off score: χ2(1) = 99.757, p < .001. Lejoyeux et 
al. (2008) found 42% (n = 125 out of 300) prevalence rate of exercise dependence 
among clients of a fitness room. This prevalence rate is also significantly higher 
compared to our results, χ2(1) = 134.173, p < .001.  
  
Research evidence also suggests that weightlifters are at increased risk for developing 
an eating disorder (Anderson et al., 1995; Goldfield et al., 1998; Mangweth et al., 
2001). In our sample of male weightlifters, 8.5% was likely to have an eating disorder 
(AN or BN). Since 31% of the participants would like to lose weight and 60% would 
like to gain weight, the presence of eating disorder symptoms in this sample of male 
weightlifter is not surprising. Furthermore, they also have an increased preoccupation 
with their body image, food and exercise, which may also increase the risk for 
developing eating disorder symptoms (Mangweth et al., 2001). 
 
5.3.2 Prevalence of muscle dysmorphia among Hungarian male weightlifters 
The first purpose of the study was to identify a group of male weightlifters with unique 
features of MD, which can be distinctive from non-muscle dysmorphic weightlifters and 
to set out a prevalence rate of MD among Hungarian male weightlifters. Study results 
differentiated three groups (normal weightlifters, low risk MD group, and high risk MD 
group) of male weightlifters, instead of two (MD and non-MD group of weightlifters). 
This result was not surprising, as Hildenbrandt et al. (2006) identified five groups 
(muscle dysmorphic, muscle concerned, fat concerned, normal behavioral, and normal) 
within their sample of male weightlifters with the use of the same statistical method 
(LCA). In the present study we were able to identify a group of weightlifters who 
displayed the characteristics of MD, called the high risk MD group. Although, this 
group was not a clinically diagnosed group with MD, they displayed the symptoms of 
MD conceptualized by Thompson et al. (1999) and fulfilled the diagnostic criteria of 
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MD described by Pope et al. (1997). Based on these characteristics, the high risk MD 
group was distinctive from the other two groups of male weightlifters. According to the 
results of the latent class analysis, the estimated prevalence rate of MD was 18.0% (n = 
55) in this sample of male weightlifters (in the study we referred them as high risk MD 
group). A further 51.6% (n = 157) displayed elevated levels of MD symptoms; thus, 
these male weightlifters could be characterized as the low risk MD group. Future 
research should focus on the at-risk groups and analyze the potential risk factors of MD. 
Finally, 30.2% (n = 92) of the participants could be described as normal weightlifters as 
they did not show the symptoms of MD.  
 
There is only one study available in Hungary that can be comparative to our study 
results. In this previous Hungarian study Túry et al. (2001) found significantly lower  
prevalence rate of MD (4.3%) among male weightlifters using interview technique, χ2(1) 
= 140.525, p < .001. However, the prevalence rate of MD in this study is significantly 
higher compared to the 8.3% prevalence rate reported by Pope et al. (1993), χ2(1) = 
38.298, p < .001, and the 10% prevalence rate found by Pope & Katz (1994), χ2(1) = 
22.118, p < .001. The comparison of our results with other studies is difficult as the 
findings in different studies are heterogeneous in terms of the study sample (e.g., 
weightlifters, bodybuilders, power lifters, men with body dysmorhic disorder), study 
design (e.g., questionnaire or interview based), and outcome measures (several 
measures of MD symptoms are available). Since the prevalence rate in the present study 
is a questionnaire based one, and the differentiation of the MD group based on a specific 
statistical method, we suggest this rate as a tentative prevalence rate. Although 
Hildenbrandt et al. (2006) found similarly high prevalence rate (16.9%) among male 
weightlifters, with the use of LCA, χ2(1) = .308, p = .579. Some authors also noted that 
the prevalence rate of MD is underestimated and many men might suffer from 
subclinical forms of MD even in the general population (Goodale et al., 2001; 
Olivardia, 2001; Pope, Phillips, et al., 2000), results should be treated carefully. 
 
Since our study sample was a special population consisted of male weightlifters, the 
generalization of the results is restricted to the male weightlifter population and can not 
be extended to the general population. Despite of the limitations, the present study is the 
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first national study assessing the prevalence of MD in high risk population of male 
weightlifters with a larger sample size. Although studies relating to MD in Central-
Eastern European region are still lacking, our results suggest that MD is prevalent in 
Hungarian male weightlifters.  
 
5.3.3 Determination of the tentative cut-off score of the Muscle Appearance 
Satisfaction Scale 
To our knowledge, no cut-off score for the MASS is available; thus, the present study 
also aimed to determine a tentative cut-off score for the measure. Considering the high 
risk MD group as a ‘gold standard’, sensitivity and specificity analyses were performed. 
According to the results, we proposed a score of 62 as an appropriate cut-off point for 
the MASS to distinguish between MD and non-MD cases among male weightlifters. 
Given that we used a nonclinical sample of MD cases, the proposed cut-off score is still 
a tentative cut point. Additionally, this cut-off score may vary in different research 
studies and may also depend on culture and other variables. In the future, it would be 
particularly interesting to examine the proposed cut-off score in other studies. The use 
of clinical MD sample for this purpose would be highly instructive. 
 
5.3.4 Characteristics and psychological correlates of muscle dysmorphia 
The third aim of the study was to explore differences between muscle dysmorphic and 
non-muscle dysmorphic groups of male weightlifters based on various psychological 
correlates.  
 
5.3.4.1 Muscle dysmorphia and high level of BMI 
The relationship between MD and BMI is still unclear and the results are inconsistent 
(Cafri et al., 2005). Our study results supported the association between MD and BMI 
(e.g., Grieve, 2007), as the mean BMI of the MD group was the highest comparing to 
the low risk MD group and normal weightlifters. Additionally, this BMI was larger than 
the normal recommended BMI for male adults (20–25). However, BMI is not an 
adequate measure of obesity in muscular men since it can not distinguish between 
muscle and fat mass. That is, use of the “fat-free mass index” (FFMI; Kouri et al., 1995) 
as an objective measure of an individual’s degree of muscularity would be more 
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appropriate for the measure of male body composition. Although the present study 
design did not allow the use of the FFMI, we can hypothesize that men with MD had a 
high level of muscle mass instead of fat mass, since they also reported highest desire 
toward weight gain instead of weight loss. As the ideal male body is the muscular one, 
we can assume that they wanted to gain muscle mass instead of fat mass. Moreover, the 
results of the present study also confirm this assumption, as the subjective importance 
of muscle mass gain was significantly higher among those who would like to gain 
weight. MD was also associated with the high desire toward weight gain and body 
weight dissatisfaction, since the high risk MD group wanted to gain 7 kg more weight in 
average. 
 
5.3.4.2 Muscle dysmorphia and exercise dependence 
Our study results also supported the relationship between MD and exercise dependence, 
since those males with MD displayed the highest level of exercise addiction. 
Accordingly, the quantity and frequency of workouts were also the highest in the high 
risk MD group. Our finding is in line with previous study results emphasizing the 
relationship between MD and exercise dependence (Hale et al., 2010; Hurst et al., 2000; 
Smith et al., 1998; Smith & Hale, 2004). These studies pointed out that those 
individuals who display higher levels of MD may be at higher risk for developing 
addictive exercise behaviour patterns. Our results also supported the proposed psycho-
behavioural model of MD (Lantz et al., 2001), which suggests that exercise dependence 
is one of the behavioural characteristic related to MD. Hale et al. (2010) found that 
symptoms of MD also predicted exercise dependence. Obsession with gaining muscle is 
associated with excessive exercise, as muscular development can be achieved through 
physical activity. 
 
5.3.4.3 Muscle dysmorphia and anabolic-androgenic steroid use 
As it was expected, elevated prevalence rate of AAS use was related with MD, since 
both current and lifetime use of AAS were more prevalent among males with MD. The 
lifetime prevalence of AAS use was 68% and still 41% of the participants in this group 
were current AAS user. These were the highest prevalence rates among the groups and 
this result is also consistent with the diagnostic criteria of MD (Pope et al., 1997). Of 
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note, the lifetime prevalence of AAS use was 24% in the low risk MD group, and only 
11% in the normal weightlifters. The current AAS use was notably lower in these 
groups, as 5% of the low risk MD group and only 1% of the normal weightlifters 
reported current AAS use. The highest frequency of the desire toward weight gain was 
reported in the high risk MD group, which may partially explain the higher frequency of 
AAS use in this group.  
 
These results are comparable with previous data; however, some research found even 
higher prevalence rate of AAS use among males with MD. Pope et al. (1993) revealed 
that 100% (four out of four) of the men with MD reported lifetime history of AAS use. 
In a previous study of MD in Hungary, Túry et al. (2001) also found 100% (six out of 
six) prevalence rate of AAS use among men with MD. The prevalence rate of AAS use 
among the 140 male bodybuilders was 9.3%. Later studies found lower prevalence rate 
of AAS use among men with MD. Pope et al. (1997) found that 40% (6 out of 15) of 
men with MD reported a history of AAS use. Similarly, Olivardia et al. (2000) found 
that 46% of the men with MD and only 7% of the normal non-MD comparison 
weightlifters reported AAS use.  
 
The increased prevalence rate of AAS use among men with MD is due to their 
preoccupation with the idea that their bodies are not sufficiently big and muscular (Cafri 
et al., 2005; Kanayama et al., 2006; Leit et al., 2002; Olivardia et al., 2000; Pope et al., 
1997; Rhea et al., 2004). This body image concern and the desire toward muscle gain 
often motivate individuals to use AAS. Research suggests that body image 
dissatisfaction (Brower, 2002) and the pursuit of muscularity (Olivardia et al., 2000), 
which are two main characteristics of MD, can increase the risk of AAS use and 
dependence. Rohman (2009) argued that the frequent AAS use in men with MD is in 
relation with their body image disorders that hinder them to realize their muscular 
development. Brower (2002) suggested that muscularity becomes central to the self-
esteem of men with MD and any loss of muscularity evokes anxiety, which often lead to 
AAS dependence. In our study sample the frequency of supplement use was also the 
highest (86.7%) in the high risk MD group comparing to the low risk MD group 
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(66.8%) and normal weightlifters (50.4%). This result also suggests that the body 
appearance control was the highest in the high risk MD group. 
 
5.3.4.4 Muscle dysmorphia and eating disorder related psychopathological 
characteristics 
Results indicated that men with MD displayed more eating disorder related 
psychopathological characteristics, as they reported higher levels of drive for thinness 
and interoceptive awareness relative to the group of normal weightlifters, and had 
higher levels of perfectionism and interpersonal distrust comparing to the normal 
weightlifters and low risk MD group. These results correspond to previous study 
findings that emphasized the association between MD, disordered eating, and eating 
disorder related characteristics (McFarland & Kaminski, 2009; Mossley, 2009; 
Olivardia et al., 2001; Pope at al., 1993; Pope et al., 1997; Pope & Katz, 1994). Of note, 
Olivardia et al. (2001) found similar results, as muscle dysmorphic men had elevated 
scores on the Eating Disorder Inventory (Garner et al., 1983), that is, they showed 
perfectionistic traits, maturity fears, feelings of ineffectiveness, and drive for thinness. 
The etiology of MD may resemble to that of eating disorders, as some behavioral and 
psychological traits of AN and BN are similar in case of MD.  
 
Significantly higher level of drive for thinness was associated with MD. However this 
result may be controversial, Olivardia (2001) also pointed out the relationship between 
MD and the drive for thinness, and he argued that the present subscale of the EDI also 
refers to the drive for leanness –which is also common in AN. Men with MD may be 
that obsessed with their percentage of their body fat like women with AN, which 
partially explains the relationship between MD and drive for thinness. Moreover, 
Kelley, Neufeld, and Musher-Eizenman (2010) confirmed this relationship as they 
suggested that both drive for thinness and drive for muscularity can be experienced 
simultaneously.  
 
The high risk MD group also reported higher levels of interoceptive awareness. This 
eating disorder related psychopathological characteristic refers to “one's lack of 
confidence in recognizing and accurately identifying emotions and sensations of hunger 
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or satiety” (Garner et al., 1983). This eating disorder related characteristic may lead to 
the development of either binge eating or BN which is common in MD (McFarland & 
Kaminski, 2009; Olivardia et al., 2001; Pope et al., 1997). Moreover, the strict dietary 
regimens, the use of ergogenics and food supplements may also distract their sensations 
of hunger and satiety. Furthermore, this kind of lack of confidence may also contribute 
to the development of body monitoring and body obsessions. 
 
Perfectionism was also related to MD. Perfectionism is defined as the pursuit of 
unrealistic goals (Nugent, 2000, cited by Grieve, 2007). In the conceptual model of MD 
(Grieve, 2007) perfectionism influences the development of MD. Research evidence 
shows that eating disordered women have unattainable body shape goals and higher 
levels of perfectionism than women without eating disorders (Vohs et al., 2001). Men 
with MD also have unrealistic body shape goals, thus it is hypothesized that 
perfectionism may also influence the development of MD. Kuennen and Waldron 
(2007) supported this hypothesis as they found a direct relationship between 
perfectionism and MD. Our study results also confirm the association between MD and 
perfectionism, indicating that men with MD are prone to pursue a perfect and 
unattainable muscular body ideal. The results also support this hypothesis, as even 
though the high risk MD group had the highest BMI, they also reported the highest 
levels of desire toward weight gain comparing to the low risk MD group and normal 
weightlifters. Moreover, as it was mentioned before, those males who wanted to gain 
weight reported the highest level of importance of muscle mass gain. 
 
MD was also associated with higher levels of interpersonal distrust. This association is 
possibly due to their impaired social and intimate relationships. Often, MD is socially 
and occupationally impairing and those who are affected usually avoid social activities 
and people (Cafri et al., 2008; Kovács & Túry, 2001; Olivardia, 2001; Pope et al., 1993; 
Pope et al., 1997). This might be because of they believe that their bodies are not 
sufficiently lean and muscular, and being afraid of humiliations relating to their 
perceived body deficiencies. As a result of their imagined body flaws –which is also a 
characteristic of body dysmorphic disorder– they avoid those situations where their 
bodies are exposed to others. Thus, they hide their bodies and wear loose and heavy 
DOI: 10.14753/SE.2013.1829
 124
clothes even in the summer. This characteristic of MD may lead to the elevated scores 
of interpersonal distrust.  
 
Although we did not assess childhood victimization, some authors emphasized that 
childhood bullying experiences may also contribute to the development of MD. Some 
study results pointed out that those boys who suffered from childhood physical 
victimization by peers and parents –because of being physically weak– are more likely 
to engage in bodybuilding activity (Fussel, 1991; Klein, 1993). The assumption that 
childhood bullying experiences are strongly associated with the development of MD 
was supported by the study of Wolke and Sapouna (2008). Their study results showed 
that those weightlifters who were subjected to childhood bullying experiences displayed 
more MD symptoms. This kind of negative childhood experience may also contribute to 
the development of interpersonal distrust. Moreover, weightlifting is not a team sport 
that requires social interactions and can be performed even alone. Furthermore, Wolke 
and Sapouna (2008) also emphasized that MD and impaired psychosocial functioning 
are often related; thus, clinicians should be aware of this association. 
 
To summarize, our results highlighted the association between eating disorder related 
psychopathological characteristics and MD. Several studies pointed out that males with 
MD are at increased risk for developing eating disorders (McFarland & Kaminski, 
2009; Mossley, 2009; Olivardia et al., 2001; Pope at al., 1993; Pope et al., 1997; Pope & 
Katz, 1994). The rigid adherence to a dietary regimen, the weight control behaviours, 
such as following a special diet, eating in every three hour even if not hungry, the use of 
food supplements, and the preoccupation with food contribute to the development of an 
eating disorder (Goldfield et al., 1998). These results showed that some underlying 
characteristics of men with MD are similar to that of patients with eating disorders, 
which may predispose them to the development of a full-blown eating disorder. 
 
Besides the eating disorder related psychopathological characteristics, we also examined 
the relationship between MD and eating disorders. This association is well-established 
in the literature (McFarland & Kaminski, 2009; Olivardia et al., 2000; Pope et al., 1993; 
Pope & Katz, 1994; Pope et al., 1997). Although, the prevalence of eating disorders in 
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the high risk MD group and low risk MD group was higher (10.9% and 9.5%, 
respectively) compared to the normal weightlifters (5.4%), we did not find significant 
association between MD and eating disorders. It can be that we did not apply the 
appropriate measure for the assessment of eating disorders, as we used the SCOFF 
questionnaire. This screening tool has been developed to raise the suspicion of a likely 
case of an eating disorder and has not been designed to be used as a diagnostic tool. 
Therefore, the assessment of eating disorders should be planned due foresight. Further 
studies should consider the use of other scales to reveal the association between MD 
and eating disorders in Hungarian risk populations.  
 
5.3.4.5 Muscle dysmorphia and low level of self-esteem 
Our study results confirm previous findings since MD was associated with lower level 
of global self-esteem in the present study of male weightlifters. The proposed 
etiological models of MD (Grieve, 2007; Lantz et al., 2001) and the model of body 
change strategies (Cafri et al., 2005) involved low self-esteem as a contributing factor to 
the development of the disorder. Besides this, many studies suggested negative 
relationship between self-esteem and MD symptoms (Grieve & Helmick, 2008; Lantz, 
Rhea, & Mayhew, 2001; Pope, Phillips, et al., 2000; Wolke & Sapouna, 2008). Some 
aspects of the relationship between MD and low self-esteem already has been described 
in Study 2; thus, only additional issues will be discussed in the present section.  
 
Ebbeck, Watkins, Concepcion, Cardinal, and Hammermeister (2009) found that those 
who are suffering from low self-esteem use weightlifting as a coping mechanism for the 
improvement of muscularity. This activity is appreciated by the society and may also 
enhance self-efficacy; therefore motivates for more exercise. Another explanation can 
be that muscularity becomes the center of self-esteem of males with MD. Due to their 
body image disorder and body dissatisfaction, they have a negative view of their 
muscularity which is the center of their self-esteem; therefore, they engage in excessive 
exercise to increase their muscle mass. This idea is also supported by Crocker (2002), 
emphasizing that those men whose self-esteem is dependent upon their appearance may 
engage in appearance-improving behaviours in order to enhance their self-esteem. 
When self-esteem and masculinity are solely based on musculature, this may lead to the 
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development of MD. Further studies should examine the mediator factors between MD 
and low self-esteem. 
 
5.3.4.6 Muscle dysmorphia and anxiety 
Many studies found a relationship between MD, general anxiety, and anxiety disorders 
(Cafri et al., 2008; Chandler et al., 2009; McFarland & Kaminski, 2009; Olivardia et al., 
2000; Wolke & Sapouna, 2008). Our study results correspond with previous research 
findings as MD was associated with higher levels of anxiety. However, the source of 
anxiety in men with MD is not clear, as it may relate to several different factors, such as 
body appearance, obsessive thoughts, body comparison, low self-esteem, or feelings of 
not being muscular or masculine enough. Furthermore, we still do not know whether the 
onset of anxiety occurs before or after the development of MD. Olivardia et al. (2000) 
suggested that compulsive weightlifting might serve as a coping strategy to deal with 
the comorbid conditions, such as feelings of anxiety. Wolke and Sapouna (2008) found 
that higher levels of MD symptoms partially mediated the relationship between 
childhood victimization and global psychopathology, including anxiety. Despite of 
these study findings, the relationship between MD and anxiety is still understudied. 
Future studies for the clarification of the sources of anxiety experienced in MD, should 
investigate the mediator and moderator factors between MD and anxiety. 
 
5.3.5 Prevalence of anabolic-androgenic steroid use among Hungarian male 
weightlifters 
Although research evidence indicates that the use of AAS is prevalent among male 
weightlifters, the AAS use in this high risk population is still understudied in Hungary. 
Therefore, the study also aimed to examine the prevalence rate of AAS use among 
Hungarian male weightlifters. Results indicated that the lifetime prevalence of AAS use 
in our study sample of Hungarian male weightlifters was 27.6%. Moreover, past and 
current steroid use was also differentiated in the study. According to the results, 17.4% 
of the weightlifters reported past steroid use and 10.2% reported current steroid use. 
 
In a previous comparable Hungarian study, 9.3% (n = 13) of the male weightlifters 
reported current steroid use (Túry et al., 2001), which was similar to the prevalence of 
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current steroid use in the present study, χ2(1) = .290, p = .590. Pope et al. (2012) found 
44% (n = 102) prevalence of lifetime AAS use among male weightlifters. The 
prevalence rate of lifetime steroid use in the current study was significantly lower 
comparing to results of the above mentioned study, χ2(1) = 33.056, p < .001. Pope et al. 
(1993) found 51% (n = 47) and Kanayama et al. (2003) also revealed same (50%, n = 
48) prevalence rate of lifetime AAS use among male weightlifters. These rates were 
also significantly higher compared to the prevalence rate in our study sample, χ2(1) = 
66.430, p < .001 and χ2(1) = 60.842,  p < .001, respectively.  However, the prevalence 
rate of lifetime AAS use in the current study is lower compared to the international data, 
the current study results indicate that lifetime AAS use among Hungarian male 
weightlifters is also prevalent. As it was suggested in previous studies (e.g., Thiblin & 
Petersson, 2005), the weightlifter population is considered as a high risk population for 
AAS use. Further national studies would be needed to confirm this hypothesis and also 
to replicate our research findings.  
 
5.3.6 Characteristics of anabolic-androgenic steroid users 
Since AAS use is a growing public health problem, many studies investigated the 
association between AAS use and various psychological correlates to find out the risk 
factors of AAS use. Therefore, we also aimed to examine the general and psychological 
characteristics of AAS users that may predispose weightlifters to AAS use. In the 
present study current and past AAS users were distinguished, since the psychological 
correlates may be different in these two groups.  
 
Results indicated that current steroid users had higher BMI than past steroid users and 
non-users. Because of the anabolic effect of AAS, the higher level of BMI in the current 
steroid users is not surprising, as the use of AAS improve fat-free mass, muscle size, 
and strength (Bhasin, et al., 1996; Kouri et al., 1995). Additionally, in the previous 
study of Hungarian male weightlifters, the body weight, BMI, and desired body weight 
of steroid users were significantly higher compared to steroid non-users (Túry et al., 
2001). 
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Our study results confirm previous research findings, as current steroid use was strongly 
associated with the symptoms of MD. Although at a lesser extent, this association was 
present in past steroid users as well. Therefore, our study results are in line with 
previous study results suggesting that AAS users display marked symptoms of MD 
(Cole et al., 2003; Kanayama et al., 2003; Kanayama et al., 2006; Pope et al., 1997; 
Rohman, 2009). The association between AAS use and MD had been discussed earlier.  
 
Results also indicated higher levels of exercise dependence in lifetime steroid users 
comparing to the non-users. Since muscle hypertrophy usually occurs through physical 
activity, it is expected that AAS use is related to excessive exercise. Furthermore, the 
prevalence rate of exercise dependence was significantly higher in lifetime steroid users 
(14.3%, n = 12) compared to steroid non-users (7.3%, n = 16). However, it should be 
also noted that excessive exercise may impede muscle growth since the muscles need 
proper rest and recovery after a hard workout in order to hypertrophy. Excessive amount 
of exercise and short recovery periods may interfere with muscle gain (Eichner, 1995). 
 
Results also revealed that current steroid users had the lowest level of self-efficacy 
comparing to past steroid users and non-users. Self-efficacy reflects to the belief that 
one’s action are responsible for successful outcomes; in other words, it refers to the 
beliefs that a person can achieve something on their own, based on his own power 
(Bandura, 1994). People with low self-efficacy believe that they need help from outside 
to achieve their goals. Based on this, those weightlifters who would like to build 
muscles and increase their strength with low self-efficacy may start using AAS. Usually 
these people believe that they can not achieve their body ideals without AAS and other 
muscle-enhancing supplements. Therefore, intervention and prevention programs 
should also focus on and include self-efficacy as it may play an important role in the 
development of AAS use. 
 
Finally, current steroid users displayed the highest level of interpersonal distrust relative 
to the past steroid users and non-users. This result is in line with previous study results, 
suggesting an increased level of interpersonal distrust among AAS users (Cole et al., 
2003; Goldfield & Woodside, 2009; Kanayama et al., 2006). Steroids may induce 
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changes in the personality and behaviour, which can have an adverse effect on the 
interpersonal relationships as well. On the other hand, the phenomenology of MD and 
exercise dependence, which are strongly associated with AAS use, may also have an 
effect on personality and interpersonal relationships. 
 
We were unable to confirm previous study results, emphasizing the relationship 
between low self-esteem and AAS use (Brower et al., 1994; Cafri et al., 2005; Blouin & 
Goldfield, 1995). This negative result suggests that AAS use may not be strictly related 
to low self-esteem (as it was also argued by Kanayama et al., 2006), but rather to the 
feelings of ineffectiveness and the desire toward weight gain.  
 
5.3.7 Risk factors of anabolic-androgenic steroid use 
Since AAS use has many adverse health effects and presumably has different risk 
factors like that of MD, we sought to identify risk factors associated with AAS use. Not 
surprisingly, results showed that the positive attitude and the willingness to try AAS and 
other substances to increase muscle mass were significant predictors of lifetime AAS 
use. Those people who have positive attitudes toward their own and others' use of 
steroids and other supplements or even consider taking AAS and neglecting the 
harmfulness of these substances have a higher risk of lifetime AAS use. Thus, 
prevention programs should also focus on the change of attitudes and perceptions about 
AAS and other, potentially risky substances besides the educational part about the 
adverse effects of AAS use. Many steroid prevention programs had been developed for 
adolescents. For instance, "The Adolescents Training and Learning to Avoid Steroids” 
(ATLAS) program has a team-oriented educational approach that motivates and 
empowers student athletes to make the right choices about steroid use (Goldberg et al., 
2000). The program was designed to change the attitudes toward AAS use and also to 
teach refusal skills, which can result in the reduction of intentions to use AAS and other 
performance-enhancing substances. Evaluation results of the randomized control trials 
were promising. 
 
According to the results, higher BMI also predicted lifetime AAS use. However, the 
relationship between BMI and AAS use is still not clear, some studies found association 
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between lower BMI and AAS use (e.g., Neumark-Sztainer et al., 1999). The proposed 
model for putative risk factors for body change strategies in males also involved BMI as 
a potential risk factor that may lead to body change strategies, including AAS use (Cafri 
et al., 2005). These studies argue that low BMI indicates small body size, thus a desire 
to gain muscle mass and high BMI suggests high level of body fat and a desire to lose 
weight. On the contrary, our results suggest that higher BMI can be a potential risk 
factor for AAS use. Of note, we also have to consider that AAS use greatly improve 
muscle mass that also increases BMI.  Again, the use of an alternative index for the 
measure of body composition, such as FFMI, would be more appropriate for future 
study purposes. 
  
Finally, lower level of education (at most high school graduate) proved to be a 
significant predictor of lifetime AAS use. Study results are mixed in terms of AAS use 
and educational level, as some found that typical AAS users were highly educated, 
while others found low educational level among AAS users (Amsterdam et al., 2010). 
Our results suggest that those males who are less educated have a higher risk of lifetime 
AAS use. Males with lower level of education may not be aware of the adverse health 
effects of AAS and may have deficient social and refusal skills; thus, they may be more 
vulnerable to misinformation and social influences relating to AAS use. Moreover, the 
lack of real and authentic information about the adverse health effects of AAS may 
contribute to the development of positive attitudes toward AAS use. Therefore, effective 
prevention strategies emphasize not only the potential consequences of AAS use, but 
also target the attitude change toward AAS use. Those students who finish their 
education at a high school level may be one target population for intervention and 
prevention programs. Further research will be needed regarding the risk factors of AAS 
use, such as attitudes, level of BMI, and educational level. 
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5.3.8 Limitations and future research 
Several limitations of the present study should be mentioned. The first limitation was 
the convenience sample, since the majority of the participants were recruited from 
various places. Since convenience sampling might have influenced which individuals 
participated in the study, we do not have any data from those ones who refused the 
participation in the study. Thus, the differences between those male weightlifters who 
participated in the study and those who refused it still remain unknown. Second, the 
current study relied on self-reported data. This may be more relevant for the measure of 
height and weight. Third, there are some concerns relating to the validity of an internet 
survey, suggesting that directly addressed questionnaires have higher validity. On the 
other hand, responses given via internet are more anonymous and allow more honest 
answers to the questions which are sensitive or embarrassing, such as body image 
concerns among males. The use of directly addressed questionnaires may be 
disadvantageous, since participants may choose the socially desirable responses instead 
of honest responding. Fourth, we conducted our study in a population of male 
weightlifters, which can be considered as a high risk population of MD; however, it is 
possible that females and non-weightlifters may also develop the disorder. Thus, the 
generalization of the study results is limited to male weightlifters. Further studies should 
investigate MD symptomatology in other populations, such as females, other sports 
men, or the general population. Another limitation of the study is the lack of clinically 
diagnosed sample. Thus, the MASS can not be used as a diagnostic tool, although it 
proved to be a valid and reliable measure for the assessment of MD symptoms among 
male weightlifters and also can be used as a screening tool for those who are at high risk 
of MD. The use of interview technique for the identification of a clinically diagnosed 
sample with MD may contribute to the better understanding of this body image 
disorder; furthermore it could also facilitate the refinement of the MASS cut-off score. 
Another limitation of the study is the low sample size in some analyses, which reduced 
the statistical power. Larger sample size would be needed for the detection of weak 
associations. Finally, the low internal consistency of the SCOFF questionnaire raises 
methodological concerns. Other Hungarian studies also found low internal consistencies 
for the scale (Paksi et al., 2009; Szabó, Túry, & Czeglédi, 2011). The low internal 
consistency of the SCOFF may be related to that it assesses both AN and BN. However, 
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the symptoms of these classical eating disorders are inconsistent. Moreover, as most of 
the eating disorder questionnaires, the SCOFF also has been developed on female 
samples. Further studies should consider the use of other scales for the assessment of 
eating disorders in this population of male weightlifters.  
 
Some limitations have to be mentioned relating to the study of AAS use. First, we have 
to be aware of that data may include some false-positive responses (i.e., some 
individuals may have responded that they used AAS, however they used only 
supplements or prohormones) and may also include some false-negative responses (i.e., 
some individuals did not want to disclose their AAS use). Second, as self-report 
measures were used in the study, there was no objective measure of AAS use, such as 
urine test. The lack of information relating to the onset of AAS use, the different types 
of the AAS that have been used in the same time, and the use of other illicit drugs is 
again another limitation. Finally, the cross-sectional nature of the study may indicate 
another limitation since the direction of causal relationships is uncertain. 
 
Future research should replicate our study results relating to the prevalence rate of both 
MD and AAS use. The exploration of MD symptomatology and AAS use should be 
extended in other populations. Further investigation of usage patterns of AAS, the risk 
factors and psychological correlates that are associated with the development of MD 
and AAS use is still needed. Additionally, it would be also important to reveal the 
protective factors as well. Longitudinal study design would be also useful to follow the 
development and course of MD, and to investigate the causal relationships. The better 
understanding of this body image disorder would contribute to the development of 
effective prevention and intervention programs. Examination of the usefulness of the 
proposed tentative cut-off score of the MASS and further refinement of the cut point 
would be also needed. 
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6. CONCLUSIONS 
 
Similar to the worldwide trend of body image research, most studies in Hungary have 
focused on women. While research evidence indicates that the prevalence of men who 
are dissatisfied with their bodies is increasing in Western cultures, the rate of body 
dissatisfaction among men in other cultures still remain uncertain. Previous studies 
described MD as a culture-bound syndrome that is strongly related to the Western body 
ideals. Our study pointed out the existence of MD symptomatology and subclinical 
levels of this male body image disorder among Hungarian male weightlifters. Moreover, 
we found a prevalence rate of 18% among male weightlifters who were at high risk for 
MD. A further 52% was at low risk for MD, who displayed some symptoms of the 
disorder. However, it would be important to replicate and extend the current study to 
confirm our results.  
 
Prior and after to the publication of Túry et al. (2001), no studies have examined MD in 
a Hungarian male weightlifter sample. Thus, the importance of this study is that it 
focuses solely on a weightlifting sample, which is considered to have a greater risk for 
developing MD symptomatology due to the nature of the activity. Since many studies 
emphasized the importance of cross-cultural examination of MD, the present study is of 
a great value, since this is the first extensive study of MD in Hungarian male 
weightlifter population. The study was also able to point out the dramatic changes in 
trends in male body image concerns and body size ideals in a ten-year perspective. 
Because of the rapid changes and the comorbid conditions that are associated with the 
increasing body image dissatisfaction among men (e.g., MD, AAS use, exercise 
dependence, eating disorders) mental health care professionals should be prepared for 
challenges. The effective intervention strategies of MD should focus not only on the 
body image disorder itself, but the associated psychological characteristics as well, for 
instance, low self-esteem, high trait anxiety, and perfectionism. 
 
Though the current study supported some aspects of previous research, there is still a lack 
of understanding in regards to MD in Central-Eastern Europe. However, our study results 
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outline that the current prevalence rate of MD is higher compared to the earlier national 
and international data reported from 1993-2000 (Pope et al., 1993 ; Pope & Katz, 1994; 
Túry et al., 2001). Furthermore, the prevalence rate of MD in the present study is 
similar to subsequent international prevalence data based on the research and diagnostic 
criteria of MD (Hildenbrandt et al., 2006). Hopefully, the validation of the MASS in 
Hungary (MASS-HU), which is the first measure of MD symptoms in Hungarian, will 
stimulate further MD research and will contribute to the cross-cultural studies on MD. 
The AAS use in this high risk population is also understudied in Hungary, since only 
one former study explored the prevalence rate of AAS use among male weightlifters 
(Túry et al., 2001). More importantly, according to our knowledge the present study is 
the first Hungarian study that investigated the psychological correlates and risk factors 
of AAS users.  
 
Besides our results, we would also like to emphasize that weightlifting as a sport is a 
healthy physical activity per se and the pathologization of this kind of sport would be 
unwarranted. However, some forms of weightlifting activity can be unhealthy. Our 
study results also highlighted the benefits of weightlifting, since normal weightlifters 
(without the symptoms of MD) did not display eating disorder related characteristics, 
had higher level of self-esteem, lower level of anxiety, and less unrealistic body weight 
goals  than those males who were at low or high risk of MD.  
 
The current study represents only initial steps; further research in this field would 
improve the understanding of the risk factors of MD and AAS use, and would therefore 
allow the development of intervention and prevention strategies. 
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7. SUMMARY 
Muscle dysmorphia (MD) is a male body image disorder, characterized by a 
pathological preoccupation with the overall muscularity and an intense drive to gain 
muscle mass. The study examined MD, related psychological correlates, and AAS use 
in Hungarian male weightlifters. As a first step we aimed to investigate the potential 
usability of the Muscle Appearance Satisfaction Scale (MASS), a measure of MD 
symptoms, among Hungarian male weightlifters (n = 60) and university students (n = 
60), since no validated instrument for measuring MD symptomatology was available in 
Hungary. The results suggested that the Hungarian version of the MASS (MASS-HU) is 
a suitable measure in Hungarian-speaking population; however, further examination 
was required for the psychometric evaluation of the instrument. Therefore, as a second 
step we focused on the examination of the psychometric properties of the MASS-HU 
and also aimed to investigate its relationship with self-esteem and exercise-related 
variables. Two independent samples of male weightlifters (ns = 289 and 43), and a 
sample of undergraduates (n = 240) were recruited for this purpose. Exploratory factor 
analysis supported the original five-factor structure of the MASS only in the 
weightlifter sample. The MASS-HU had excellent scale score reliability and good test-
retest reliability. The construct validity of the MASS-HU suggested an inverse 
relationship between self-esteem and MD. The MASS-HU was found to be a useful 
measure for the assessment of MD among male weightlifters. As a third step we aimed 
to reveal the prevalence rate of MD among male weightlifters (n = 304), as well as to 
explore the psychological correlates of the disorder. Furthermore, we also targeted to 
define a tentative cut point of the MASS. The last purpose was to determine the 
prevalence rate of AAS use among male weightlifters and to examine the characteristics 
and risk factors associated with AAS use. The results of this study revealed 18.0% 
prevalence rate of MD among Hungarian male weightlifters. A tentative cut-off score of 
the MASS was also determined. A score of 62 as an appropriate cut-off point for the 
MASS was proposed to distinguish between MD and non-MD cases among male 
weightlifters. Results also indicated that MD was associated with younger age, higher 
BMI, elevated levels of eating disorder related psychopathological characteristics and 
trait anxiety, and with lower level of self-esteem. Moreover, higher prevalence rate of 
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both current and lifetime AAS use was found in MD group. The examination of the 
AAS use revealed that the lifetime prevalence of AAS use in our study sample of 
Hungarian male weightlifters was 27.6%. Current AAS use was associated with higher 
BMI, elevated levels of MD symptoms, exercise dependence, higher level of 
interpersonal distrust, and lower level of self-efficacy. The prevalence rate of exercise 
dependence was higher in lifetime steroid users compared to steroid non-users. The 
positive attitude and the willingness to try AAS and other substances to increase muscle 
mass, higher BMI, and low educational level emerged as significant predictors of 
lifetime AAS use. Our findings demonstrated that MD symptomatology and its 
subclinical forms may be prevalent among Hungarian male weightlifters. The study was 
also able to explore the psychological correlates of MD and AAS use that contribute to 
the better understanding of these problems and eventually to the development of 
effective prevention and intervention programs. 
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8. ÖSSZEFOGLALÁS 
Az izomdiszmorfia vizsgálata fokozott kockázatú hazai populációkon 
Az izomdiszmorfia (ID) speciális férfi testképzavar, melyet az izomzattal való túlzott 
foglalatosság és az izomtömeg növelésének intenzív vágya jellemez. A tanulmány az 
ID-t, annak pszichológiai korrelátumait és az anabolikus-androgén szteroid használatot 
vizsgálta. Mivel Magyarországon jelenleg nem áll rendelkezésre olyan mérőeszköz, 
mely az ID tüneteit és súlyosságát mérné fel, ezért első lépésként az Izomzattal Való 
Elégedettség Skála (Muscle Appearance Satisfaction Scale; MASS) magyar nyelvű 
változatának használhatóságát vizsgáltuk súlyzós edzést végző férfiak (n=60) és 
egyetemisták (n=60) körében. Az eredmények alapján a MASS magyar nyelvű változata 
(MASS-HU) alkalmas mérőeszköznek bizonyult magyar nyelvű populáció körében, a 
kérdőív azonban további pszichometriai vizsgálatokat igényelt. Ennek alapján második 
lépésként a MASS-HU pszichometriai vizsgálatát, illetve a mérőeszköz önértékeléssel 
és testedzéshez kötődő változókkal való kapcsolatának vizsgálatát tűztük ki célul. A 
vizsgálatban két független, súlyzós testedzést folytató férfi minta (n=289 és 43) és egy 
egyetemistákból álló férfi minta (n=240) vett rész. Az exploratív faktoranalízis 
eredménye alapján a MASS eredeti ötfaktoros szerkezete alátámasztást nyert a súlyzós 
testedzést folytató férfi mintán. A mérőeszköz belső megbízhatósága kiválónak, teszt-
reteszt reliabilitása pedig jónak bizonyult. A MASS-HU konstruktum validitása fordított 
irányú kapcsolatot mutatott az önértékelés és az ID között. Összességében a MASS-HU 
megbízható eszköznek bizonyult az ID tüneteinek felmérésére a súlyzós testedzést 
folytató férfiak körében. Harmadik lépésként célul tűztük ki az ID prevalenciájának és 
pszichológiai korrelátumainak feltárását súlyzós testedzést folytató férfiak között 
(n=304), valamint a MASS kísérleti ponthatárának definiálását. További célként a 
szteroidhasználat prevalenciájának, jellemzőinek és rizikófaktorainak feltárását 
határoztuk meg. A vizsgálat 18,0%-os ID prevalenciát tárt fel a súlyzós testedzést 
folytató férfiak körében. A MASS kísérleti ponthatáraként a 62 pont bizonyult olyan 
elválasztási ponthatárnak, amely alkalmas lehet az ID esetek kiszűrésére a fenti 
populációban. Az ID pozitív irányú kapcsolatot mutatott a BMI-vel, az evészavarral 
kapcsolatos pszichopatológiai jellemzőkkel és a vonásszorongással, illetve negatív 
irányú kapcsolatot az életkorral és az önértékeléssel. Az ID tüneteit mutató csoportban 
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magasabb volt a szteroidhasználat pontprevalenciája és élettartam prevalenciája is. A 
szteroidhasználat élettartam prevalenciája az egész mintában 27,6% volt. A jelenlegi 
szteroidhasználat pozitív irányú kapcsolatot mutatott a BMI-vel, az ID tüneteivel, a 
testedzésfüggőséggel és az interperszonális bizalmatlansággal, illetve negatív irányú 
kapcsolatot az énhatékonysággal. Továbbá a testedzésfüggőség prevalenciája 
szignifikánsan magasabb volt a szteroidhasználók körében, mint a szteroidot nem 
használók között. A szteroidok és más izomtömeg-növelő szerek kipróbálásával 
kapcsolatos pozitív attitűd és hajlandóság, a magasabb BMI és az alacsonyabb iskolai 
végzettség szignifikáns előrejelzője volt a szteroidhasználatnak. A vizsgálat eredményei 
rámutattak arra, hogy az ID és annak szubklinikai formái gyakoriak lehetnek a súlyzós 
testedzést folytató férfiak körében. A tanulmány továbbá feltárta az ID és a 
szteroidhasználat pszichológia korrelátumait. Ezek az eredmények hozzájárulhatnak a 
problémakör mélyebb megértéséhez, és a hatékony prevenciós és intervenciós 
programok kidolgozásához. 
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APPENDIX 
 
A KUTATÁSBAN FELHASZNÁLT KÉRDŐÍVEK 
 
 
Izomzattal Való Elégedettség Skála (Muscle Appearance Satisfaction Scale; 
MASS-HU) 
 
Kérem, válaszoljon a következő állításokra aszerint, hogy azok mennyire vonatkoztak önre 
az elmúlt négy hét során! Nincsenek jó vagy rossz válaszok.  
 
1 = határozottan nem értek vele egyet 
2 = nagyrészt nem értek vele egyet 
3 = közömbös/nem tudom 
4 = nagyrészt egyetértek vele 
5 = határozottan egyetértek vele 
 
1. Amikor a tükörben az izmaimat nézem, gyakran elégedettséget érzek izmaim 
jelenlegi méretével kapcsolatban. 
2. Ha a napirendem arra kényszerít, hogy egy nap kihagyjam a súlyemelést, nagyon 
nyugtalannak érzem magam. 
3. Gyakran kérdezgetem a barátaimat és/vagy rokonaimat, hogy nagynak nézek-e ki. 
4. Elégedett vagyok az izmaim méretével. 
5. Gyakran költök izomnövelő kiegészítőkre. 
6. Az izomtömeg növelése céljából helyesnek tartom a szteroidhasználatot. 
7. Gyakran úgy érzem, mintha a súlyzózás rabja lennék.  
8. Ha az edzésem rosszul sikerül, az  valószínűleg negatív hatást gyakorol a napom 
hátralevő részére.  
9. Bármit kipróbálnék, hogy növeljem az izmaimat. 
10. Gyakran megtartom az edzést még akkor is, ha az izmaim vagy az ízületeim fájnak a 
korábbi edzésektől. 
11. Gyakran sok időt töltök azzal, hogy az izmaimat nézegetem a tükörben. 
12. Több időt töltök edzéssel a teremben, mint a legtöbben, akik edzenek. 
13. Annak érdekében, hogy izmos legyen valaki, képesnek kell lennie rá, hogy sok 
fájdalmat figyelmen kívül hagyjon.  
14. Elégedett vagyok az izmaim feszességével/formájával. 
15. Az önértékelésem leginkább arra összpontosul, hogyan néznek ki az izmaim. 
16. Gyakran nem veszek tudomást sok fizikai fájdalomról, amikor súlyt emelek annak 
érdekében, hogy izmosabb legyek.  
17. Muszáj nagyobb izmokra szert tennem, bármire legyen is szükségem hozzá. 
18. Gyakran keresek másoktól megerősítést, hogy az izmaim elég nagyok. 
19. Gyakran nehezemre esik ellenállni annak, hogy az izmaim nagyságát 
ellenőrizgessem. 
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Evészavar Kérdőív (Eating Disorder Inventory, EDI) 
 
Ez a kérdőív különböző véleményeket, érzéseket és viselkedéseket mér. A tételek 
némelyike ételekkel és evéssel kapcsolatos. Más tételek az Ön saját magával 
kapcsolatos érzéseire vonatkoznak. Nincs jó vagy rossz válasz, próbáljon meg tehát 
őszintén válaszolni.  
1 = mindig 
2 = rendszerint 
3 = gyakran 
4 = néha 
5 = ritkán 
6 = soha 
 
1. Édességeket és szénhidráttartalmú ételeket anélkül eszem, hogy idegességet éreznék. 
2. Azt hiszem, a gyomrom túl nagy. 
3. Jó lenne, ha vissza tudnék térni a gyermekkor biztonságához. 
4. Eszem, ha nyugtalan vagyok. 
5. Teletömöm magam étellel. 
6. Szeretnék fiatalabb lenni. 
7. Diétázásra gondolok. 
8. Megrémülök, ha érzelmeim túl erősek. 
9. Úgy gondolom, combjaim túl vastagok.  
10. Hasznavehetetlen embernek érzem magam. 
11. Rendkívül bűnösnek érzem magma túlevés után. 
12. Azt hiszem, a gyomrom éppen jó méretű. 
13. Csak a kiemelkedő teljesítmény elég jó, megfelelő a családomban. 
14. A legboldogabb időszak az életben a gyermekkor. 
15. Ki tudom fejezni érzelmeimet. 
17. Megbízom másokban. 
18. Egyedül érzem magam a világban. 
19. Elégedett vagyok az alakommal. 
20. Általában úgy érzem, hogy a dolgokat ellenőrzés alatt tartom életemben. 
21. Zavarba ejt, hogy nem tudom, milyen érzelmet érzek. 
22. Inkább felnőtt lennék, mint gyermek. 
23. Könnyen kapcsolatba tudok kerülni másokkal. 
24. Szeretném, ha valaki más lennék. 
25. Eltúlzom vagy felnagyítom a testsúly fontosságát. 
26. Világosan meg tudom határozni, milyen  érzelmet érzek. 
27. Elégedetlen vagyok magammal.  
28. Voltak falási rohamaim, amikor úgy éreztem, hogy nem tudom abbahagyni az evést.  
29. Gyermekként nagyon erősen próbáltam szüleimnek vagy tanáraimnak. 
30. Vannak szoros kapcsolataim. 
31. Tetszik a fenekem formája. 
32. Nagyon foglalkoztat a vágy, hogy soványabb legyek. 
33. Nem tudom, mi zajlik bennem. 
34. Nehezemre esik, hogy kimutassam érzelmeimet másoknak. 
35. A felnőttkor elvárásai túl nagyok. 
36. Gyűlölöm, ha különböző dolgokban nem a legjobb vagyok.  
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37. Biztonságot érzek saját magammal kapcsolatban. 
38. Falásrohamokra (túlevésekre) gondolok. 
39. Boldog vagyok, hogy már nem vagyok gyermek. 
40. Nem tudom pontosan, hogy éhes vagyok-e vagy sem. 
41. Rossz véleményem van magamról. 
42. Úgy érzem, meg tudok felelni a velem. 
43. Szüleim kiemelkedőt vártak tőlem. 
44. Aggódom, hogy érzéseim fölött elveszítem az uralmat. 
45. Úgy gondolom, hogy a csípőm túl széles. 
46. Mások előtt mérsékelten eszem, de teletömöm magam, ha elmennek. 
47. Normális étkezés után is felfúvódottnak érzem magam. 
48. Úgy érzem, az emberek gyerekkorukban a legboldogabbak. 
49. Ha hízom egy kg-ot, aggódom, hogy folytatódik a hízás. 
50. Úgy érzem, értékes személy vagyok.  
51. Ha zaklatott vagyok, nem tudom, hogy szomorú, rémült vagy dühös vagyok-e. 
52. Úgy érzem, hogy tökéletesen kell csinálnom a dolgokat vagy sehogysem. 
53. Azt gondolom, meg kell próbálnom hányni, hogy fogyni tudjak. 
54. Az embereket bizonyos távolságra kell tartanom (kényelmetlen számomra, ha valaki 
túl közel próbál kerülni hozzám). 
55. Azt hiszem, combjaim éppen megfelelő méretűek. 
56. Belül (érzelmileg) üresnek érzem magam.  
57. Tudok személyes gondolatokról, érzésekről beszélni. 
58. Az élet legszebb évei azok, amikor az ember felnőtté válik.  
59. Úgy gondolom, a fenekem túl nagy. 
60. Vannak érzelmeim, melyeket nem tudok pontosan meghatározni. 
61. Titokban eszem vagy iszom. 
62. Azt hiszem, csípőm éppen jó méretű. 
63. Igen magas céljaim vannak. 
64. Ha zaklatott vagyok, aggódom, hogy enni kezdek. 
 
 
 
SCOFF kérdőív 
 
Az alábbi kérdések az étellel való viszonnyal illetve a testtel kapcsolatosak. Kérjük jelöle 
X-szel a megfelelő választ! 
    igen    nem
Szokott hányni, mert kellemetlenül telinek érzi magát?   
Aggódik amiatt, mert elvesztette a kontrollt afölött, hogy mennyit eszik?   
Az utóbbi időben fogyott-e több mint hat kg-ot háromhónapos időszak 
alatt? 
  
Kövérnek hiszi magát, míg mások azt mondják, hogy túl sovány?   
Mondaná azt magáról, hogy az étel uralja az életét?   
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Testi Attitűdök Tesztje (Body Attitudes Test) 
 
 
A következő állítások a testtel és a testtel kapcsolatos érzésekre vonatkoznak. Kérjük, az 
alábbi állítások mindegyikénél jelölje, hogy az milyen mértékben igaz Önre! 
 
1 = mindig 
2 = rendszerint 
3 = gyakran 
4 = néha 
5 = ritkán 
6 = soha 
 
1. Ha összehasonlítom a saját testemet a kortársaiméval, elégedetlen vagyok vele.  
2. A testem érzéketlen tárgynak tűnik.  
3. A csípőm túl szélesnek tűnik számomra.  
4. Jól érzem magam a bőrömben. 
5. Nagyon vágyom arra, hogy vékonyabb legyek 
6. Azt gondolom, hogy a melleim túl nagyok. 
7. Hajlamos vagyok elrejteni a testemet (pl. bő ruhákat hordok). 
8. Ha megnézem magam a tükörben, elégedetlen vagyok a testemmel. 
9. Könnyű számomra ellazítani a testemet. 
10. Azt gondolom, túl kövér vagyok. 
11. Tehernek érzem a testemet.  
12. Úgy tűnik nekem, mintha a testem nem is az enyém volna. 
13. Úgy érzem, mintha egyes testrészeim dagadtak lennének.  
14. A testem szorongást jelent számomra. 
15. A testi megjelenésem nagyon fontos számomra.  
16. Olyan nagy a hasam, mintha terhes lennék. 
17. Feszültséget érzek a testemben. 
18. Irigylem mások testi megjelenését. 
19. Olyan dolgok történnek a testemben, melyek megijesztenek. 
20. Figyelem, hogy milyennek látszom a tükörben. 
 
 
Testedzés Addikció Kérdőív (Exercise Addiction Inventory) 
A következő kérdések a sportolásról, testmozgásról, edzésről szólnak. Kérjük, az alábbi 
állítások mindegyikénél jelölje, hogy az milyen mértékben igaz Önre! 
 
1 = Nagyon nem értek egyet 
2 = Inkább nem értek egyet 
3 = Egyet is értek, meg nem is 
4 = Inkább egyetértek 
5 = Nagyon egyetértek 
 
1. A testedzés a legfontosabb dolog az életemben. 
2. Konfliktusok adódnak köztem és a családom és/vagy partnerem között amiatt, hogy 
mennyit edzek. 
DOI: 10.14753/SE.2013.1829
 175
3. A testedzést arra használom, hogy a hangulatomon változtassak (pl. hogy 
kellemesebben érezzem magam, vagy hogy ne kelljen a problémáimmal 
foglalkoznom). 
4. Az elmúlt időszak során növeltem a napi edzésmennyiségemet. 
5. Ha ki kell hagynom egy edzést, rosszkedvű és ideges leszek. 
6. Ha csökkentem a szokásos edzésmennyiségemet, akkor, amikor újra elkezdem az 
edzést, addig folytatom, amíg az eredeti mennyiséget el nem érem. 
 
 
Állapot és Vonásszorongás Kérdőív – Vonásszorongás alskála (Strait-Trait 
Anxiety Inventory) 
Néhány olyan megállapítást olvashat az alábbiakban, amelyekkel az emberek önmagukat 
szokták jellemezni. Karikázza be a számok közül a megfelelőt attól függően, hogy 
ÁLTALÁBAN HOGYAN ÉRZI MAGÁT. Nincsenek helyes válaszok. Ne gondolkozzon 
túl sokat, hanem azt a választ jelölje meg, amely általában jellemző Önre. 
 
1 = egyáltalán nem 
2 = valamennyire 
3 = eléggé 
4 = nagyon 
 
Általában… 
 
1. Jól érzem magam. 
2. Gyorsan elfáradok. 
3. A sírás ellen küszködnöm kell. 
4. A szerencse engem elkerül. 
5. Sokszor hátrányos helyzetbe kerülök, mert nem tudom elég gyorsan  elhatározni 
magam. 
6. Kipihentnek érzem magam. 
7. Nyugodt, megfontolt, tettrekész vagyok. 
8. Úgy érzem, annyi megoldatlan problémám van,hogy nem tudok úrrá lenni rajtuk. 
9. A semmiségeket is túlzottan a szívemre veszem. 
10. Boldog vagyok. 
11. Hajlamos vagyok túlságosan komolyan venni a dolgokat. 
12. Kevés az önbizalmam. 
13. Biztonságban érzem magam. 
14. A kritikus helyzeteket szívesen elkerülöm. 
15. Csüggedtnek érzem magam 
16. Elégedett vagyok.  
17. Lényegtelen dolgokat is sokáig foglalkoztatnak, és nem hagynak nyugodni.  
18. A csalódások annyira megviselnek, hogy nem tudom kiverni őket a fejemből. 
19. Kiegyensúlyozott vagyok.  
20. Feszült lelkiállapotba jutok és izgatott leszek, ha az utóbbi időnek gondjai-bajaira 
gondolok. 
 
 
DOI: 10.14753/SE.2013.1829
 176
Rosenberg Önértékelés Skála (Rosenberg Self-Esteem Scale) 
 
Az alábbiakban néhány állítást sorolunk fel azzal kapcsolatban, amit általában Önmagával 
kapcsolatban érezhet. Soronként egy választ jelöljön meg attól függően, hogy mennyire ért 
egyet az adott állítással. 
 
1 = egyáltalán nem értek egyet 
2 = nem értek egyet 
3 = egyetértek 
4 = teljesen egyetértek 
 
1. Úgy érzem, értékes ember vagyok, legalábbis másokhoz képest. 
2. Úgy érzem, sok jó tulajdonságom van. 
3. Mindent egybevetve, hajlamos vagyok arra, hogy egy csődtömegnek tartsam 
magam. 
4. Képes vagyok olyan jól csinálni a dolgokat, mint mások. 
5. Úgy érzem, nem sok mindenre lehetek büszke. 
6. Jó véleménnyel vagyok magamról. 
7. Összességében elégedett vagyok magammal. 
8. Bárcsak jobban tudnám magam tisztelni. 
9. Időnként értéktelennek érzem magam. 
10. Néha azt gondolom, hogy semmiben sem vagyok jó. 
 
 
Általános Énhatékonyság Skála (General Self-Efficacy Scale) 
 
Mennyire jellemzőek Önre az alábbi dolgok? Kérjük, soronként egy választ jelöljön meg, 
attól függően, hogy mennyire ért egyet az adott állítással! 
 
1 = egyáltalán nem jellemző 
2 = alig jellemző 
3 = jellemző 
4 = teljesen jellemző 
 
1. Mindig sikerül megoldanom a nehéz problémákat, ha nagyon akarom. 
2. Ha valaki szembeszegül velem, megtalálom a módját, hogy elérjem, amit 
szeretnék. 
3. Nem esik nehezemre, hogy kitartsak szándékaim mellett és elérjem a céljaimat. 
4. Ötletességemnek köszönhetően tudom, miként kezeljem a váratlan helyzeteket. 
5. Biztos vagyok benne, hogy jól tudok boldogulni a váratlan helyzetekben. 
6. Megfelelő erőfeszítéssel majdnem minden problémára találok megoldást. 
7. Meg tudom őrizni a nyugalmamat a nehézségekkel szemben, mert támaszkodni 
tudok megoldóképességemre. 
8. Ha szembesülök egy problémával, általában több ötletem támad a megoldásra. 
9. Ha sarokba szorítanak, rendszerint kitalálom, mitévő legyek. 
10. Bármi történik, általában kezelni tudom a helyzeteket. 
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